National Academies Press: OpenBook
« Previous: APPENDIX D Committee and Staff Biographies
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Bibliography

Aaby P, Clements CJ. Measles immunization research: a review. Bulletin of the World Health Organization 1989;67:443-448.

Abe T. Nonaka C, Hiraiwa M, Ushijima H, Fujii R. Acute and delayed neurologic reaction to inoculation with attenuated live measles virus. Brain and Development 1985;7:421-423.

Abrahamson HA. Vaccines, poliomyelitis, and the Guillain-Barre syndrome (editorial). Journal of Asthma Research 1976;14:1-4.

Abu Eldan J, Borcic B, Smerdel S. Persistence of immunity against measles in persons immunized with Edmonston-Zagreb vaccine. Acta Medica Croatica 1991;45:297-304.

Adam E, Burian V, Kubatova E, Kratochvilova M, Burianova B, Kyselova M et. al. Comparative study of the reactogenicity and efficacy of different combined vaccines against diphtheria, pertussis and tetanus. Progress in Immunobiological Standardization 1969:3:290-291.

Adam E, Burian V, Kubatova E, Kratochvilova M, Burianova B, Kyselova M et. al. Comparative study of the reactogenicity and effectiveness of different combined vaccines against diphtheria, pertussis and tetanus. Journal of Hygiene, Epidemiology, Microbiology, and Immunology 1970;14:88-101.

Adam E, Domorazkova E, Kratochvilova M, Burian V, Janotova J, Drevo M et. al. [The experience with vaccination against measles in Czech districts] Zkusenosti s ockovanim proti spalnickam v ceskych krajich. Ceskoslovenska Pediatrie 1970;25:438-440.

Adam E, Fosenbauerova E, Domorazkova E, Kratochvilova M, Kubatova E, Mares I et. al. [Comparative studies of measles vaccines prepared from further attenuated strains Schwarz and SEVAC] Srovnavaci studie spalnickovych vakcin pripravenych z dale atenuovanych kmenangu Schwarz a SEVAC. Ceskoslovenska Pediatrie 1968;23:581-593.

Adams JM. Persistent or slow vital infections and related diseases. Western Journal of Medicine 1975;122:380-393.

Adams JM. Program Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. Abstract 974, p. 273. Washington, DC: American Society for Microbiology;1992.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Adams JM, Brown WJ, Cremer NE, Eberle ED, Fewster ME, Lennette EH. Atypical demyelinating disease. Journal of Neurology, Neurosurgery and Psychiatry 1974;37:874-878.

Adams JM, Brown WJ, Eberle ED, Verity A. Vaccinia virus implicated in diffuse demyelinating disease. Proceedings of the Society for Experimental Biology and Medicine 1973; 143:799-803.

Adams JM, Francke E, Lillestol M. Poliomyelitis vaccination (letter). New England Journal of Medicine 1977;297:1290-1291.

Adams WG, Deaver KA, Cochi SL et al. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. Journal of the American Medical Association 1993;269:221-226.

Adenyi-Jones SC, Faden H, Ferdon MB, Kwong MS, Ogra PL. Systemic and local immune responses to enhanced-potency inactivated poliovirus vaccine in premature and term infants. Journal of Pediatrics 1992;120:686-689.

Adler JB, Mazzotta SA, Barkin JS. Pancreatitis caused by measles, mumps, and rubella vaccine. Pancreas 1991;6:489-490.

Adler SP. The effects and side effects of vaccines. Virginia Medical Journal 1982;109:410-411.

Advisory Commission on Childhood Vaccines, Martin Smith, Chairman. Vaccine Injury Compensation Program: past, present, and future. June 20, 1991. Unpublished.

Afzal MA, Pickford AR, Forsey T, Minor PD. Heterogeneous mumps vaccine. Lancet 1992;340:980-981.

Agrawal K, Pandit K, Kannan AT. Single dose tetanus toxoid: a review of trials in India with special reference to control of tetanus neonatorum. Indian Journal of Pediatrics 1984;81:285-295.

Aho K, Somer T, Salo OP. Rheumatoid factor and immuno-conglutinin responses following various vaccinations. Proceedings of the Society for Experimental Biology and Medicine 1967;124:229-33.

Ahonkhai VI, Lukacs LJ, Jonas LC, Calandra GB. Clinical experience with PedvaxHIB, a conjugate vaccine of Haemophilus influenzae type b polysaccharide—Neisseria meningitidis outer membrane protein. Vaccine 1991;9(Suppl.):S38-41, S42-43.

Ahonkhai VI, Lukacs LJ, Jonas LC, Matthews H, Vella PP, Ellis RW et. al. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB): clinical evaluation. Pediatrics 1990;85(4 Pt 2):676-681.

Ahronheim G, Allard M, Forsey T, Rydbeck R, Teuwen D, Yamada A. Mumps associated with trivalent vaccine containing Urabe Am 9 mumps strain (abstract). Program Abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy, p. 148. Washington, DC: American Society for Microbiology; 1990.

Ahronheim GA, Allard M, Forsey T, Rydbeck R, Teuwen DE, Yamada A. Mumps associated with trivalent vaccine containing Urabe Am 9 mumps strain (abstract). Pediatric Research 1991;29:166A.

Ajjan N, Bentejac MC. [Anti-mumps vaccination] La vaccination anti-ourlienne. Revue de Pediatric 1985;21:55-61.

Ajjan N, Biron G, Bentejac MC. [The dangers of vaccination] Les dangers de la vaccination. Revue Medicale 1980;21:739-750.

Ajjan N, Fayet MT, Biron G et. al. Combination of attenuated measles vaccine (Schwarz) with meningococcus A and A + C vaccine. Developments in Biological Standardization 1978;41:209-216.

Akama K, Yamamoto A. [Side effects of tetanus toxoid. II. Antigenic materials derived from the constituents of the medium for toxoid preparation]. Nippon Saikingaku Zasshi 1969;24:595-601.

Akosa AB, All MH, Khoo CT, Evans DM. Angiolymphoid hyperplasia with eosinophilia associated with tetanus toxoid vaccination. Histopathology 1990;16:589-593.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Al-Qudah AA, Shahar E, Logan WJ, Murphy EG. Neonatal Guillain-Barre syndrome. Pediatric Neurology 1988;4:255-256.

Albert JM, Ott HJ. Calcifying dermatomyositis following antitetanus vaccination. Archives of Internal Medicine 1983;143:1457-1458.

Albrecht P, Lorenz D, Klutch MJ, Vickers JH, Ennis FA. Fatal measles infection in marmosets: pathogenesis and prophylaxis. Infection and Immunity 1980;27:969-978.

Albrecht RM. Poliomyelitis from a vaccinee. Lancet 1968;1:1371.

Alderslade R, Bellman MH, Rawson NS B., Ross EM, Miller DL. The National Childhood Encephalopathy Study: a report on 1000 cases of serious neurological disorders in infants and young children from the NCES research team. In: Department of Health and Social Security. Whooping Cough: Reports from the Committee on the Safety of Medicines and the Joint Committee on Vaccination and Immunization. London: Her Majesty's Stationery Office; 1981.

Alexander ER. Landmark perspective: Inactivated poliomyelitis vaccination—issues reconsidered. Journal of the American Medical Association 1984;251:2710-2712.

Allen TW. Efficacy of PRP, PRP-D vaccines in children 18 months of age and older. Journal of the American Osteopathic Association 1991;91:323.

Allerdist H. [Epidemiologic problems of measles-mumps vaccination] Epidemische Probleme der Masern-Mumpsimpfung. Offentliche Gesundheitswesen 1979;41 (Suppl. 1):51-56.

Allerdist H. Neurological complications following measles vaccination. Developments in Biological Standardization 1979;43:259-264.

Allerdist H. [Neurological complications following measles virus vaccination: Evaluation of the cases seen between 1971-1977] Uber Zentralnervose Komplikationen nach Masemschutzimpfung: eine Analyse des Hamburger Krankengutes von 1971 bis 1977. Monatsschrift fur Kinderheilkunde 1979;127:23-28.

Alter HJ, Scanlon RT, Schechter GP. Thrombocytopenic purpura following vaccination with attenuated measles virus. American Journal of Diseases of Children 1968;115:111-113.

Alter M. The epidemiology of Guillain-Barre syndrome. Annals of Neurology 1990;27(Suppl.):S7-S12.

Alter MJ, Hadler SC, Margolis HS. The changing epidemiology of hepatitis B in the United States: need for alternative vaccination strategies. Journal of the American Medical Association 1988;263:1218-1222.

Alves RS, Barbosa ER, Scarf M. Postvaccinal parkinsonism. Movement Disorders 1992;7:178-180.

Alvord EC Jr. Incubation period and severity of experimental allergic encephalomyelitis: analogy with swine-flu-vaccine-induced Guillain-Barre syndrome (letter). Annals of Neurology 1986;19:100-101.

Alvord EC Jr., Jahnke U, Fischer EH. The causes of the syndromes of Landry (1859) and of Guillain, Barre and Strohl (1916). Revue Neurologique 1987;143:571-579.

Ambrosino DM, Lee MY, Chen D, Shamberger RC. Response to Haemophilus influenzae type b conjugate vaccine in children undergoing splenectomy. Journal of Pediatric Surgery 1992;27:1045-1048.

Ambrosino DM, Sood SK, Lee MC, Chen D, Collard HR, Bolon DL et al. IgG1, IgG2 and IgM responses to two Haemophilus influenzae type b conjugate vaccines in young infants . Pediatric Infectious Disease Journal 1992;11:855-859.

American Family Physician. Combining DTP vaccine and H. influenzae type b vaccine. American Family Physician 1992;45:909-910.

American Family Physician. New poliovirus vaccine. American Family Physician 1991;43:2270.

American Journal of Diseases of Children. Recommendations of the Immunization Practices Advisory Committee (ACIP): mumps prevention. American Journal of Diseases of Children 1989;143:1141-1142.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

American Academy of Pediatrics, Committee on Infectious Diseases. Haemophilus influenzae type b conjugate vaccine. Pediatrics 1988;81:908-911.

American Academy of Pediatrics, Committee on Infectious Diseases. Haemophilus influenzae type b conjugate vaccines: immunization of children at 15 months of age. Pediatrics 1990;86:794-796.

American Academy of Pediatrics, Committee on Infectious Diseases. Haemophilus influenzae type b conjugate vaccines: recommendations for immunization of infants and children 2 months of age and older: update. Pediatrics 1991;88:169-172.

American Academy of Pediatrics, Committee on Infectious Diseases. Health guidelines for the attendance in daycare and foster care settings for children infected with human immunodeficiency virus. Pediatrics 1987;79:466-471.

American Academy of Pediatrics, Committee on Infectious Diseases. Personal and family history of seizures and measles immunization. Pediatrics 1987;80:741-742.

American Academy of Pediatrics, Committee on Infectious Diseases. Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics; 1964.

American Academy of Pediatrics, Committee on Infectious Diseases. Report of the Committee on Infectious Diseases: 22nd edition. Elk Grove Village, IL: American Academy of Pediatrics; 1991.

American Academy of Neurology, Therapeutics and Technology Assessment Subcommittee. Assessment: DTP vaccination. Neurology 1992;42(3 Pt. 1):471-472.

Aminova MG, Cheredova NG, Novokreshchenova FA, Atakhanov KA, Shakhmuradova VS. [Clinical reactions in children after the administration of the Leningrad-4 live measles vaccine according to data from Kirghizia] Klinicheskie reaktsii u detei na vvedenie zhivoi korevoi vaktsiny iz shtamma Leningrad-4 po dannym Kirgizii. Trudy Leningradskogo Nauchno-issledovatelskogo Instituta Epidemiologii i Mikrobiologii 1965;28:186-191.

Amir J, Liang X, Granoff DM. Variability in the functional activity of vaccine-induced antibody to Haemophilus influenzae type b. Pediatric Research 1990;27(4 Pt 1):358-364.

Amir J, Scott MG, Nahm MH, Granoff DM. Bactericidal and opsonic activity of IgG1 and IgG2 anticapsular antibodies to Haemophilus influenzae type b. Journal of Infectious Diseases 1990;162:163-171.

Ammundsen E. [Complications of polio vaccination with Sabin vaccine] Komplikationer ved poliovaccinationen med Sabin-vaccine. Fra Sundhedsstyrelsen 1968;4:337-338.

Amsel SG, Hanukoglu A, Fried D, Wolyvovics M. Myocarditis after triple immunization. Archives of Disease in Childhood 1986;61:403-405.

Anand JK. Multiple factors in leukaemogenesis. British Medical Journal 1972;4:364.

Andelman MB, Schwarz A, Spiegelblatt H. Field trials with further attenuated live measles vaccine without gamma globulin. American Journal of Public Health / Nations Health 1966;56:1891-1897.

Andersen O, Eeg-Olofsson E. A prospective study of parapareses in western Sweden. Acta Neurologica Scandinavica 1976;54:312-320.

Anderson GR, Gottshall RY, Nelsom E, Angela F. Quadruple vaccines containing pertussis and poliomyelitis vaccines. Health Laboratory Science 1978;15:138-43.

Anderson P. Antibody responses to H. influenzae type b and diphtheria toxin induced by conjugates of oligosaccharides of the type b capsule with the nontoxic protein CRM197. Infection and Immunity 1983;39:233-238.

Anderson P, Johnston RB Jr., Smith DH. Human serum activities against Haemophilus influenzae, type b. Journal of Clinical Investigation 1972 ;51:31-38.

Anderson P, Pichichero M, Edwards K, Porch CR, Insel R. Priming and induction of Haemophilus influenzae type b capsular antibodies in early infancy by Dpo20, an oligosaccharideprotein conjugate vaccine. Journal of Pediatrics 1987;111:644-650.

Andersson T, Siden A. A clinical study of the Guillain-Barre syndrome. Acta Neurologica Scandinavica 1982;66:316-327.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Andre FE. Control of poliomyelitis by vaccination in Belgium. Reviews of Infectious Diseases 1984;6(Suppl. 2):S419-S423.

Andre FE. Poliomyelitis vaccines in Belgium: 20 years of experience. Developments in Biological Standardization 1979;43:187-193.

Andre FE. Summary of safety and efficacy data on a yeast-derived hepatitis B vaccine. American Journal of Medicine 1989;87(3a):14S-20S.

Andre FE, Peetermans J. Effect of simultaneous administration of live measles vaccine on the ''take rate'' of live mumps vaccine. Developments in Biological Standardization 1986;65:101-107.

Andre FE, Safary A. Clinical experience with a yeast derived hepatitis B vaccine. In: Zuckerman AJ, ed. Viral Hepatitis and Viral Disease. New York: Alan R Liss; 1988.

Andreoni G, Curatolo D, Cervini E, Provvidenza G, Rocchi G, Velli V. [Isolation of poliovirus in poliomyelitic patients vaccinated with Sabin vaccine] Isolamento di virus polio in poliomielitici vaccinati con vaccino Sabin. Giornale di Malattie Infettive e Parassitarie 1966;18:662-663.

Andreoni G, Rocchi G. [Etiologic studies in the patients with central nervous system diseases hospitalized in Rome during the period 1964-1970] Indagine eziologica in pazienti con affezioni del sistema nervoso centrale ricoverati a Roma nel periodo 1964-1970. Annali Sclavo 1971;13:291-298.

Andrews NC, Baltimore D. Lack of evidence for VPg priming of poliovirus RNA synthesis in the host factor-dependent in vitro replicase reaction. Journal of Virology 1986;58:212-215.

Annals of Emergency Medicine. Tetanus immunization recommendations for persons seven years of age and older. Annals of Emergency Medicine 1986;15:1111-1112.

Annals of Internal Medicine. Mumps vaccine. Annals of Internal Medicine 1968;68:632-633.

Annals of Internal Medicine. Mumps vaccine: recommendation of the Public Health Service Advisory Committee on Immunization Practices, Centers for Disease Control, U.S. Department of Health, Education, and Welfare, Atlanta, Georgia. Annals of Internal Medicine 1978;88:819-820.

Annals of Internal Medicine. Diphtheria, tetanus, and pertussis: guidelines for vaccine prophylaxis and other preventive measures. Annals of Internal Medicine 1981:95:723-728.

Annals of Internal Medicine. Mumps vaccine: recommendation of the Immunization Practices Advisory Committee. Annals of Internal Medicine 1983:98:192-194.

Annals of Internal Medicine. Diphtheria, tetanus, and pertussis: guidelines for vaccine prophylaxis and other preventive measures: recommendation of the Immunization Practices Advisory Committee. Annals of Internal Medicine 1985; 103:896-905.

Annunziato D, Kaplan MH, Hall WW, Ichinose H, Lin JH, Balsam D et al. Atypical measles syndrome: pathologic and serologic findings. Pediatrics 1982;70:203-209.

Aprile MA, Kadar D, Wilson S. Sensitization of guinea-pigs to measles vaccines. Clinical Experimental Immunology 1969:5:531-539.

Arakawa Y. Amaki S, Miyamoto M, Matsuo Y, Honda T, Shikata T. Safety and efficacy of hepatitis B vaccine in hospital personnel. Japanese Journal of Medicine 1986;25:25-33.

Araujo OE, Flowers FP et al. Stevens-Johnson syndrome. Journal of Emergency Medicine 1984;2:129-135.

Arbeter AM, Arthur JH, Blakeman GJ et. al. Measles immunity: reimmunization of children who previously received live measles vaccine and gamma globulin. Journal of Pediatrics 1972;81:737-741.

Arbeter AM, Baker L, Starr SE, Levine BL, Books E, Plotkin SA. Combination measles, mumps, rubella and varicella vaccine. Pediatrics 1986;78(4 Pt. 2):742-747.

Arlazoroff A, Bleicher Z, Klein C, Vure E, Lahat E. Gross B et. al. Vaccine-associated contact paralytic poliomyelitis with atypical neurological presentation. Acta Neurologica Scandinavica 1987:76:210-214.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Armenian HK. Case investigation in epidemiology. American Journal of Epidemiology 1991;134:1067-1072.

Arnason BG. Neuroimmunology (editorial). New England Journal of Medicine 1987;316:406-408.

Arnason BG, Soliven B. Acute inflammatory demyelinating polyradiculoneuropathy. In: Syck PJ et al., eds. Peripheral Neuropathy, 3rd edition. W.B. Saunders; 1992.

Artbus M. Injections repetees de serum de cheval chez le lapin. Comptes Rendus des Seances de la Societe de Biologie et ses Filiales 1903;55:817-820.

Asbury AK. Diagnostic considerations in Guillain-Barre syndrome. Annals of Neurology 1981;9(Suppl.):1-5.

Asbury AK. Guillain-Barre syndrome: historical aspects. Annals of Neurology 1990;27(Suppl.):S2-S6.

Asbury AK, Arnason BG, Karp HR, McFarlin DE. Criteria for diagnosis of Guillain-Barre syndrome. Annals of Neurology 1978;3:565-566.

Asbury AK, Arnason BG, Adams RD. The inflammatory lesion in idiopathic polyneuritis. Medicine 1969;48:173-215.

Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barre syndrome. Annals of Neurology 1992;27(Suppl.):S21-S24.

Asbury AK, Gibbs CJ Jr, eds. Autoimmune neuropathies: Guillain-Barre syndrome. Annals of Neurology 1990;27(Suppl.):S1-S79.

Ashworth N. Health comment. Health Quarterly Magazine (New Zealand Department of Health) 1988;40:2.

Asindi AA, Bell EJ, Browning MJ, Stephenson JB. Vaccine-induced polioencephalomyelitis in Scotland. Scottish Medical Journal 1988;33:306-307.

Askerov VF, Piriev GG. [Clinico-immunological reactions to a live measles vaccine of strain L-16 in children suffering from exudative diathesis and bronchial asthma]. Pediatriya 1977;56:32-33.

Askerov VF, Sadykhova AN. [Effect of measles infection and measles vaccination on the immunological reactivity in the child] Vliianie korevoi infektsii i protivokorevoi vaktsinatsii na immunologicheskuiu reaktivnost' detskogo organizma. Pediatriia 1968;7:34-39.

Assaad FA, Cockburn WC, Perkins FT. The relation between acute persisting spinal paralysis and poliomyelitis vaccine (oral): results of a WHO enquiry. Bulletin of the World Health Organization 1976;53:319-331.

Assis JL. Neurological complication of antirabies vaccination in Sao Paulo, Brazil: clinical and therapeutical aspects. Journal of Neurological Sciences 1975;26:593-598.

Association for the Study of Infectious Disease. A retrospective survey of the complications of mumps. Journal of the Royal College of General Practitioners 1974;24:552-556.

Astabatsian MA, Bolotovskii VM, Gelikman BG, Mikheeva IV. [Reactogenic properties and immunogenicity of measles and mumps vaccines when used by different procedures] Reaktogennye svoistva i immunogennost korevoi i parotitnoi vaktsin pri razlichnoi taktike ikh primenenii. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii 1986;6:9-15.

Aukrust L, Almeland TL, Refsum D, Aas K. Severe hypersensitivity or intolerance reactions to measles vaccine in six children: clinical and immunological studies. Allergy 1980;35:581-587.

Australian Family Physician. Tetanus immunoprophylaxis. Australian Family Physician 1978;7:431-435.

Avery OT, Goebel WF. Chemo-immunological studies on conjugated carbohydrate-proteins. II. Immunological specificity of synthetic sugar-protein antigens. Journal of Experimental Medicine 1929;50:533-550.

Ayoola EA, Johnson AO. Hepatitis B vaccine in pregnancy: immunogenicity, safety and transfer of antibodies to infants. International Journal of Gynaecology and Obstetrics 1987;25:297-301.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Azeemuddin S. Thrombocytopenia purpura after combined vaccine against measles, mumps, and rubella (letter). Clinical Pediatrics 1987;26:318.

Azimi PH, Cramblett HG, Haynes RE. Mumps meningoencephalitis in children. Journal of the American Medical Association 1969;207:509-512.

Azzopardi P. Mumps meningitis, possibly vaccine-related—Ontario. Canada Diseases Weekly Report 1988;14:209-211.

Babbott FL Jr., Gordon JE. Modem measles. American Journal of Medical Science 1954;228:334-361.

Bach C, Allard M. [Acute thrombocytopenic purpura after measles vaccination. Report of a case]. Purpura thrombopenique aigu apres vaccination antirougeoleuse. A propos d'une observation. Semaine des Hopitaux de Paris 1974;50:589-593.

Bachand AJ, Rubenstein J, Morrison AN. Thrombocytopenic purpura following live measles vaccine. American Journal of Diseases of Children 1967;113:283-285.

Backes CR. Immunization practices and controversies 1981: Part 1. The "big seven" vaccines. Journal of the American Osteopathic Association 1981;80:595-603.

Bader M. Perspectives on the relative resurgence of mumps in the United States. American Journal of Diseases of Children 1988;142:1021-1022.

Bader M. Polio vaccination during pregnancy (letter). Journal of the American Medical Association 1983;249:2018-2019.

Bader M. Risks from polio vaccination (letter). Journal of the American Medical Association 1984;251:728-729.

Baer CL, Bratt DE, Edwards R, McFarlane H, Utermohlen V. Response of mildly to moderately malnourished children to measles vaccination. West Indian Medical Journal 1986;35:106-111.

Baguley DM, Glasgow GL. Subacute sclerosing panencephalitis and Salk vaccine. Lancet 1973;2:763-765.

Bajoghli M, Naficy AR, Vafai A, Shafa G. Paralytic poliomyelitis in Isfahan. Journal of Tropical Pediatrics and Environmental Child Health 1977;23:236-238.

Bak P. Guillain-Barre syndrome in a Danish county. Neurology 1985;35:207-211.

Bakanov MI. [Development of bronchial asthma attacks in children under the effect of prophylactic immunization] Vozniknovenie pristupov bronkhial'noi astmy u detei pod vliianiem profilakticheskoi immunizatsii. Voprosy Okhrany Materinstva i Detstva 1968;13:78-79.

Balduzzi P, Glasgow LA. Paralytic poliomyelitis in a contact of a vaccinated child. New England Journal of Medicine 1967;276:796-797.

Balfour HH Jr., Amren DP. Rubella, measles and mumps antibodies following vaccination of children: a potential rubella problem. American Journal of Diseases of Children 1978; 132:573-577.

Banatvala JE. Insulin-dependent (juvenile-onset, type I) diabetes mellitus: Coxsackie B viruses revisited. Progress in Medical Virology 1987;34:33-54.

Banker DD. Problems in preparation, testing and use of diphtheria, pertussis and tetanus vaccines. Progress in Drug Research 1975;19:229-240.

Banton HJ, Miller PA. An observation of antitoxin titers after booster doses of tetanus toxoid. New England Journal of Medicine 1949;240:13-14.

Bar-Joseph G, Etzioni A, Hemli J, Gershoni-Baruch R et al. Guillain-Barre syndrome in three siblings less than 2 years old. Archives of Disease in Childhood 1991;66:1078-1079.

Baraft LJ, Cherry JD. Nature and rates of adverse reactions associated with pertussis immunization. In: Third International Symposium on Pertussis, National Institutes of Health, 1978. Publication No. (NIH) 79-1830. Bethesda, Md.: Department of Health, Education, and Welfare; 1979:291-296.

Baraft LJ, Cherry JD. Reactogenicity of DTP and DT vaccine. Clinical Research 1979;27:112.

Baraff L J, Cherry JD. Reactogenicity of DTP and DT vaccines. Pediatric Research 1979;13:794.

Baraff LJ, Cherry JD, Cody CL, March SM, Manclark CR. DTP vaccine reactions: effect of

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

prior reactions on rate of subsequent reactions. Developments in Biological Standardization 1985;61:423-428.

Baraff LJ, Manclark CR, Cherry JD, Christenson P, Marcy SM. Analyses of adverse reactions to diphtheria and tetanus toxoids and pertussis vaccine by vaccine lot, endotoxin content, pertussis vaccine potency and percentage of mouse weight gain. Pediatric Infectious Disease Journal 1989;8:502-507.

Barbanti-Brodano G, Oyanagi S, Katz M, Koprowski H. Presence of two different viral agents in brain cells of patients with subacute sclerosing panencephalitis (SSPE). Proceedings of the Society for Experimental Biology and Medicine 1970;134:230-236.

Barbor PR, Grant DB. Encephalitis after measles vaccination. Lancet 1969;2:55-56.

Barbour ML. Haemophilus influenzae type b: carriage and immunity four years after conjugate vaccination. Program Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. Abstract 978, p. 273. Washington, DC: American Society for Microbiology; 1992.

Barkin RM, Pichichero ME. Diphtheria-pertussis-tetanus vaccine: reactogenicity of commercial products. Pediatrics 1979;63:256-260.

Barkin RM, Hendley JO, Zahradnik J et al. Capsular polysaccharide Haemophilus influenzae type b vaccine: clinical and immunologic responses to two vaccines . Pediatric Infectious Disease Journal 1987;6:20-23.

Barkin RM, Pichichero ME, Samuelson JS, Barkin SZ. Pediatric diphtheria and tetanus toxoids vaccine: clinical and immunologic response when administered as the primary series. Journal of Pediatrics 1985;106:779-781.

Barkin RM, Samuelson JS, Gotlin LP. DTP reactions and serologic response with a reduced dose schedule. Journal of Pediatrics 1984;105:189-194.

Barkin RM, Samuelson JS, Gotlin LP. Diphtheria and tetanus toxoids and pertussis vaccine adsorbed (DTP): response to varying immunizing dosage and schedule. Developments in Biological Standardization 1985;61:297-307.

Barkin RM, Samuelson JS, Gotlin LP, Barkin SZ. Primary immunization with diphtheria-tetanus toxoids vaccine and diphtheria-tetanus toxoids-pertussis vaccine adsorbed: comparison of schedules. Pediatric Infectious Disease 1985;4:168-171.

Barnett LA, Fujinami RS. Molecular mimicry: a mechanism for autoimmune injury. The FASEB Journal 1992;6:840-844.

Barra A, Cordonnier C, Preziosi MP, Intrator L, Hessel L, Fritzell B et al. Immunogenicity of Haemophilus influenzae type b conjugate vaccine in allogeneic bone marrow recipients. Journal of Infectious Diseases 1992;166:1021-1028.

Barrucand D, Schmitt J, Schmidt CL. [Neuropsychiatric complications of rabies immunization] Accidents neuro-psychiatriques de la vaccination antirabique. Annales Medicales de Nancy 1977;16:705-714.

Barsky P. Measles: Winnipeg, 1973. Canadian Medical Association Journal 1974;110:931-934.

Bart KJ, Orenstein WA, Hinman AR. The current status of immunization principles: recommendations for use and adverse reactions. Journal of Allergy and Clinical Immunology 1987;79:296-315.

Bartelheimer HK, Mai K. [Tetanus vaccination in relation to the importance of protection by vaccination] Aktuelles zur Tetanusimpfung im Hinblick auf die Erkennung des Impfshcutzes. Monatsschrift fur Kinderheilkunde 1970;118:558-560.

Basillico FC, Bernat JL. Vaccine-associated poliomyelitis in a contact. Journal of the American Medical Association 1978;239:2275.

Basu RN. Measles vaccine: feasibility, efficacy and complication rates in a multicentric study. Indian Journal of Pediatrics 1984;51:139-143.

Basu SN. Paralytic poliomyelitis following inoculation with combined diphtheria-tetanus-pertussis prophylactic: a review of sixteen cases with special reference to immunization schedules in infancy. Journal of the Indian Medical Association 1973 ;60:97-99.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Basu SN. A review of paralytic poliomyelitis cases occurring after polio vaccination. Journal of the Indian Medical Association 1986;84:203-206.

Bateman DE, Elrington G, Kennedy P, Saunders M. Vaccine related poliomyelitis in nonimmunised relatives and household contacts. British Medical Journal 1987;294:170-171.

Bather R, Furesz J, Fanok AG et al. Long-term infection of diploid African green monkey brain cells by Schwarz measles vaccine virus. Journal of General Virology 1973;20:401-405.

Baublis JV, Payne FE. Measles antigen and syncytium formation in brain cell cultures from subacute sclerosing panencephalitis (SSPE). Proceedings of the Society for Experimental Biology and Medicine 1968;129:593-597.

Baust W, Meyer D, Wachsmuth W. Peripheral neuropathy after administration of tetanus toxoid. Journal of Neurology 1979;222:131-133.

Baxley LM. Tetanus is still deadly Occupational Health and Nursing 1981;29:40-42.

Beale AJ. Hazards of vaccine production. FEMS Microbiology Letters 1992;79:469-473.

Beale AJ. Measles vaccines. Proceedings of the Royal Society of Medicine 1974;67:1116-1119.

Beard CM, Benson RC, Kelalis PP, Elveback LR, Kurland LT. The incidence and outcome of mumps orchitis in Rochester, Minnesota, 1935-1974. Mayo Clinic Proceedings 1977;52: 3-7.

Beasley RP, Hwang LY, Lee GC. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 1983;2:1099-1102.

Beaussart M, Lacombe A, Fourrier A, Camier P. [Electroencephalographic study during measles vaccination using the Schwarz vaccine] Etude electroencephalographique au cours de la vaccination contre la rougeole par le vaccin Schwarz. Revue Neurologique 1969;121:324-325.

Beck M, Welsz-Malecek R, Mesko-Prejac M, Radman V, Juzbasic M, Rajninger-Miholic Met al, Mumps vaccine L-Zagreb, prepared in chick fibroblasts. I. Production and field trials. Journal of Biological Standardization 1989;17:85-90.

Beck SA, Williams LW, Shirrell MA, Burks AW. Egg hypersensitivity and measles-mumps-rubella vaccine administration. Pediatrics 1991;88:913-917.

Beckmann R, Manz F, Moser R. [Increased occurrence of "sporadic" spinal progressive muscular atrophy in infancy] Gehauftes "sporadisches" Vorkommen spinaler progressiver Muskelatrophien im Kindesalter. Monatsschrift fur Kinderheilkunde 1970;118:41-44.

Becus-Laurentiu M, Szabo-Adorjan E, Pozsgi N, Szabo S. Etude histochimique de l'ovaire de ratte: l'effet du choc anaphylactique et du vaccin pertussis. Archives Roumaines de Pathologie Experimentale et de Microbiologie 1974;33:97-106.

Beede WE, Newcomb RW. Lower motor neuron paralysis in association with asthma. Johns Hopkins Medical Journal 1980;147:186-187.

Beersma MF, Kapsenberg JG, Renier WO, Galama JM, van Druten JA, Lucas CJ. [Subacute sclerosing panencephalitis in The Netherlands (1976-1986)] Subacute scleroserende panencefalitis in Nederland (1976-1986). Nederlands Tijdschrift voor Geneeskunde 1988; 132:1194-1199.

Begaud B, ed, Analyse d'Incidence en Pharmacovigilance: Application a la Notification Spontanee. Bordeaux: ARME-Pharmacovigilance Editions: 1991.

Begg NT, Noah ND, Crowley S, Al-Jawad ST, Kovar IZ. Mumps, measles, and rubella vaccination and encephalitis (letter). British Medical Journal 1989;299:978.

Beghi E, Cornelio F, Marconi M, Rizzuto N, Tonali P. The epidemiology of inflammatory polyradiculoneuropathy: a critical review of the distribution. characteristics and outcome of the disease. Plasmapheresis Study Group. Italian Journal of Neurologic Science 1991:12:63-73.

Beghi E, Kurland LT, Mulder DW. Incidence of acute transverse myelitis in Rochester, Minne-

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

sota, 1970-1980, and implications with respect to influenza vaccine. Neuroepidemiology 1982;1:176-188.

Beghi E, Kurland LT, Mulder DW, Nicolosi A. Brachial plexus neuropathy in the population of Rochester, Minnesota, 1970-1981. Annals of Neurology 1985;18:320-323.

Beghi E, Kurland LT, Mulder DW, Wiederholt WC. Guillain-Barre syndrome: clinicoepidemiologic features and effect of influenza vaccine. Archives of Neurology 1985;42:1053-1057.

Beghi E, Nicolosi A, Kurland LT, Mulder DW, Hauser WA, Shuster L. Encephalitis and aseptic meningitis, Olmsted County, Minnesota, 1950-1981. I. Epidemiology. Annals of Neurology 1984;16:283-294.

Behan PO. Diffuse myelitis associated with rubella vaccination. British Medical Journal 1977;1:166.

Bell EJ, Riding MH, Grist NR. Paralytic poliomyelitis: a forgotten diagnosis? British Medical Journal 1986;293:193-194.

Bell JF. Canine distemper, measles, and SSPE. American Journal of Epidemiology 1978;107:354-355.

Bellanti JA, Sanga RL, Klutinis B et al. Antibody responses in serum and nasal secretions of children immunized with inactivated and attenuated measles-virus vaccines. New England Journal of Medicine 1969;260:628-633.

Bellini WJ, Rota JS, Greer FW, Zaki SR et al. Measles vaccination death in a child with severe combined immunodeficiency: report of a case. Laboratory Investigation 1992;66:19A.

Bellman MH, Rawson NS, Wadsworth J, Ross EM, Cameron S, Miller DL. A developmental test based on the STYCAR sequences used in the National Childhood Encephalopathy Study. Child: Care, Health and Development 1985;11:309-323.

Bellman MH, Ross EM, Miller DL. Infantile spasms and pertussis immunization. Lancet 1983;1:1031-1034.

Benacerraf B, Kabat EA. A quantitative study of the Artbus phenomenon induced passively in the guinea pig. Journal of Immunology 1950;64:1-19.

Bendersky-Malbec N. [Mumps in 1982: current situation concerning anti-mumps vaccine] Les oreillons en 1982: raise au point sur le vaccin anti-ourlien. Concours Medecin 1982;104:167-177.

Bengtsson B. [The side effects of the vaccination of 650 children against measles] Biverkningar vid masslingsvaccination av 650 barn. Lakartidningen 1971;68:2235-2244.

Benison S. International medical cooperation: Dr. Albert Sabin, live poliovirus vaccine and the Soviets. Bulletin of the History of Medicine 1982;56:460-483.

Benjamin CM, Chew GC, Silman AJ. Joint and limb symptoms in children after immunization with measles, mumps, and rubella vaccine. British Medical Journal 1992;204:1075-1078.

Benjamin CM, Silman AJ. Adverse reactions and mumps, measles and rubella vaccine. Journal of Public Health Medicine 1991;13:32-34.

Bennett AD, Modlin J, Orenstein WA, Brandling. Current status of mumps in the United States. Journal of Infectious Diseases 1975;132:106-109.

Bensasson M, Lanoe R, Assan R. [A case of algodystrophy of the upper limb occurring after tetanus vaccination] Un cas de syndrome algodystrophique du membre superieur survenu apres vaccination antitetanique. Semaine des Hopitaux de Paris 1977;53:2965-2966.

Bergeisen GH, Bauman RJ, Gilmore RL. Neonatal paralytic poliomyelitis: a case report. Archives of Neurology 1986;43:192-194.

Berger JR, Ayyar DR, Sheremata WA. Guillain-Barre syndrome complicating acute hepatitis B: A case with detailed electrophysiological and immunological studies. Archives of Neurology 1981;38:366-368.

Bergeson PS. Immunizations to the deltoid region (letter). Pediatrics 1990;85:134-135.

Bergey GK, Bigalke H, Nelson PG. Differential effects of tetanus toxin on inhibitory and excitatory synaptic transmission in mammalian spinal cord neurons in culture: a presynaptic locus of action for tetanus toxin. Journal of Neurophysiology 1987;57:121-131.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Bergmannova V, Stehlikova J, Domorazkova E. [Immunization of children with reactions to the mixed vaccine against diphtheria, tetanus and whooping cough]. Ceskoslovenska Pediatrie 1988;43:522-526.

Bergouignan FX, Saintarailles J, Roux D, Guillon J, Bonnici JF, Fleury H et al. [Prevention of poliomyelitis: live or killed vaccine? Remarks apropos of 2 cases of poliomyelitis] Prevention de la poliomyelite: vaccin vivant ou rue? Reflexions a propos de 2 cas de poliomyelite. Presse Medicale 1984;13:2241-2243.

Berkovich S, Fikrig S, Brunell PA, Steiner M. Effect of live attenuated mumps vaccine virus on the expression of tuberculin sensitivity. Journal of Pediatrics 1972;80:84-87.

Berkowitz CD, Ward JI, Chiu CE, Marcy SM, Gordon L, Hendley JO et al. Persistence of antibody and booster responses to reimmunization with Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children initially immunized at 15 to 24 months of age. Pediatrics 1990;85:288-293.

Berkowitz CD, Ward JI, Meier K et al. Safety and immunogenicity of Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children 15 to 24 months of age. Journal of Pediatrics 1987;110:509-514.

Berlin BS. Convulsions after measles immunization (letter). Lancet 1983;1:1380.

Bernal A. Garcia-Saiz A, Liacer A, De Ory F, Tello O, Najera R. Poliomyelitis in Spain, 1982-1984: virologic and epidemiologic studies. American Journal of Epidemiology 1987;126: 69-76.

Bernard KW, Smith PW, Kader FJ, Moran MJ. Neuroparalytic illness and human diploid cell rabies vaccine. Journal of the American Medical Association 1982;248:3136-3138.

Bernier RH. Improved inactivated poliovirus vaccine: an update. Pediatric Infectious Disease 1986;5:289-292.

Bernstein DI, Smith VE, Schiff GM, Rathfon HM, Boscia JA. Comparison of acellular pertussis vaccine with whole cell vaccine as a booster in children 15 to 18 months and 4 to 6 years of age. Pediatric Infectious Disease Journal 1993;12:131-135.

Bernstein L, Ross RK. Prior medication use and health history as risk factors for non-Hodgkin's lymphoma: preliminary results from a case-control study in Los Angeles County. Cancer Research 1992;52(Suppl.):5510s-5515s.

Bernuau J. [Hepatitis B virus vaccination: a neglected, understated risk] Vaccination contre le virus B de l'hepatite: "un risque ignore, sous-evalue, neglige". Concours Medical 1990;112:1062.

Berry S, Hernandez H, Kanashiro R, Campos M, Azabache V, Gomez G et al. Comparison of high titer Edmonston-Zagreb, Biken-CAM and Schwarz measles vaccines in Peruvian infants. Pediatric Infectious Disease Journal 1992;11:822-827.

Bhagwat SM, Samuel MR. Oral polio vaccine (Sabin): vaccine-associated poliolike illnesses. Indian Journal of Medical Science 1966;29:903-906.

Bhaskaram P, Madhusudan J, Radhakrishna KV, Raj S. Immunological response to measles vaccination in poor communities. Human Nutrition and Clinical Nutrition 1986:40:295-299.

Bhatnagar SK, Mohan M, Kumar P, Balaya S, Prabhakar AK, Bhargava SK. Optimum age for measles immunization: study of pre- and postimmunization level of HI antibody titres. Indian Pediatrics 1981;18:625-629.

Bianchi R, Dappen U, Hoigne R. [Anaphylactic shock of humans towards foreign species serum: symptomatology, prevention and therapy] Der anaphylaktische Schock des Menschen auf artfremdes Serum: Symptomatologie, Prophylaxe und Therapie. Helvetica Chirurgica Acta 1967;34:257-273.

Biarez O, Sarrut B, Doreau CG, Etienne J. Comparison and evaluation of nine bibliographic databases concerning adverse drug reactions. DICP, The Annals of Pharmacotherapy 1991;25:1062-1065.

Biberi-Moroeanu S, Muntiu A. Commentary on the oral poliomyelitis vaccine (Sabin): associ-

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

ated cases of acute persisting spinal paralysis. Archives Roumaines de Pathologie Experimentale Microbiologie 1978;37:355-368.

Bichel J. Postvaccinial lymphadenitis developing into Hodgkin's disease. Acta Medica Scandinavica 1976;199:523-525.

Bienfang DC, Kantrowitz FG, Noble JL, Raynor A. Ocular abnormalities after influenza immunization. Archives of Ophthalmology 1977;95:1649.

Bilyk MA, Dubchik GK. [Anaphylactic reaction following subcutaneous administration of tetanus anatoxin] Anafilakticheskaia reaktsiia posle podkozhnogo vvedeniia stolbmiachnogo anatoksina. Klinicheskaia Meditsina 1978;56:137-138.

Biron P, Montpetit P, Infante-Rivard C, Lery L. Myasthenia gravis after general anesthesia and hepatitis B vaccine. Archives of Internal Medicine 1988;148:2685.

Bjorkholm B, Bottiger M, Christenson B et al. Antitoxin antibody levels and the outcome of illness during an outbreak of diphtheria among alcoholics. Scandinavian Journal of Infectious Diseases 1986;18:235-239.

Bjorkholm B, Granstrom M, Wahl M, Hedstrom C-E, Hagberg L. Adverse reactions and immunogenicity in adults to regular and increased dosage of diphtheria vaccine. European Journal of Clinical Microbiology 1987;6:637-640.

Black FL, Hierholzer W, Woodall JP, Pinheiro F. Intensified reactions to measles vaccine in unexposed populations of American Indians. Journal of Infectious Diseases 1971;124:306-317.

Black FL, Pinheiro F, Hierholzer WJ, Lee RV. Epidemiology of infectious disease: the example of measles. Ciba Foundation Symposium 1977;49:115-130.

Black FL, Woodall JP, Pinheiro FD. Measles vaccine reactions in a virgin population. American Journal of Epidemiology 1969;89:168-175.

Black SB. Dramatic reduction in invasive Hib disease in a large California population following HbOC conjugate vaccine in infancy. Program Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. Abstract 309, p. 162. Washington, DC: American Society for Microbiology; 1992.

Black SB, Cherry JD, Shinefield HR, Fireman B, Christenson P, Lampert D. Apparent decreased risk of invasive bacterial disease after heterologous childhood immunization. American Journal of Diseases of Children 1991;145:746-749.

Black SB, Shinefield HR, Fireman B, Hiatt R, Polen MV, E., Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group. Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children. Pediatric Infectious Disease Journal 1991;10:97-104.

Black SB, Shinefield HR, Fireman B, Hiatt R. Safety, immunogenicity, and efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b vaccine in a United States population: possible implications for optimal use. Journal of Infectious Diseases 1992;165(Suppl. 1):S139-S143.

Black SB, Shinefield HR, Hiatt RA, Fireman BH, Beekly M, Callas ER et al. Efficacy of Haemophilus influenzae type b capsular polysaccharide vaccine. Pediatric Infectious Disease Journal 1988;7:149-156.

Black SB, Shinefield HR, Kaiser Permanente Pediatric Vaccine Study Group. Immunization with oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a large health maintenance organization population: extended follow-up and impact on Haemophilus influenzae disease epidemiology. Pediatric Infectious Disease Journal 1992;11:610-613.

Black SB, Shinefield HR, Lampert D, Fireman B, Hiatt RA, Polen M et al. Safety and immunogenicity of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in infancy . Pediatric Infectious Disease Journal 1991;10:92-96.

Black SB, Shinefield HR, Northern California Permanente Medical Care Program Departments of Pediatrics Vaccine Study Group. b-CAPSA I Haemophilus influenzae, type b, capsular polysaccharide vaccine safety. Pediatrics 1987;79:321-325.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Blake L. Immunizations may pose risks (letter). Nursing BC 1992;24:7-8.

Blanco JD, Gibbs RS. Immunizations in pregnancy. Clinical Obstetrics and Gynecology 1982;25:611-617.

Blattner RJ. Paralytic poliomyelitis: contacts of vaccinated children. Journal of Pediatrics 1967;71:759-762.

Blom L. Nystrom L, Dahlquist G. The Swedish childhood diabetes study: vaccinations and infections as risk determinants for diabetes in childhood. Diabetologia 1991;34:176-181.

Bloom JL, Schiff GM, Graubarth H, Lipp RW Jr, Jackson JE, Osborn RL et al. Evaluation of a trivalent measles, mumps, rubella vaccine in children. Journal of Pediatrics 1975;87:85-87.

Blumberg BS, Sutnick AI, London, WT. Australia antigen and hepatitis. Journal of the American Medical Association 1969:207:1895-1896.

Blumberg S, Bienfang D, Kantrowitz FG. A possible association between influenza vaccination and small-vessel vasculitis. Archives of Internal Medicine 1980;140:847-848.

Blumstein GI, Kreithen H. Peripheral neuropathy following tetanus toxoid administration. Journal of the American Medical Association 1966;198:1030-1031.

Bock LL. Mumps virus vaccine. Pediatrics 1969;43:907.

Bodansky HJ, Dean BM, Grant PJ, McNally J, Schweiger MS, Hambling MH et al. Does exposure to rubella virus generate endocrine autoimmunity? Diabetic Medicine 1990;7:611-614.

Bodansky HJ, Dean BM, Bottazzo GF, Grant PJ, McNally J, Hambling MH et al. Islet-cell antibodies and insulin autoantibodies in association with common viral infections. Lancet 1986;2:1351-1353.

Bodansky HJ, Littlewood JM, Bottazzo GF, Dean BM, Hambling MH. Which virus causes the initial islet lesion in type I diabetes. Lancet 1984;1:401-402.

Bodechtel G. [Juvenile spinal muscular atrophy following polio vaccination?] Juvenile spinale Muskelatrophie nach Polio-Impfung? (letter). Munchener Medizinische Wochenschrift 1975:117:269.

Bodechtel G, Haas R, Joppich G, Lennartz H, Siegert R. [Vaccination complications after oral poliomyelitis vaccination] Zur Frage der Impfschaden nach der Poliomyelitis-Schluckimpfung. Munchener Medizinische Wochenschrift 1977;119:521-528.

Bodian D. A reconsideration of the pathogenesis of poliomyelitis. American Journal of Hygiene 1952;55:414-438.

Bodian D, Morgan I. M., Howe HA. Differentiation of types of poliomyelitis viruses. III. The grouping of fourteen strains into three basic immunological types. American Journal of Hygiene 1949;49:234-245.

Boe E, Nyland H. GuillainoBarre syndrome after vaccination with human diploid cell rabies vaccine. Scandinavian Journal of Infectious Diseases 1980;12:231-232.

Boese T, Lipinski C. [Vaccine-related paralytic poliomyelitis with severe pareses: report of one case] Impfpoliomyelitis mit schwerer Restlahmung: Kasuistischer Beitrag zur Frage der Impfschadigung nach oraler Polioimpfung nach Sabin. Klinische Paediatrie 1978;190:607-609.

Bogli F. [Immunization campaigns in Switzerland] Impfkampagne in der Schweiz. Schweiz Apotheker-Zeitung / Journal suisse de pharmacie 1988;126:160-161.

Bojinov PS, Kirov I, Georgiev I, Miltov G, Kohen M, Ninov N et al. Encephale-myelopolyradiculonevrites a la suite de l'utilization de vaccin antipoliomyelituque de Sabin a germe vivant. Presse Medicale 1964;72:75-79.

Boletin de la Oficina Sanitaria Panamericana. [Indications and contraindications for immunization] Indicaciones y contraindicaciones de la inmunizacion. Boletin de la Oficina Sanitaria Panamericana 1984;97:72-79.

Boles JM. [Major local reaction after self-injection of diphtheria-tetanus vaccine] Reaction

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

locale majeure apres rappel de vaccination antitetanique et antidiphterique. Medecine et Maladies Infectieuses 1985;15:558-560.

Boling HL. An adult's reaction to measles vaccine. American Journal of Nursing 1980;80:1442-1443.

Bolotovskij VM, Zetilova LP. Comparative study of the reaction-causing properties and the immunological and epidemiological effectiveness of Leningrad-16 and Schwarz live measles vaccines. Bulletin of the World Health Organization 1968;39:293-298.

Bondarev VN, Dadiomova MA. [The changes of the nervous system in children after vaccination] K voprosu o postvaktsinal'nykh izmeneniiakh nervnoi sistemy u detei. Pediatriia 1969;48:20-24.

Bondarev VN, Dadiomova MA, Torosov TM. [On the pathogenesis of several postvaccinal pathologic reactions in children] O patogeneze nekotorykh postvaktsinal'nykh patologicheskikh reaktsii u detei. Voprosy Okhrany Materinstva i Detstva 1968:13:46-48.

Bonelater VN, Dadiomova MA, Pratusevich RM. [Several complications after immunization with associated whooping cough-diphtheria-tetanus, antimeasles and antipoliomyelitis vaccines] Nekotorye oslozhneniia posle immunizatsii assotsiirovannoi kokliushno-difteriino-stolbniachnoi, protivokorevoi i protivopoliomielitnoi vaktsinami. Pediatriia 1968;47:26-29.

Booy R, Moxon ER. Immunization of infants against Haemophilus influenzae type b in the UK. Archives of Disease in Childhood 1991;66:1251-1254.

Booy R, Moxon ER, MacFarlane JA, Mayon-White RT, Slack MP E. Efficacy of Haemophilus influenzae type b conjugate vaccine in the Oxford region. Lancet 1992;340:47.

Booy R, Taylor SA, Dobson SR, Isaacs D, Sleight G. Aitken S et al. Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunization schedule. Archives of Disease in Childhood 1992;67:475-478.

Borgoho JM, Greiber R, Solari G, Concha F, Carrillo B, Hilleman MR. A field trial of combined measles-mumps-rubella vaccine: satisfactory immunization with 188 children in Chile. Clinical Pediatrics 1973;12:170-172.

Borsche A. [What are the hazards of vaccinations in childhood?] Wie gefahrlich sind Impfungen im Kindesalter. Zeitschrift fur Allemeinmedizin 1976;52:666-674.

Bothig B, Gerike E, Starke G, Giesecke H. [On the simultaneous use of live-virus vaccines, for example measles-polio vaccine] Beltrag zur Frage der simultanen Applikation von Lebendvirus-Impfstoffen am Beispiel Masern—Polio. Revue Roumaine de Virologie 1974;25:15-21.

Bottazzo GF. Gorsuch AN, Dean BM, Cudworth AG, Doniach D. Complement-fixing islet-cell antibodies in type-I diabetes: possible monitors of active beta-cell damage. Lancet 1980;1:668-672.

Bottiger M, Christenson B, Romanus V, Taranger J, Strandell A. Swedish experience of two dose vaccination programme aiming at eliminating measles, mumps, and rubella. British Medical Journal 1987;295:1264-1267.

Bottiger M, Heller L, Kamensky P, Svanberg B. [Measles vaccination of preschool children: reactions and side effects after immunization with vaccine of three different strengths]. Lakartidningen 1974;71:3270-3274.

Bottiger M, Mellin P, Romanus V, Soderstrom H, Wesslen T, von Zeipel G. [Epidemiology of a case of poliomyelitis] Epidemiologin kring ett poliofall i Sverige. Lakartidningen 1979;76:30-34.

Boulton-Jones JM, Sissons JG, Naish PF, Evans DJ, Peters DK. Self-induced glomerulonephritis. British Medical Journal 1974;3:387-390.

Bourke J, Roy CW. Paralytic poliomyelitis. New Zealand Medical Journal 1992;105:36-37.

Bouteille M, Fontaine C, Vedredd CL, Delarue J. Sur un cas d'encephalite subaigue a inclusions: etude anatomo-clinique et ultrastructurate. Revue Neurologique 1965;113:454-458.

Bouter KP, Diepersloot RJ, Wismans PJ, Gmelig Meyling FH, Hoekstra JB, Heijtink RA et al. Humoral immune response to a yeast-derived hepatitis B vaccine in patients with type 1 diabetes mellitus. Diabetic Medicine 1992;9:66-69.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Bouvier-Colle MH, Flahaut A, Messiah A, Jougla E, Hatton F. Sudden infant death and immunization: an extensive epidemiological approach to the problem in France—winter 1986. International Journal of Epidemiology 1989;18:121-126.

Boxall EH, Plester GL, Webber S. Vaccine hypersensitivity or coincidental virus infection (letter). Vaccine 1989;7:77.

Boyd JS. Tetanus in the African and European theatres of war, 1939-1945. Lancet 1946;1:113-119.

Braginskaia VP, Shabad AT, Manvelova MA, Aleksina SG, Podshivalova VA. [Use of reduced doses of diphtheria-tetanus toxoid for revaccination of children with changed reactivity] Primenenie umen'shennykh doz difteriino-stol'bniachnogo anatoksina dlia revaktsinatsii detei s izmenennoi reaktvinost'iu. Voprosy Okhrany Materinstva i Detstva 1974;19:65-69.

Braginskaya VP, Sokolova AF. [Postvaccinal complications and their prevention]. Pediatriya 1974;53:26-31.

Brandt AM. Polio, politics, publicity, and duplicity: ethical aspects in the development of the Salk vaccine. International Journal of Health Services 1978;8:257-270.

Breman JG, Hayner NS. Guillain-Barre syndrome and its relationship to swine influenza vaccination in Michigan, 1976-1977. American Journal of Epidemiology 1984;119:880-889.

Brieger P, Ehrlich P. Beitrage zur Kenntniss der Milch immunisirter Thiere. Zeitschrift fur Hygiene und Infektionskrankheiten 1893;13:336-346.

Brigaud M, Aymard M, Thouvenot D, Chomel JJ, Mahmood RA, Mathew PP et al. Poliomyelitis survey in Middle-East countries. Developments in Biological Standardization 1978;41:149-158.

Brightman CA, Scadding GK, Dumbreck LA, Latchman Y, Brostoff J. Yeast-derived hepatitis B vaccine and yeast sensitivity (letter). Lancet 1989;1:903.

Brindle MJ, Twyman DG. Allergic reactions to tetanus toxoid. British Medical Journal 1962;1:1116-1117.

Brink EW, Wassilak SG. Diseases controlled primarily by vaccination: diphtheria. In: Last JM, Wallace RB, eds. Maxcy-Rosenau-Last Public Health and Preventive Medicine, 13th ed. Norwalk, CT: Appleton & Lange; 1992.

British Medical Journal. Vaccination against measles: a clinical trial of live measles vaccine given alone and live vaccine preceded by killed vaccine. A report to the Medical Research Council by the Measles Vaccines Committee. British Medical Journal 1966;1:441-446.

British Medical Journal. Vaccination against measles. British Medical Journal 1968;1:395-396.

British Medical Journal. Medical news: measles vaccine. British Medical Journal 1969;1:791.

British Medical Journal. A measles vaccine withdrawn. British Medical Journal 1969;1:794-795.

British Medical Journal. Reactions to tetanus toxoid (editorial). British Medical Journal 1974;1:48.

British Medical Journal. Guillain-Barre syndrome and influenza vaccine (editorial). British Medical Journal 1977;1:1373-1374.

British Medical Journal. Subacute sclerosing panencephalitis (editorial). British Medical Journal 1979;2:6198.

British Medical Journal. Prevention of mumps (editorial). British Medical Journal 1980;281:1231-1232.

British Medical Journal. Report from the PHLS Communicable Disease Surveillance Centre. British Medical Journal 1986;293:195-196.

British Medical Journal. Measles, mumps, and rubella vaccine. British Medical Journal 1988 ;297:780-781.

Broadhurst LE, Erickson RL. Kelley PW. Decreases in invasive Haemophilus influenzae diseases in US Army children, 1984 through 1991. Journal of the American Medical Association 1993;269:227-231.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Brodsky L, Stanievich J. Sensorineural hearing loss following live measles virus vaccination. International Journal of Pediatric Otorhinolaryngology 1985;10:159-163.

Brody JA, McAlister R. Depression of tuberculin sensitivity following measles vaccination. American Review of Respiratory Diseases 1964;90:611-617.

Brody JA, Overfield T, Hammes LM. Depression of the tuberculin reaction by viral vaccines. New England Journal of Medicine 1964;271:1294-1296.

Brooks R, Reznik A. Guillain-Barre syndrome following trivalent influenza vaccine in an elderly patient. Mount Sinai Journal of Medicine 1980;47:190-191.

Brouwer R. Vaccination of infants in their first year of life with split inactivated measles vaccine incorporated in a diphtheria-pertussis-tetanus-polio (inactivated) vaccine (DPTPM), compared with live measles vaccination. Journal of Biological Standardization 1976;4: 13-23.

Brown EG, Furesz J, Dimock K, Yarosh W, Contreras G. Nucleotide sequence analysis of Urabe mumps vaccine strain that caused meningitis in vaccine recipients. Vaccine 1991;9:840-842.

Brown FR, Wolfe HI. Chick embryo grown measles vaccine in an egg-sensitive child. Journal of Pediatrics 1967;71:868-869.

Brown GC, Kendrick PL. Serologic response of infants to combined inactivated measles-poliomyelitis vaccine. American Journal of Public Health/Nations Health 1965;55:1813-1819.

Brummer E, Bhardwaj N, Lawrence HS. A method for eliciting indurated DTH reactions to soluble protein antigens in the flank skin of mice: correlation of visual measurements with 1251-UdR uptake indices. International Archives of Allergy and Applied Immunology 1981;64:266-276.

Brunell PA. The prevention of infectious diseases by immunization. Journal of Allergy and Clinical Immunology 1987;79:848-852.

Brunell PA, Bass JW, Daum RS et al. Hemophilus type b polysaccharide vaccine. Pediatrics 1985;76:322-324.

Brunell PA, Novelli VM, Lipton SV, Pollock B. Combined vaccine against measles, mumps, rubella, and varicella. Pediatrics 1988;81:779-784.

Brunell PA, Weigle K, Murphy MD et al. Antibody response following measles-mumps-rubella vaccine under conditions of customary use. Journal of the American Medical Association 1983;250:1409-1412.

Bruno G, Giampietro PG, Grandolfo ME, Milita O, Businco L. Safety of measles immunization in children with IgE-mediated egg allergy (letter). Lancet 1990;335:739.

Bryett KA, Mathews AH, Bakhshi SS, Schweiger MS. Diphtheria and tetanus vaccine: a comparative study of reactogenicity. British Journal of Clinical Practice 1989;43:52-54.

Buchner H, Ferbert A, Hundgen R. [Polyneuritis cranialis, brain-stem encephalitis and myelitis following influenza] Polyneuritis cranialis, hirnstammenzephalitis und myelitis nach influenzaschutzimpfung. Nervenarzt 1988;59:679-682.

Buck BE, Yang LC, Caleb MH, Green JM, South MA. Measles virus panniculitis subsequent to vaccine administration. Journal of Pediatrics 1982;101:366-373.

Bulletin of the World Health Organization. Evidence on the safety and efficacy of live poliomyelitis vaccines currently in use, with special reference to type 3 poliovirus. Bulletin of the World Health Organization 1969;40:925-945.

Bunch C, Schwartz FC, Bird GW. Paroxysmal cold haemoglobinuria following measles immunization. Archives of Disease in Childhood 1972;47:299-300.

Bunnell CE, Monif GR. Interstitial pancreatitis in the congenital rubella syndrome. Journal of Pediatrics 1972;80:465-466.

Bunrain WL, Missall SR. Local subcutaneous atrophy following measles, mumps, and rubella vaccination (letter). American Journal of Diseases of Children 1976;130:335.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Burgess MA. Immunization: risks vs benefits in the community. Current Therapeutics 1987;28:19-31.

Burkholder JN. Severe vaccine reaction (letter). Canadian Medical Association Journal 1978;118:1027.

Burmester GR, Altstidl U, Kalden JR. Stimulatory response towards the 65 kDa heat shock protein and other mycobacterial antigens in patients with rheumatoid arthritis. Journal of Rheumatology 1991;18:171-176.

Buser F. Side reaction to measles vaccination suggesting the Arthus phenomenon. New England Journal of Medicine 1967;277:250-251.

Bussens P, Pilette J. [Unrecognized complications of oral antipoliomyelitis vaccination] Complications meconnues de la vaccination antipoliomyelitique par voie orale. Revue Medicale de Liege 1976;31:608-611.

Butler H. Hepatitis B in New Zealand. Submitted to Institute of Medicine Vaccine Safety Committee, April 4, 1992. Unpublished.

Buynak EB, Hilleman MR. Live attenuated mumps virus vaccine. I. Vaccine development. Proceedings of the Society for Experimental Biology and Medicine 1966;123:768-775.

Buynak EB, Weibel RE, Whitman JE Jr., Stokes JJ, Hilleman MR. Combined live measles, mumps, and rubella virus vaccines. Journal of the American Medical Association 1969;207:2259-2262.

Bychenko BD, Stroganova MK, Matveev KI, Runova VF, Petrov AN. [Use of tetanus allergen to determine human sensitivity to tetanus toxoid] Primenenie stolbniachnogo allergena dlia opredeleniia chuvstvitelnost liudei k stolbniachnomu anatoksinu. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii 1971;48:83-87.

Cabrera J, Griffin DE, Johnson RT. Unusual features of the Guillain-Barre syndrome after rabies vaccine prepared in suckling mouse brain. Journal of Neurological Science 1987;81:239-245.

Cailleba A, Beytout J, Lauras H et al. Shock associated with disseminated intravascular coagulation syndrome after injection of DT-tab vaccine [Choc associe a un syndrome de coagulation intravasculaire disseminee apres une injection de vaccin DT. tab]. Presse Medicale 1984;13:1900.

Campbell AG. Brother-to-sister transmission of measles after MMR immunization (letter). Lancet 1989;1:442.

Campbell AG. Mumps, measles, and rubella vaccination and encephalitis (letter). British Medical Journal 1989;299:916.

Campbell H, Byass P, Ahonkhai VI, Vella PP, Greenwood BM. Serologic responses to an Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine in very young Gambian infants. Pediatrics 1990;86:102-107.

Campion JJ, Casto DT. Haemophilus influenzae type b conjugate vaccine. Journal of Pediatric Health Care 1988;2:215-218.

Canadian Medical Association Journal. Tetanus toxoid. Canadian Medical Association Journal 1968;98:123.

Canadian Medical Association Journal. Anaphylaxis due to vaccination in the office (letters). Canadian Medical Association Journal 1986;134:1109.

Canadian Medical Association Journal. In support of a compensation plan for vaccine-associated injuries. Canadian Medical Association Journal 1986;135:747-749.

Canadian Medical Association Journal. Vaccine-associated poliomyelitis in Quebec. Canadian Medical Association Journal 1987;137:418-419.

Canadian Medical Association Journal. A case of mumps meningitis: a complication of vaccination? Canadian Medical Association Journal 1988;138:135.

Canadian Medical Association Journal. Universal vaccination against hepatitis B. Canadian Medical Association Journal 1992;146:36.

Canadian Medical Association Journal. Alleged link between hepatitis B vaccine and chronic fatigue syndrome. Canadian Medical Association Journal 1992;146:37-38.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Canadian Medical Association Journal. Statement on Haemophilus influenzae type b conjugate vaccines for use in infants and children. Canadian Medical Association Journal 1992;146:1363-1366, 1369-1372.

Canadian Medical Association Journal. Adverse events after hepatitis B vaccination. Canadian Medical Association Journal 1992;147:1023-1026.

Canadian Medical Association Journal. Statement on Haemophilus influenzae type b conjugate vaccines for use in infants and children. Canadian Medical Association Journal 1993;148:199-214.

Capeding MR, Lazaro JA, Kaneko YY. Pre-discharge immunization among hospitalized Filipino children. Pediatric Infectious Disease Journal 1990;9:570-573.

Carey AB, Meltzer EO. Diagnosis and ''desensitization'' in tetanus vaccine hypersensitivity. Annals of Allergy 1992;69:336-338.

Carlo WR, Schneeweiss B. [Acute thrombocytopenic purpura following virus vaccinations] Akute thrombozytopenische Purpura nach Virusimpfungen. Kinderarztliche Praxis 1972;40:448-453.

Carmeli Y, Oren R. Hepatitis B vaccine side-effect. Lancet 1993;341:250-251.

Carrada-Bravo T. [Epidemiology and control of poliomyelitis. II. Poliovirus vaccines] Epidemiologia y control de la poliomielitis. II. Vacunas antipoliomieliticas. Boletin Medico del Hospital Infantil de Mexico 1983;40:604-612.

Carroll JE, Jedziniak M, Guggenheim MA. Guillain-Barre syndrome: another cause of the "floppy infant." American Journal of Diseases of Children 1977;131:699-700.

Casas Vila MC. [Adverse drug reactions in children: in vivo diagnosis] Reacciones adversas a medicamentos en el nino: diagnostico in vivo. Revista Espanola Alergologia e Immunologia Clinica 1992;7(Suppl. 1):5-7.

Cassata F, Raimondo L. [On the side-effects of poliomyelitis vaccination with the Sabin method] Considerazioni sugli effetti collaterali della vaccinazione antipolio col metodo Sabin. Pediatria (Napoli) 1970;78:26-43.

Castan P, Dehing J. [Coma revealing an acute leukosis in a child, 15 days after an oral antipoliomyelitis vaccination: anatomo-clinical study and reflections on cerebral lesions in acute leukoses] Coma revelateur d'une leucose aigue chez un enfant, quinze jours apres une vaccination perorale antipoliomyelitique: etude anatomo-clinique et reflexions sur les lesions cerebrales des leucoses aigues. Acta Neurologica et Psychiatrica Belgica 1965;65:349-367.

Castillo Salinas F, Sole Mir E, Ferrer Comalat A, Morales Sanchez M. [Benign intracranial hypertension caused by DTP and polio immunization] Hipertension endocraneal benigna tras inmunizacion con DTP y polio. Anales Espanoles de Pediatria 1990;32:466-467.

Castillo J, Medina G, Carnevale A. Frequency of sister-chromatid exchanges in children vaccinated against measles. Mutation Research 1983;119:65-69.

Cates KL. Serum opsonic activity for Haemophilus influenzae type b in infants immunized with polysaccharide-protein vaccines. Journal of Infectious Diseases 1985;152:1076-1077.

Cates KL, Marsh KH, Granoff DM. Serum opsonic activity after immunization of adults with Haemophilus influenzae type b-diphtheria toxoid conjugate vaccine. Infection and Immunity 1985;48:183-189.

Cavanagh NP, Brett EM, Marshall WC, Wilson J. The possible adjuvant role of Bordetella pertussis and pertussis vaccine in causing severe encephalopathic illness: a presentation of three case histories. Neuropediatrics 1981;12:374-381.

Cencora V, Challoner F, Gooch S, Livingstone A, Widgery D. Immunization of neonates at risk of hepatitis B. British Medical Journal 1988;297:481.

Centers for Disease Control. Recommendations of the Public Health Service Advisory Committee on Immunization Practices: Measles vaccines. Morbidity and Mortality Weekly Report 1967;16:169-271.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Centers for Disease Control. Poliomyelitis prevention. Morbidity and Mortality Weekly Report 1982;31:22-26, 31-34.

Centers for Disease Control. Vaccine-associated poliomyelitis: United States, 1981. Morbidity and Mortality Weekly Report 1982;31:97-98.

Centers for Disease Control. The safety of hepatitis B virus vaccine. Morbidity and Mortality Weekly Report 1983;32:134-136.

Centers for Disease Control. Adverse Events Following Immunization: Surveillance Report No. 1, 1979-1982. Atlanta, Georgia: U.S. Department of Health and Human Services, Public Health Service; August 1984.

Centers for Disease Control. Paralytic poliomyelitis—United States, 1982 and 1983. Morbidity and Mortality Weekly Report 1984;33:635-638.

Centers for Disease Control. Hepatitis B vaccine: evidence confirming lack of AIDS transmission. Morbidity and Mortality Weekly Report 1984;33:685-687.

Centers for Disease Control, Immunization Practices Advisory Committee. Polysaccharide vaccine for prevention of Haemophilus influenzae type b disease. Morbidity and Mortality Weekly Report 1985;34:201-205.

Centers for Disease Control. Recommendations for protection against viral hepatitis . Morbidity and Mortality Weekly Report 1985;34:313-335.

Centers for Disease Control. Adverse Events Following Immunization: Surveillance Report No. 2, 1982-1984. Atlanta, Georgia: U.S. Department of Health and Human Services, Public Health Service; December 1986.

Centers for Disease Control. Update: poliomyelitis outbreak—Finland, 1984-1985. Morbidity and Mortality Weekly Report 1986;35:82-86.

Centers for Disease Control. Poliomyelitis—United States, 1975-1984. Morbidity and Mortality Weekly Report 1986;35:180-182.

Centers for Disease Control. Epidemiologic classification of reported cases of paralytic poliomyelitis, U.S.A., 1975-1986. Unpublished. Received from CDC, 1987.

Centers for Disease Control. Poliomyelitis prevention: enhanced-potency inactivated poliomyelitis vaccine—supplementary statement. Morbidity and Mortality Weekly Report 1987;36: 795-798.

Centers for Disease Control. Update: prevention of Haemophilus influenzae type b disease. Morbidity and Mortality Weekly Report 1988;37:13-16.

Centers for Disease Control. Adverse Events Following Immunization: Surveillance Report No. 3, 1985-1986. Atlanta, Georgia: U.S. Department of Health and Human Services, Public Health Service; February 1989.

Centers for Disease Control. Update: Haemophilus influenzae type b vaccine. Morbidity and Mortality Weekly Report 1989;38:14.

Centers for Disease Control. Mumps prevention. Morbidity and Mortality Weekly Report 1989 ;38: 388-392, 397-400.

Centers for Disease Control. Measles prevention. Morbidity and Mortality Weekly Report 1989;38(Suppl. 9): 1-18.

Centers for Disease Control. Recommendations of the Immunization Practices Advisory Committee, Supplementary Statement: change in administration schedule for Haemophilus b conjugate vaccines. Morbidity and Mortality Weekly Report 1990;39:232-233.

Centers for Disease Control. Food and Drug Administration approval of a Haemophilus b conjugate vaccine for infants. Morbidity and Mortality Weekly Report 1990;39:698-699.

Centers for Disease Control. Vaccine Adverse Event Reporting System—United States. Morbidity and Mortality Weekly Report 1990;39:730-733.

Centers for Disease Control. Decline in Haemophilus influenzae type b meningitis—Seattle-King County, Washington, 1984-1989. Morbidity and Mortality Weekly Report 1990;39:924-925.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Centers for Disease Control. Food and Drug Administration approval of use of Haemophilus b conjugate vaccine for infants. Morbidity and Mortality Weekly Report 1990;39:925-926.

Centers for Disease Control. Protection against viral hepatitis. Recommendations of the Immunization Practices Advisory Committee (ACIP). Morbidity and Mortality Weekly Report 1990;39(RR-2):1-26.

Centers for Disease Control. Haemophilus b conjugate vaccines for prevention of Haemophilus influenzae type b disease among infants and children two months of age and older. Recommendations of the Immunization Practices Advisory Committee (ACIP). Morbidity and Mortality Weekly Report 1991;40(RR-1):1-7.

Centers for Disease Control. Surveillance of Escherichia coli O157 isolation and confirmation, United States, 1988. Morbidity and Mortality Weekly Report 1991;40(SS-1):1-6.

Centers for Disease Control. Misclassification of infant deaths—Alaska, 1990-1991. Morbidity and Mortality Weekly Report 1992;41:584-591.

Centers for Disease Control. Food and Drug Administration approval of use of a new Haemophilus b conjugate vaccine and a combined diphtheria-tetanus-pertussis and Haemophilus b conjugate vaccine for infants and children. Morbidity and Mortality Weekly Report 1993;42:296-298.

Centers for Disease Control and Prevention. Recommendations of the Advisory Committee on Immunization Practices (ACIP): Use of vaccines and immune globulins in persons with altered immunocompetence. Morbidity and Mortality Weekly Report 1993;42(RR-4):1-18.

Centers for Disease Control and Prevention. Standards for Pediatric Immunization Practices. Morbidity and Mortality Weekly Report 1993;42(RR-5):1-13.

Centers for Disease Control and Prevention, Division of Immunization. Summaries of five cases, from review of records to identify all deaths among confirmed cases of vaccine-associated paralytic poliomyelitis reported to CDC during the period 1980-1991. Unpublished data.

Cernescu C, Cajal N, Popescu-Tismana G. SSPE: epidemiological and serological features in a series of cases recorded between 1975 and 1984. Virologie 1985;36:247-254.

Cernescu C, Milea S, Berbescu C, Pastia M, Popescu L. S.S.P.E.: some clues to pathogenesis from epidemiological data . Virologie 1988;39:247-256.

Cernescu C, Popescu-Tismana G, Alaicescu M, Popescu L, Cajal N. The continuous decrease in the number of SSPE annual cases ten years after compulsory anti-measles immunization. Revue Roumaine de Virologie 1990;41:13-18.

Cesario TC, Nakano JH, Caldwell GG, Youmans RA. Paralytic poliomyelitis in an unimmunized child: apparent result of a vaccine-derived poliovirus. American Journal of Diseases of Children 1969;118:895-898.

Chaiken BP, Williams NW, Preblud SR, Parkin W, Altman R. The effect of a school entry law on mumps activity in a school district. Journal of the American Medical Association 1987;257:2455-2458.

Chaleomchan W, Hemachudha T, Sakulramrung R, Deesomchok U. Anticardiolipin antibodies in patients with rabies vaccination induced neurological complications and other neurological diseases. Journal of Neurological Science 1990;96:143-151.

Champagne S, Thomas E. A case of mumps meningitis: a postimmunization complication? / Cas de meningite ourlienne: complication vaccinale? Canada Diseases Weekly Report / Rapport hebdomadaire des maladies au Canada 1987;13:155-157.

Champsaur HF, Bottazzo GF, Bertrams J, Assan R, Bach C. Virologic, immunologic, and genetic factors in insulin-dependent diabetes mellitus. Journal of Pediatrics 1982;100:15-20.

Chan CY, Lee SD, Tsai YT, Yue MI, Lo KJ. Long-term follow-up of hepatitis B vaccination in infants born to noncarrier mothers in Taiwan. Chinese Medical Journal 1992;50:83-88.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Chan CC, Sogg RL, Steinman L. Isolated oculomotor palsy after measles immunization. American Journal of Ophthalmology 1980;89:446-448.

Chan H-L, Stern RS, Arndt KA, Langlois J, Jick SS, Jick H et al. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. Archives of Dermatology 1990; 126:43-47.

Chandra P. Trends in immunization. Antiseptic 1979;76:729-739.

Chandra RK. Polio-virus vaccines: an iota of risk? Indian Journal of Pediatrics 1965;32:335-336.

Chandra RK. Reactions following measles vaccination. Indian Journal of Pediatrics 1967;34:423-424.

Chandra RK. Reduced secretory antibody response to live attenuated measles and poliovirus vaccines in malnourished children. British Medical Journal 1975;2:583-585.

Chang HH. Immunization problems in measles, rubella and mumps. Journal of the Korean Medical Association 1982;25:801-806.

Chang TW. Weinstein L. MacMahon HE. Paralytic poliomyelitis in a child with hypogammaglobulinemia: probable implication of type I vaccine strain. Pediatrics 1966;37:630-636.

Chanukoglu A. Fried D, Gotlieb A. [Anaphylactic shock due to tetanus toxoid]. Harefuah 1975;89:456-457.

Chauplannaz G, Trepo C, Brunon AM. Bady B. [Polyneuropathy following vidarabine therapy of chronic active hepatitis] Neuropathie apres traitement d'une hepatite chronique active par vidarabine. Revue Neurologique 1984;140:743-745.

Chen DS, Hsu HM, Sung JL et al. A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. Journal of the American Medical Association 1987;257:2597-2603.

Chen R. Safety of simultaneous administration of DTP and Hib: Preliminary analysis of VAERS data. Presentation given at meeting of Advisory Commission on Childhood Vaccines, March 10, 1993, Washington. DC.

Chen RT, Moses JM, Markowitz LE, Orenstein WA. Adverse events following measles-mumps-rubella and measles vaccinations in college students. Vaccine 1991;9:297-299.

Chen RT, Rastogi SC, Mullen JR, Hayes SW, Cochi SL, Donlon JA, Wassilak SG. The Vaccine Adverse Event Reporting System (VAERS). Atlanta, Georgia: Centers for Disease Control; submitted for publication.

Chen TQ, Li CZ, Ni SF, Shi M, Luo GX, Dong DX. [Studies on new attenuated strains of type I live poliovirus vaccine. II. Investigation on a series of field trials with "Zhong 19" strain]. Chung Kuo I Hsueh Ko Hsueh Yuan Hsueh Pao 1983;5:373-377.

Cherkeziya SE, Mikhailova GR, Gorshunova LP. [Chromosomal aberrations in mice caused by immunization with a set of antiviral vaccines] Narusheniia v khromosomnom apparate myshei, vyzvannye immunizatsiei kompleksom protivovirusnykh vaktsin. Voprosy Virusologii 1979;:547-550.

Cherry JD, Brunell PA, Golden GS, Karzon DT. Report of the task force on pertussis and pertussis immunization—1988. Pediatrics 1988;81(6, Part 2):939-984.

Cheshik SG, Nefedova LA, Bolotovskii VM. [A clinical study of the reactivity of live antimeasles vaccines] Klinicheskoe izuchenie reaktogennosti zhivykh protivokorevykh vaktsin. Sovetskaia Meditsina 1966;29:126-132.

Chinese Medical Journal. Effects of immunization with live mumps vaccine administered by nasal spraying and atomization. Chinese Medical Journal 1976;2:372-375.

Chinese Medical Journal. Studies on new attenuated strains of type III live poliomyelitis vaccine. I. Development of a new type III attenuated poliovirus. Chinese Medical Journal 1980:93:583-590.

Cho CT, Lansky LJ, D'Souza BJ. Panencephalitis following measles vaccination. Journal of the American Medical Association 1973;224:1299.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Chonmaitree T, Lucia H. Presence of vaccine-strain poliovirus in cerebrospinal fluid of patient with near-miss sudden infant death syndrome (letter). American Journal of Diseases of Children 1986;140:1212-1213.

Christau B, Helin P. [Reactive arthritis following vaccination against hepatitis B] Reaktiv artrit efter vaccination mod hepatitis B. Ugeskrift for Laeger 1987;149:1882.

Christensen PE. Side reactions to tetanus toxoid. Scientific Publication, Pan American Health Organization 1972;253:36-43.

Christenson B, Bottiger M. Changes of the immunological patterns against measles, mumps and rubella: a vaccination programme studied 3 to 7 years after the introduction of a two-dose schedule. Vaccine 1991;9:326-329.

Christenson B, Bottiger M, Heller L. Mass vaccination programme aimed at eradicating measles, mumps, and rubella in Sweden: first experience. British Medical Journal 1983;287:389-391.

Christenson B, Bottiger M. Serological immunity to diphtheria in Sweden in 1978 and 1984. Scandinavian Journal of Infectious Diseases 1986;18:227-233.

Christenson B, Heller L, Bottiger M. The immunizing effect and reactogenicity of two live attenuated mumps virus vaccines in Swedish schoolchildren. Journal of Biological Standardization 1983;11:323-331.

Christian MA. Influenza and hepatitis B vaccine acceptance: a survey of health care workers. American Journal of Infection Control 1991;19:177-184.

Christopher PJ. Measles vaccine failures. Medical Journal of Australia 1988;148:103.

Chumakov MP, Voroshilova MK, Grachev VP, Dzagurov SG, Sinyak KM. The development and the study of live measles vaccine from highly attenuated strain Enders-Schwarz-Chumakov (ESC). Progress in Immunobiological Standardization 1969;3:194-195.

Chumakov MP, Voroshilova MK, Grachev VP, Sinyak KM, Boiko VM, Seibil VB et al. Investigation and application of the USSR AMS live measles vaccine from the ESC strain for mass vaccination against measles. Journal of Hygiene, Epidemiology, Microbiology and Immunology 1970;14:1-18.

Chun H, T'eh-chang H, Kuo-hua T, Shou-teh C, Wen-huan W, Chi-ming C et al. Clinical and immunologic observations on two lines of attenuated measles vaccine virus upon passage in chick embryo cell culture. Chinese Medical Journal 1975;1:283-286.

Chung WK, Yoo JY, Sun HS, Lee HY, Lee IJ, Kim SM, Prince AM. Prevention of perinatal transmission of hepatitis B virus: a comparison between the efficacy of passive and passive-active immunization in Korea. Journal of Infectious Diseases 1985;151:280-286.

Church JA, Richards W. Recurrent abscess formation following DTP immunizations: association with hypersensitivity to tetanus toxoid. Pediatrics 1985;75:899-900.

Ciaccio M, Rebora A. Lichen planus following HBV vaccination: a coincidence? (letter). British Journal of Dermatology 1990;122:424.

Cizewska S, Huber Z, Sluzewski W. [Prophylactic inoculations and seizure activity in the EEG] Szczepienia ochronne a czynnosc napadowa w EEG: doniesienie wstepne. Neurologia i Neurochirurgia Polska 1981;15:554-557.

Cizman M, Mozetic M, Furman-Jakopic M, Pleterski-Rigler D, Radescek-Rakar R, Susec-Michieli M. [Aseptic meningitis following combined vaccination with the Leningrad-3 strain of mumps virus and the Edmonston-Zagreb strain of measles virus] Serozni meningitis po kombiniranem cepljenju s sevom virusa mumpsa Leningrad-3 in sevom virusa ospic Edmonston-Zagreb. Zdravstreni Vestnik 1986;55:587-591.

Cizman M, Mozetic M, Radescek-Rakar R, Pleterski-Rigler D, Susec-Michieli M. Aseptic meningitis after vaccination against measles and mumps. Pediatric Infectious Disease Journal 1989;8:302-308.

Claesson BA, Schneerson R, Lagergard T, Trollfors B, Taranger J, Johansson J et al. Persistence of serum antibodies elicited by Haemophilus influenzae type b-tetanus toxoid con-

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

jugate vaccine in infants vaccinated at 3, 5 and 12 months of age. Pediatric Infectious Disease Journal 1991;10:560-564.

Claesson BA, Schneerson R, Robbins JB, Johansson J, Lagergard T, Taranger J et al. Protective levels of serum antibodies stimulated in infants by two injections of Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugate. Journal of Pediatrics 1989;114:97-100.

Claesson BA, Trollfors B, Lagergard T, Taranger J, Bryla D, Otterman G et al. Clinical and immunologic responses to the capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18-to 23-month-old children. Journal of Pediatrics 1988;112:695-702.

Clark C, Hashim G, Rosenberg R. Transverse myelitis following rubeola vaccination. Neurology 1977;27:360.

Clements CJ, Von RC F., Mann JM. HIV infection and routine childhood immunization: a review. Bulletin of the World Health Organization 1987;65:905-911.

Clements DA, Rouse JB, London WL, Yancy WS, Moggio MV, Wilfert CM. Antibody response of 18 month old children 1 month and 18 months following Haemophilus influenzae type b vaccine administered singly or with DTP vaccine. Journal of Paediatrics and Child Health 1990;26:46-49.

Clinical Pharmacy. Clearinghouse formed for reports of hepatitis B vaccine adverse effects. Clinical Pharmacy 1983;2:297.

Clinical Pediatrics. Influenza vaccination (1977-1978). Clinical Pediatrics 1977;16:867-868.

Cocchi P, Corti R. [Measles vaccination] La vaccinazione anti-morbillo. Pediatria Medica e Chirurgica 1984;6:5-11.

Cochi SL, Broome CV, Hightower AW. Immunization of U.S. children with H. influenzae vaccine: a cost-effectiveness model of strategy assessment. Journal of the American Medical Association 1985;253:521-529.

Cochi SL, Preblud SR, Orenstein WA. Perspectives on the relative resurgence of mumps in the United States. American Journal of Diseases of Children 1988;142:499-507.

Cocktell JL. Vaccine reactions: the challenge to pediatricians. Virginia Medicine 1982;109:380-381.

Cockwell P, Allen MB, Page R. Vasculitis related to hepatitis B vaccine (letter). British Medical Journal 1990;301:1281.

Cody CL, Baraff LJ, Cherry JD, Marcy SM, Manclark CR. Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics 1981;68:650-660.

Coe CJ. Guillain-Barre syndrome in Korean children. Yonsei Medical Journal 1989;30:81-87.

Coffin CM, Roberts RL, Monafo WJ, Haslam DB, Bellini WJ, Zaki S. Disseminated measles infection following vaccination in severe combined immune deficiency syndrome. Pediatric Pathology 1993;13:102.

Cogne M, Ballet JJ, Schmitt C, Bizzine B. Total and IgE antibody levels following booster immunization with aluminum absorbed and nonabsorbed tetanus toxoid in humans. Annals of Allergy 1985;54:148-151.

Cohen H, Brouwer R, Bijkerk H, Phaff JM. National antimeasles vaccination programme. Nederlands Tijdschrift voor Geneeskunde 1978;122:46-51.

Cohen HI. Safety of measles vaccine in egg-sensitive individuals (letter). Journal of Pediatrics 1978;92:859.

Cohen J. Debate on AIDS origin: Rolling Stone weighs in. Science 1992;255:1505.

Cohen P, Scadron SJ. Effects of active immunization of mother upon offspring. Journal of Pediatrics 1946;29:609-619.

Cohn J. Thrombocytopenia in childhood: an evaluation of 433 patients. Scandinavian Journal of Hematology 1976;16:226-240.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Coleman PJ, Shaw FE Jr., Serovich J, Hadler SC, Margolis HS. Intradermal hepatitis B vaccination in a large hospital employee population. Vaccine 1991;9:723-727.

Coll JR. The incidence and complications of mumps. General Practitioner 1974;24:545-551.

Collier LH. Reactions after plain and adsorbed tetanus vaccines (letter). Lancet 1980;1:148.

Collier LH, Polakoff S, Mortimer J. Reactions and antibody responses to reinforcing doses of adsorbed and plain tetanus vaccines. Lancet 1979;1:1364-1368.

Coilingham KE, Pollock TM, Roebuck MO. Paralytic poliomyelitis in England and Wales, 1976-7. Lancet 1978;1:976-977.

Colville A, Pugh S. Mumps meningitis and measles, mumps, and rubella vaccine. Lancet 1992;340:786.

Combes MA, Clark WK. Sciatic nerve injury following intragluteal injection: pathogenesis and prevention. American Journal of Diseases in Children 1960;100:579.

Committee on Infectious Diseases. Prevention of hepatitis B virus infections. Pediatrics 1985;75:362-364.

Concours Medical. [The efficacy and use of Haemophilus influenzae type b vaccine combined with PRP-T vaccine] Vaccin PRP-T anti-hemophilus: efficacite et modalites d'emploi. Concours Medical 1992;114:184.

Connolly JH. Subacute sclerosing panencephalitis. Journal of Clinical Pathology 1972;6(Suppl.): 73-77.

Connolly JH. Subacute sclerosing panencephalitis. Postgraduate Medical Journal 1972;48):342-345.

Connolly JH, Allen IV, Hurwitz LJ, Miller JH. Measles-virus antibody and antigen in subacute sclerosing panencephalitis. Lancet 1967;1:542-544.

Connolly JH, Allen IV, Hurwitz LJ, Millar JH. Subacute sclerosing panencephalitis: clinical, pathological, epidemiological, and virological findings in three patients. Quebec Journal of Medicine 1968;37:625-644.

Connolly JH, Robinson FL J., Canavan DA. Mumps or Coxsackie A9 virus antibody in the cerebrospinal fluid of patients with meningitis or encephalitis. Irish Journal of Medical Science 1975;144:60-66.

Connolly KH, Hammer SM. The acute aseptic meningitis syndrome. Infectious Disease Clinics of North America 1990;4:599-622.

Contardi I, Lusardi C, Cartanco GG. [A comparative study of 3 different types of trivalent measles-mumps-rubella vaccine] Studio comparativo su tre differenti tipi di vaccini trivalenti anti morbillo-parotite-rosolia. Pediatria Medica e Chirurgica 1992;14:421-424.

Contreras G, Furesz J. Possible influence of measles virus infection of cynomolgus monkeys on the outcome of the neurovirulence test for oral poliovirus vaccine. Biologicals 1992;20: 27-33.

Cook JV, Holowach J, Atkins JE Jr., Powers JR. Antibody formation in early infancy against diphtheria and tetanus toxoid. Journal of Pediatrics 1948;33:141-146.

Cooke DR. A study of the side effects of Lirugen measles vaccine in Aboriginal children. Medical Journal of Australia 1972;1:387-388.

Coombs RR, Gell PG. Classification of allergic reactions responsible for clinical hypersensitivity and disease. In: Gell PG, Coombs RR, eds. Clinical Aspects of Immunology, 2nd edition. Oxford and Edinburgh: Blackwell Scientific Publications; 1968.

Cornblath DR, Mellits ED, Griffin JW, and the GBS Study Group. Motor conduction studies in the Guillain-Barre syndrome: description and prognostic value. Annals of Neurology 1988;23:354-359.

Corrigan JJ Jr. Thrombocytopenia: a laboratory sign of septicemia in infants and children. Journal of Pediatrics 1974;83:219-221.

Cosnes A, Flechet ML, Revuz J. Inflammatory nodular reactions after hepatitis B vaccination due to aluminium sensitization. Contact Dermatitis 1990;23:65-67.

Costa M, Giannini V. [Case report of encephalitis occurring during and after measles] Encefalite

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

intra e metamorbillosa: contributo casistico. Giornale di Malattie Infettive e Parassitarie 1975;27:453-455.

Coulehan JL, Hallowell C, Michaels RH et al. Immunogenicity of a Haemophilus influenzae type b vaccine in combination with diphtheria-pertussis-tetanus vaccine in infants. Journal of Infectious Diseases 1983;148:530-534.

Coulter HL. Vaccination, Social Violence, and Criminality: The Medical Assault on the American Brain. Berkeley, CA: North Atlantic Books; 1990.

Coulter HL, Fisher BL. DPT: A Shot in the Dark. San Diego: Harcourt Brace Jovanovich; 1985.

Courrier A, Stenbach G, Simonnet P, Rumilly P, Lopez D, Coquillat G et al. Peripheral neuropathy following fetal bovine cell rabies vaccine (letter). Lancet 1986;1:1273.

Coursaget P, Bringer L, Sarr G, Bourdil C, Fritzell B, Blondeau C et al. Comparative immunogenicity in children of mammalian cell-derived recombinant hepatitis B vaccine and plasma-derived hepatitis B vaccine. Vaccine 1992;10:370-382.

Coursaget P, Relyveld E, Brizard A, Frenkiel MP, Fritzell B, Teulieres L et al. Simultaneous injection of hepatitis B vaccine with BCG and killed poliovirus vaccine. Vaccine 1992;10:319-321.

Coursaget P, Yvonnet, B, Chothard J, Sarr M, Vincelot TP, N'doye R, Diop-Mar I, Chiron JP. Seven year study of hepatitis B vaccine efficacy in infants from an endemic area (Senegal). Lancet 1986;2:1143-1145.

Coursaget P, Yvonnet B, Relyveld EH, Barres JL, Diop-Mar I, Chiron JP. Simultaneous administration of diphtheria-tetanus-pertussis-polio and hepatitis B vaccines in a simplified immunization program: immune response to diphtheria toxoid, tetanus toxoid, pertussis, and hepatitis B surface antigert . Infection and Immunity 1986;51:784-787.

Coursaget P, Yvonnet B, Sarr M et al. Clinical trial of hepatitis B vaccine in a simplified immunization programme. Bulletin of the World Health Organization 1986;64:867-871.

Coutinho RA, Lelie N, Albrecht Van Lent P. Efficacy of a heat inactivated hepatitis B vaccine in male homosexuals: outcome of a placebo controlled double blind trial. British Medical Journal 1983;286:1305-1308.

Cox NH, Forsyth A. Thiomersal allergy and vaccination reactions. Contact Dermatitis 1988;18: 229-233.

Cox NH, Moss C, Forsyth A. Cutaneous reactions to aluminium in vaccines: an avoidable problem. Lancet 1988;2:43.

Craighead JE. The role of viruses in the pathogenesis of pancreatic disease and diabetes mellitus. Progress in Medical Virology 1975;19:161-214.

Crawford GE, Gremillion DH. Epidemic measles and rubella in Air Force recruits: impact of immunization. Journal of Infectious Diseases 1981;144:403-410.

Cristi G, Dalbuono S. [Probable neurological complications caused by the Sabin type of oral antipoliomyelitis vaccine] Probabili complicazioni neurologiche da vaccino antipoliomielitico orale tipo Sabin . Rivista di Neurologia 1967;37:251-257.

Croft PB. Para-infectious and postvaccinal encephalomyelitis. Postgraduate Medical Journal 1969;45:392-400.

Crosnier J, Jungers P, Courouce AM. Randomised controlled trial of hepatitis B surface antigen vaccine in French haemophilus units. II. Haemodialysis patients. Lancet 1981;2:797-800.

Crossley KB, Gerding DN, Petzel RA. Acceptance of hepatitis B vaccine by hospital personnel. Infection Control 1985;6:147-149.

Crovari P, Gasparini R, D'Aste E, Culotta C, Romano L. [Case-control study on the association of neurological syndromes and compulsory vaccinations in Liguria during the period January 1980-February 1983] Studio caso-controllo sulla associazione tra sindromi neurologiche e vaccinazioni obbligatorie in Liguria nel periodo Gennaio 1980-Febbraio 1983. Bollettino dell Istituto Sieroterapico Milanese 1984;63:118-124.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Crowley S, Al-Jawad ST, Kovar IZ. Mumps, measles, and rubella vaccination and encephalitis. British Medical Journal 1989;299:660.

Cruickshank JG, Orme RL, Haas L, Gill NO, Roebuck MO, Magrath DI et al. Two cases of vaccine-associated paralytic poliomyelitis linked in time and place (letter). Lancet 1984;2:804-805.

Curtis T. Did a polio vaccine experiment unleash AIDS in Africa? Washington Post. April 5, 1992:C3.

Cutts FT, Zell ER, Mason D, Bernier RH, Dini EF, Orenstein WA. Monitoring progress toward U.S. Preschool Immunization Goals. Journal of the American Medical Association 1992;267:1952-1955.

D'Alessandro G, Dardanoni L, Albanese M, Brancato P, Cascio G, Romano N et al. [Research on the cases of paralytic poliomyelitis and neurological syndromes observed in Sicily during the 1st phase of the campaign of anti-poliomyelitis vaccination with attenuated viruses] Indagini su casi di poliomielite paralitica e sindromi neurologiche osservati in Sicilia durante la prima fase di attuazione della vaccinazione antipoliomielitica con virus attenuati. Igiene Moderna 1967;60:37-71.

D'Costa DF, Cooper A, Pye IF. Transverse myelitis following cholera, typhoid and polio vaccination. Journal of the Royal Society of Medicine 1990;83:653.

D'Cruz OF, Shapiro ED, Spiegelman KN, Leicher CR, Breningstall GN, Khatri BO et al. Acute inflammatory demyelinating polyradiculoneuropathy (Guillain-Barre syndrome) after immunization with Haemophilus influenzae type b conjugate vaccine . Journal of Pediatrics 1989;115:743-746.

Da Villa G, Piazza M, Iorio R, Picciotto L, Peluso P, De Luca G et al. A pilot model of vaccination against hepatitis B virus suitable for mass vaccination campaigns in hyperendemic areas. Journal of Medical Virology 1992;36:274-278.

Dacou-Voutetakis C, Constantinidis M, Moschos S, Vlachou C, Matsaniotis MD. Diabetes mellitus following mumps: insulin reserve. American Journal of Diseases of Children 1974;127:890-891.

Daggett P. Influenza and asthma (letter). Lancet 1992;339:367.

Dahlquist G, Blom L, Lonnberg G. The Swedish childhood diabetes study: a multivariate analysis of risk determinants for diabetes in different age groups. Diabetologia 1991;34:757-762.

Dal Bo S. [Allergic reactions against anti-tetanus toxoid] Reazioni allergiche da tossoide antitetanico. Folia Allergologica 1969;16:63-73.

Dal Canto MC, Rabinowitz SG. Experimental models of virus-induced demyelination of the central nervous system. Annals of Neurology 1982;11:109-127.

Daneault N, Albert G, Girouard Y, Remillard G, Furesz J. Postvaccinal poliomyelitis: a case report. Canadian Journal of Neurological Science 1986;12:202.

Daschbach RJ. Serum sickness and tetanus immunization. Journal of the American Medical Association 1972;220:1619.

Dashefsky B, Wald E, Guerra N, Byers C. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants. Pediatrics 1990;85(4 Pt 2):682-689.

Daum RS, Sood SK, Osterholm MT, Pramberg JC, Granoff PD, White KE et al. Decline in serum antibody to the capsule of Haemophilus influenzae type b in the immediate postimmunization period. Journal of Pediatrics 1989;114:742-747.

David D, Zehntner B. [Tetanus vaccination: adverse effects in diverse vaccination sites and mode of administration] Tetanusimpfung: Nebenwirkungen bei verschiedenen Impflokalisationen und Modus. Schweizerische Medizinische Wochenschrift 1971;101:1055-1056.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

David MF. Induction of anaphylaxis by commercially prepared pertussis and DPT vaccines in rats. Annals of the Royal College of Physicians and Surgeons of Canada 1975;8:41-42.

Davidson M, Letson W, Ward JI, Ball A, Bulkow L, Christenson P et al. DTP immunization and susceptibility to infectious diseases. American Journal of Diseases of Children 1991;145:750-754.

Davidson NM. S.S.P.E. in New Zealand (letter). Lancet 1973;2:1332-1333.

Davidson WL, Buynak EB, Leagus B, Whitman JE, Hilleman MR. Vaccination of adults with live attenuated mumps virus vaccine. Journal of the American Medical Association 1967;201:995-998.

Davies II. Immunological adjuvants of natural origin and their adverse effects. Adverse Drug Reaction and Acute Poisoning Review 1986;5:1-21.

Davignon L, Lussier G, Quevillon M, Lavergne B, Fauvel M, Aubert D. [Results of clinical trials of the superattenuated measles vaccine of the Institute Armand-Frappier] Resultats d'essais cliniques realises avec le vaccin rougeoleux surattenue I.A.F. Journal of Biological Standardization 1982;10:347-355.

Davis LE, Bodian D. Price D, Butler IJ, Vickers JH. Chronic progressive poliomyelitis secondary to vaccination of an immunodeficient child. New England Journal of Medicine 1977;297: 241-245.

Dawson JR. Cellular inclusions in cerebral lesions of lethargic encephalitis. American Journal of Pathology 1933;9:7-15.

Dawson JR. Cellular inclusions in cerebral lesions of epidemic encephalitis (second report). Archives of Neurology and Psychiatry 1934;31:685-700.

De Carli E, Gandolfo G. [Contribution to the statistics of reactions occurring in the subjects vaccinated with the Sabin method in the town of Pordenone from 1 March 1964 to 30 June 1965] Contributo ad una statistica delle reazioni avutesi fra i vaccinati col metodo Sabin nel comune di Pordenone dal 1 marzo 1964 al 30 giugno 1965. Annali della Sanita Pubblica 1966;27:1039-1049.

De la Plaza N, Isola MB. [Infrequent complication of oral anti-poliomyelitis vaccination] Complicacion poco frecuente de la vacunacion antipoliomielitica oral. Prensa Medica Argentina 1966;53:1680-1683.

De Prins F, Van Assche FA, Desmyter J, De Groote G, Gepts W. Congenital rubella and diabetes mellitus. Lancet 1978;1:439-440.

de Quadros CA, Andrus JK, Olive JM, Da Silveira CM, Eikhof RM, Carrasco P et al. Eradication of poliomyelitis: progress in the Americas. Pediatric Infectious Disease Journal 1991 :10:222-229.

De Ritis L, Pecorari R. [Thrombocytopenic purpura following measles vaccination] Porpora trombocitopenica in seguito a vaccinazione antimorbillosa. Pediatria Medica e Chirurgica 1990;12:161-163.

De Silva L, Rogers M. Hepatitis B vaccine: urticarial reaction (letter). Medical Journal of Australia 1985;143:323-324.

Deacon SP, Langford DT, Shepherd WM, Knight PA. A comparative clinical study of adsorbed tetanus vaccine and adult-type tetanus-diphtheria vaccine. Journal of Hygiene 1982;89:513-519.

Decker MD, Edwards KM, Bradley R, Palmer P. Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines. Journal of Pediatrics 1992;120(2 Pt. 1): 184-189.

Deforest A, Long SS, Lischner HW, Girone JA, Clark JL, Srinivasan R et al. Simultaneous administration of measles-mumps-rubella vaccine with booster doses of diphtheria-tetanus-pertussis and poliovirus vaccines. Pediatrics 1988;81:237-246.

Deibel R. Antigenic variations among type III poliomyelitis viruses. New York State Journal of Medicine 1964;64:2058-2065.

Deibel R, Barron A, Millian S, Smith V. Central nervous system infections in New York State. New York State Journal of Medicine 1974;74:1929-1935.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Deivanayagam N, Nedunchelian K. Epidemiological and clinical features of acute poliomyelitis children admitted in an urban hospital. Indian Pediatrics 1992;29:25-28.

Dekker PA. Paralytic poliomyelitis in children in Ethiopia: a review of 2604 cases. Ethiopian Medical Journal 1986;24:55-62.

Deliyannakis E. Peripheral nerve and root disturbances following active immunization against smallpox and tetanus. Military Medicine 1971;136:458-462.

Dentico P, Buongiorno R, Volpe A, Zavoianni A, Pastore G, Schiraldi O. Long-term immunogenicity, safety and efficacy of a recombinant hepatitis B vaccine in healthy adults. European Journal of Epidemiology 1992;8:650-655.

Department of Health and Social Security. Whooping Cough: Reports from the Committee on the Safety of Medicines and the Joint Committee on Vaccination and Immunization. London: Her Majesty's Stationery Office; 1981.

Derenne F, Vanderheyden JE, Bain H, Jocquet P, Jacquy J, Yane F et al. [Acute maternal anterior poliomyelitis in a nonendemic zone] Poliomyelite anterieure aigue maternelle en zone non endemique. Acta Neurologica et Psychiatrica Belgica 1989;89:358-365.

Desai BV, Dixit S, Pope RM. Limited proliferative response to type II collagen in rheumatoid arthritis. Journal of Rheumatology 1989;16:1310-1314.

Desmyter J. [Bogaert's disease and vaccination against measles] De ziekte van van Bogaert en de mazelenvaccinatie. Tijdschrift voor Geneeskunde 1978;34:339-341.

Deutsche Medizinische Wochenschrift. [Safety of hepatitis B vaccine] Sicherheit von Impfstoffen gegen Hepatitis B. Deutsche Medizinische Wochenschrift 1983;108:754-755.

Devey ME, Bleasdale K, Isenberg DA. Antibody affinity and IgG subclass of responses to tetanus toxoid in patients with rheumatoid arthritis and systemic lupus erythematosus. Clinical and Experimental Immunology 1987;68:562-569.

Di Cristofano A. [Measles vaccination in children allergic to eggs] La vaccinazione contro il morbillo in bambini allergici all'uovo. Professioni Infermieristiche 1989;42:24-30.

Di Giusto CA, Bernhard JD. Erythema nodosum provoked by hepatitis B vaccine (letter). Lancet 1986;2:1042.

Di Stasio L, Esposito G, Di Stasio M. [Contribution to the study of neonatal, fulminating laryngo-tracheo-bronchitis after antidiphtheria antitetanus prophylaxis] Contributo allo studio delle laringo-tracheo-bronchiti fulminanti neonati dopo profilassi antidifterico-antitetanica . Osp Ital Pediatr Spec Chir 1979;14(Suppl. 2):143-148.

Diamond S. Childhood routine immunizations. On Contin Pract 1990;17:9-16.

Dickersin K. The existence of publication bias and risk factors for its occurrence. Journal of the American Medical Association 1990;263:1385-1389.

Dickersin K, Berlin JA. Meta-analysis: state-of-the-science. Epidemiological Reviews 1992;14:154-176.

Dickersin K, Hewitt P, Mutch L, Chalmers I, Chalmers TC. Perusing the literature: comparison of MEDLINE searching with a Perinatal Trials Database. Controlled Clinic Trials 1985;6:306-317.

Dickersin K, Min YI, Meinert CL. Factors influencing publication of research results: follow-up of applications submitted to two institutional review boards. Journal of the American Medical Association 1992;267:374-378.

Dieckhoefer K, Scholl R, Wolf R. [Neurological disorders after protective tetanus vaccination]. Neurologische Storungen nach Tetanusschutzi. Medizinische Welt 1978;29:1710-1712.

Dietzsch HJ, Kiehl W. [Central nervous complications after measles vaccination] Zentralnervose Komplikationen nach Masern-Schutzimpfung. Deutsche Gesundheitswesen 1976;31:2489-2491.

Dietzsch H J, Leupold W, Rogner G. [Occurrence and importance of complications in measles] Haufigkeit und Bedeutung der Masernkomplikationen. Zeitschrift fur Aerztliche Fortbildung 1971;65:138-140.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Diop Mar I, Conde K, Sow A, Badiane S. [Neuropathies in the course of diphtheria] Les neuropathies au cours de la diphterie. Bulletin de la Societe Medicale d'Afrique Noire de Langue Francaisc 1976;21:455-464.

Dirtmann S. [Smallpox vaccination: atypical course] Die Pockenschutzimpfung und ihre atypischen Verlaufsformen. Beltrage zur Hygiene und Epidemiologie 1981;25:26-76.

Dittmann S. [Measles immunization: atypical course] Die Masernschutzimpfung und ihre atypischen Verlaufsformen. Beltrage zur Hygiene und Epidemiologie 1981;25:76-94.

Dittmann S. [Diphtheria immunization: atypical course] Die Diphtherieschutzimpfung und Ihre atypischen Verlaufsformen. Beltrage zur Hygiene und Epidemiologie 1981;25:143-154.

Dittmann S. [Measles immunization] Masernschutzimpfung. Beltrage zur Hygiene und Epidemiologie 1981;25:213-217.

Dittmann S. [Diphtheria immunization] Diphterieschutzimpfung. Beitrage zur Hygiene und Epidemiologie 1981;25:237-239.

Dittmann S. [Tetanus immunization] Tetanusschutzimpfung. Beitrage zur Hygiene und Epidemiologie 1981;25:239-240.

Dodson WE. Metabolic encephalopathies in neurological pathophysiology. In: Eliasson SG, Prensky AL, Hardin WB Jr., eds. Neurological Pathophysiology. New York: Oxford; 1978.

Dodson WE, Pasternak J, Trotter JL. Rapid deterioration in subacute sclerosing panencephalitis after measles immunization (letter). Lancet 1978;1:767-768.

Dolinova L. [Bilateral uveoretinoneuritis following DTP vaccination] Bilateralni uveoretinoneuritida po ockovani DITEPE. Ceskoslovenska Oftalmologie 1974;30:114-116.

Dolovich J, Hargreave FE, Chalmeis R, Shier KJ, Cauldie J, Bienenstock J. Late cutaneous allergic responses in isolated-IgE-dependent reactions. Journal of Allergy and Clinical Immunology 1973;52:38-46.

Domok I. Experiences associated with the use of live poliovirus vaccine in Hungary, 1959-1982. Reviews of Infectious Diseases 1984;6(Suppl. 2):S413-S418.

Domorazkova E, Drevo M, Bergmannova V, Stehlikova J, Vodickova M, Slonim D. [Comparison of clinical and serological results after the intravenous and subcutaneous administration of measles vaccine]. Ceskoslovenska Pediatric 1982;37:19-22.

Domorazkova E, Janotova J, Vodickova M, Drevo M. [Relationship between the age of the child and the degree of body temperature and antibody titre after vaccination against measles] Vztah veku ditete k vysce teploty a titru protilatek po ockovani proti spalnickam. Ceskoslovenska Pediatrie 1975;30:468-470.

Donaghy M, Gray JA, Squier W, Kurtz JB, Higgins RM, Richardson AJ et al. Recurrent Guillain-Barre syndrome after multiple exposures to cytomegalovirus. American Journal of Medicine 1989;87:339-341.

Donchev D, Arabadzhieva T, Zhukovets V, Iancheva B. [A comparative study of live measles vaccines in controlled epidemiologic trials] Sravnietl'noe izuchenie zhivykh korevykh vaktsin v kontroliruemom epidemiologicheskom opyte. Voprosy Virusologii 1969;14:104-107.

Donner M, Halonen H, Haltia M. [Subacute sclerosing panencephalitis] Subakuutti sklerosoiva panenkefaliitti. Duodecim 1969;85:541-553.

Dontschev D, Gatscheva N, Kossev B. [On the epidemiological effectiveness of mass vaccination against mumps in the People's Republic of Bulgaria] Uber die Epidemiologische wirksamkeit der Massenimpfung gegen Mumps in der VR Bulgarien . Padiatrie und Grenzgebiete 1980;19:151-156.

Doffman RF, Herweg JC. Live, attenuated measles virus vaccine. Inguinal lymphadenopathy complicating administration. Journal of the American Medical Association 1966;198:320-321.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Dorndorf W, van Rey W, Arndt T. Zur Frage neurologischer komplikationen nach der oralen poliomyelitisimpfung (Sabin). Nervenarzt 1963;34:473-480.

Dosik H, Tricarico F. Haemolytic-uraemic syndrome following mumps vaccination. Lancet 1970;1:247.

Douglas SD, Anolik R. Postvaccination paralysis in a 20-month-old child. Hospital Practice 1981;16:40A.

Drucker J, Soula G, Diallo O, Fabre P. Evaluation of a new combined inactivated DPT-polio vaccine. Developments in Biological Standardization 1986;65:145-151.

Drug and Therapeutics Bulletin. Contraindications to childhood immunization. Drug and Therapeutics Bulletin 1988;26:81-84.

Drug and Therapeutics Bulletin. Haemophilus influenzae b immunization. Drug and Therapeutics Bulletin 1993;31:1-2.

Drug and Therapeutics Bulletin. Update on MMR vaccination. Drug and Therapeutics Bulletin 1991;29:61-62.

Deutsche Apotheker Zeitung. [Haemophilus influenzae type b vaccination] Haemophilus influenzae type b Impfprophylaxe mit hib-vakzine. Deutsche Apotheker Zeitung 1991;131:2179-2180.

Duclos P, Koch J, Hardy M. Immunizing Agent-Associated Adverse Events, Canada, 1987-1990. Ottawa, Ontario: Laboratory Centre for Disease Control; 1992.

Ducos J, Colombies P, Ohayon E. [Oral administration of polio vaccine: subsequent hypersensitivity reaction—blast transformation test for etiologic diagnosis] Administration orale de vaccin antipoliomyelitique: reaction d'hypersensibilite consequente—interet du test de transformation blastique pour le diagnostic etiologique. Presse Medicale 1968;76:2347-2348.

Dudgeon JA. Antibody response and clinical reactions in children given measles vaccine with immunoglobulin. British Medical Journal 1986;293:206.

Dufour FD, Arce MA, St, Geme JW Jr. Correlation between the potency of mumps virus skin test antigen and cutaneous delayed hypersensitivity. Journal of Pediatrics 1972;81:742-746.

Dunlop JM, RaiChoudhury K, Roberts JS, Bryett KA. An evaluation of measles, mumps and rubella vaccine in a population of Yorkshire infants. Public Health 1989;103:331-335.

Dunmire C, Ruckdeschel JC, Mardiney MR Jr. Suppression of in vitro lymphocyte responsiveness to purified protein derivative by measles virus: a reexploration of the phenomenon. Cellular Immunology 1975;20:205-217.

Duplay H, Monnier B, Bracco J, Dellamonica P. [Acute glomerulonephritis associated with Fisher's syndrome after tetanus prophylaxis (letter)] Glomerulonephrite aigue associee a un syndrome de M. Fisher apres prevention anti-tetanique. Nouvelle Presse Medicale 1980;9:315.

Durrer A. [Vaccination of children against bacterial meningitis] La vaccination des enfants contre la meningite bacterienne. Schweizerische Apotheker-Zeitung / Journal Suisse de Pharmacie 1992;130:89-90.

Duverne J, Volle H, Gogue Y. [Hyperergic accidents of the Sanarelli-Shwartzman type caused by DT-polio vaccination in children] Accidents hyperergiques du type Sanarelli-Shwartzman par vaccination DT-polio chez l'enfant. Bulletin de la Societe Francaisc de Dermatologie et de Syphiligraphie 1966;73:221-223.

Duvina PL, Bini E. [Complications due to oral poliomyelitis vaccination] Complicazioni in corso di vaccinazione antipoliomielitica orale. Giornale di Malattie Infettive e Parassitarie 1970;22:307.

Duvina PL, Bini R. [Reactions caused by the Sabin poliovirus vaccine in infants. (Considerations on 134 cases hospitalized in 1965)] Le reazioni da poliovaccino Sabin nel lattante. (Considerazioni su 134 casi ricoverati nel 1965). Rivista di Clinica Pediatrica 1966;78:400-411.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Dyken PR, Cunningham SC, Ward LC. Changing character of subacute sclerosing panencephalitis in the United States. Pediatric Neurology 1989;5:339-341.

Dyrberg T, Schwimmbeck PL, Oldstone MB A, et al. Inhibition of diabetes in BB rats by virus infection. Journal of Clinical Investigation 1988;81:928-931.

Dyro FM. Vaccination mononeuropathy. Annals of Neurology 1978;3:468.

Easton JG. Egg-derived vaccines (letter). Annals of Allergy 1991;66:519.

Edees S, Pullan CR, Hull D. A randomised single blind trial of a combined mumps measles rubella vaccine to evaluate serological response and reactions in the UK population. Public Health 1991;105:91-97.

Eden AN. Guillain-Barre syndrome in a six-month-old infant. American Journal of Diseases of Children 1961;102:224-227.

Edsall G. The current status of tetanus immunization. Hospital Practice 1971;6:57-66.

Edsall G et al. Diphtheria, tetanus, and pertussis immunization. Archives of Environmental Health 1967;15:473-477.

Edsall G et al. Specific Prophylaxis of tetanus. Journal of the American Medical Association 1959;171:417-428.

Edsall G, Altman JS, Gaspar AJ. Combined tetanus-diphtheria immunization of adults: use of small doses of diphtheria toxoid. American Journal of Public Health 1954;44:1537-1545.

Edsall G, Elliott MW, Peebles TC, Levine L, Eldred MC. Excessive use of tetanus toxoid boosters. Journal of the American Medical Association 1967;202:17-19.

Edsall G, Elliott MW, Peebles TC, Eldred MC. Excessive use of tetanus toxoid boosters. Journal of the American Medical Association 1967;202:111-113.

Edwards KM, Decker MD, Halsey NA, Koblin BA, Townsend T, Auerbach B et al. Differences in antibody response to whole-cell pertussis vaccines. Pediatrics 1991;88:1019-1023.

Edwards KM, Decker MD, Porch CR, Palmer P, Bradley R. Immunization after invasive Haemophilus influenzae type b disease: serologic response to a conjugate vaccine. American Journal of Diseases of Children 1989 ;143:31-33.

Edwards R. A report on the incidence of adverse events following low dose hepatitis B vaccination. 1989. Unpublished.

Egashira Y. On some problems of complications in the central nervous system due to vaccination. Japanese Journal of Medical Sciences and Biology 1968;21:297-298.

Eggers HJ, Mertens T. Polio vaccination (letter). Journal of the American Medical Association 1987;258:322-323.

Eggers HJ, Weyer J. Provocation paralysis (letter). Lancet 1993;341:62.

Ehrengut W. [Present problems of tetanus vaccination] Gegenwartige Fragen der Tetanusschutzimpfung. Monatsschrift fur Kinderheilkunde 1969;117:117-118.

Ehrengut W. Diabetes mellitus dutch impfenzephalitis? [Diabetes mellitus from postvaccinal encephalitis?]. Deutsche Medizinische Wochenschrift 1970;95:1135.

Ehrengut W. Susceptibility to infection after vaccination. British Medical Journal 1972;1:683.

Ehrengut W. [Immunization in allergic patients: 1] Schutzimpfungen bei Allergikem: 1. Medizinische Klinik 1973;68:939-942.

Ehrengut W. [Immunization in allergic patients: 2] Schutzimpfungen bei Allergikern: 2 . Medizinische Klinik 1973;68:972-974.

Ehrengut W. [Convulsive reactions after pertussis immunization] Uber konvulsive Reaktionen nach Pertussis-Schutzimpfung. Deutsche Medizinische Wochenschrift 1974;99:2273-2279.

Ehrengut W. [Complications of immunizations] Impfkomplikationen. Deutsche Medizinische Wochenschrift 1975; 100:499.

Ehrengut W. [Multiple immunizations and their complications] Mehrfachschutzimpfungen und ihre Komplikationen. Deutsches Arzteblatt 1976;15:1009-1012.

Ehrengut W. Dermatomyositis and vaccination (letter). Lancet 1978;1:1040-1041.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Ehrengut W. Whooping-cough vaccination: comment on report from Joint Committee on Vaccination and Immunization. Lancet 1978;2:370-371.

Ehrengut W. Die parenteral Pertussis-Schutzimfung: Schaden-Nutzen Relation. Monatsschrift fur Kinderheilkunde 1981;129:67-69.

Ehrengut W. Central nervous sequelae of vaccinations (letter). Lancet 1986;1:1275-1276.

Ehrengut W. [Neural complications following immunization against diphtheria] Neurale komplikastionen nach diphtherie-schutzumpfung und impfungen mit diphtherietoxoidmischimpfstoffen. Deutsche Medizinische Wochenschrift 1986;111:939-942.

Ehrengut W. Mumps vaccine and meningitis (letter). Lancet 1989;2:751.

Ehrengut W. Attenuation and antigenicity of mumps vaccine: significance for vaccination praxis. Padiat Prax 1990;40:379-381.

Ehrengut W. Central nervous system sequelae of immunization against measles, mumps, rubella and poliomyelitis. Acta Paediatrica Japonica 1990;32:8-11.

Ehrengut W, Allerdist H. [Neurological complications after influenza vaccination] Uber neurologische Komplikationen nach der Influenza-schutzimpfung. Munchener Medizinische Wochenschrift 1977;119:705-710.

Ehrengut W, Ehrengut J. Convulsions following oral polio immunization. Developments in Biological Standardization 1979;43:165-171.

Ehrengut W, Ehrengut-Lange J. [Intercurrent fatal diseases after oral polio vaccination and smallpox vaccination] Interkurrente todliche Erkrankungen nach Polioschluckimpfung und Pockenschutzimpfung. Munchener Medizinische Wochenschrift 1969:111:1092-1099.

Ehrengut W, Ehrengut-Lange J. [On convulsive reactions following oral vaccination against polio] Uber konvulsive Reaktionen nach Polioschluckimpfung. Klinische Paediatrie 1979;191:261-270.

Ehrengut W, Staak M. [Anaphylactic reaction following injection of tetanus toxoid] Anaphylaktische Reaktion nach Tetanus toxoid-Injektion. Deutsche Medizinische Wochenschrift 1973;98:517.

Ehrengut W, Zastrow K. [Complications ''following'' mumps vaccinations in the Federal Republic of Germany (including combined vaccine immunizations)] Komplikationen "nach" Mumpsschutzimpfungen in der Bundesrepublik Deutschland (einschliesslich Mehrfachschutzimpfungen). Monatsschrift fur Kinderheilkunde 1989;137:398-402.

Ehrengut W, Georges AM, Andre FE. The reactogenicity and immunogenicity of the Urabe Am 9 live mumps vaccine and persistence of vaccine induced antibodies in healthy young children. Journal of Biological Standardization 1983;11:105-113.

Eicher W, Neundorfer B. [Paralysis of the recurrent laryngeal nerve following a booster injection of tetanus toxoid (associated with local allergic reaction)] Rekurrenslahmung nach Tetanus toxoid-Auffrischimpfung (mit allergischer Lokalreaktion). Munchener Medizinische Wochenschrift 1969;111:1692-1695.

Einarson TR, Leeder JS, Koren G. A method for meta-analysis of epidemiological studies. Drug Intelligence and Clinical Pharmacy 1988;22:813-824.

Einhorn MS, Weinberg GA, Anderson EL et al. Immunogenicity in infants of Haemophilus influenzae type b polysaccharide in a conjugate vaccine with Neisseria meningitidis outer-membrane protein. Lancet 1986;2:299-302.

Eisen AH, Cohen JJ, Rose B. Reaction to tetanus toxoid. New England Journal of Medicine 1963;269:1408-1411.

Ekunwe EO. Immunization by inhalation of aerosolized measles vaccine. Annals of Tropical Paediatrics 1990;10:145-149.

Eller JJ. Inactivated myxovirus vaccines, atypical illness, and delayed hypersensitivity. Journal of Pediatrics 1969;74:664-666.

Elliman D. Adverse reactions and immunization schedules. Current Opinion in Infectious Disease 1989;2:773-778.

Elliman D, Dhanraj B. Safe MMR vaccination despite neomycin allergy (letter). Lancet 1991;337:365.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Elliman D, Miller CL. Antibody response and clinical reactions in children given measles vaccine with immunoglobulin (letter). British Medical Journal 1986;292:1597-1598.

Elliott RB, Martin M. Dietary protein: a trigger of insulin-dependent diabetes in the BB rat. Diabetologia 1984;26:297-299.

Emanuel I, Ansell JS. Congenital abnormalities after mumps vaccination in pregnancy. Lancet 1971;2:156-157.

Emini EA, Ellis RW, Miller WJ. Production and immunological analysis of recombinant hepatitis B vaccine. Journal of Infection 1986;13(Suppl. A.):3-9.

Enders JF. Techniques of laboratory diagnosis, tests for susceptibility, and experiments on specific prophylaxis. Journal of Pediatrics 1946;29:129-142.

Enders JF, Peebles TC. Propagation in tissue culture of cytopathic agents from patients with measles. Proceedings of the Society for Experimental Biology and Medicine 1954;86:277-286.

Enders JF, Weller TH, Robbins FC. Cultivation of the Lansing strain of poliomyelitis virus in cultures of various human embryonic tissues. Science 1949;109:85-87.

Enders-Ruckle G. Frequency, serodiagnosis and epidemiological features of subacute sclerosing panencephalitis (SSPE) and epidemiology and vaccination policy for measles in the Federal Republic of Germany (FRG). Developments in Biological Standardization 1978;41:195-207.

Enders-Ruckle G, Spiess H, Wolf H. [First results with a quintuple vaccine against measles, diphtheria, whooping cough, tetanus and poliomyelitis] Erste Ergebnisse mit einem Funffachimpistoff gegen Masern, Diphtherie, Pertussis, Tetanus, Poliomyelitis. Deutsche Medizinische Wochenschrift 1966;91:575-580.

Enell H, Simonsson H. [Vaccination against measles—adverse effects, cause of reduced protective effect in investigated material] Masslingsvaccinering—biverkningar, orsak till minskad skyddseffekt i ett studerat material. Lakartidningen 1973;70:3357-3358.

Englund JA, Suarez CS, Kelly J, Tate DY, Balfour HH Jr. Placebo-controlled trial of varicella vaccine given with or after measles-mumps-rubella vaccine. Journal of Pediatrics 1989;114:37-44.

Erdmann G. [Vaccination allergy] Impfallergie. Allergologie 1987;10:48-55.

Eskola J, Kayhty H, Takala AK, Peltola H, Ronnberg PR, Kela E et al. A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease. New England Journal of Medicine 1990;323:1381-1387.

Eskola J, Kayhty H, Takala A, Ronnberg PR, Kela E, Peltola H. Reactogenicity and immunogenicity of combined vaccines for bacteraemic diseases caused by Haemophilus influenzae type b, meningococci and pneumococci in 24-month-old children. Vaccine 1990;8:107-110.

Eskola J, Peltola H, Takala AK, Kayhty H, Hakulinen M. Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy. New England Journal of Medicine 1987;317:717-722.

Eskola J, Takala AK, Kayhty H, Peltola H, Makela PH. Protection achieved by Haemophilus influenzae type b (Hib) conjugate vaccines is better than expected on the basis of efficacy trials. Program Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. Abstract 979, p. 273. Washington, DC: American Society for Microbiology; 1992.

Evans OB. Guillain-Barre syndrome in children. Pediatrics in Review 1986;8:69-74.

Evans OB et al. Pediatrics for the clinician. Pediatrics 1979;64:96-105.

Eyquem E, de Saint Martin J. [Anti-tetanus immunization: complexity and polymorphism of humoral and cellular manifestations] Immunization anti-tetanique: complexite et polymorphisme des manifestations humorales et cellulaires. Revue Francaise de Transfusion et Immunohematologie 1987;30:193-221.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Fabiani F, Cioffi P. [On some neurologic complications during vaccination with the Sabin vaccine] Su alcune complicanze neurologiche in torso di vaccinazione alla Sabin. Rivista di Neurobiologia 1967;13:127-130.

Facktor MA, Bernstein RA, Fireman P. Hypersensitivity to tetanus toxoid. Journal of Allergy and Clinical Immunology 1973;52:l-12.

Faden H, Duffy L. Effect of concurrent vital infection on systemic and local antibody responses to live attenuated and enhanced-potency inactivated poliovirus vaccines. American Journal of Diseases of Children 1992;146:1320-1323.

Fagan EA, Williams R. Hepatitis B vaccination. British Journal of Clinical Practice 1987;41:569-576.

Faich GA. Adverse drug reaction monitoring. New England Journal of Medicine 1986;314:1589-1592.

Fajans SS. Diabetes Mellitus. In: DeGroot LJ et al., ed. Endocrinology. Philadelphia: W.B. Saunders; 1989.

Family Practice News. HHS urged to tighten definitions of vaccine injuries. Family Practice News 1992;22:37.

Family Practice News. Not yet clear if new Hib vaccines can be mixed. Family Practice News 1991;21:20.

Fankhauser R, Freudiger U, Vandevelde M, Fatzer R. [Atrophy of Purkinje cells following measles virus vaccination in the dog] Purkinjezellatrophie nach Masernvirus-Vakzinierung beim Hund. Schweizer Archiv fur Neurologie, Neurochirurgie und Psychiatric 1973;112:353-363.

Fardon DF. Unusual reactions to tetanus toxoid. Journal of the American Medical Association 1967;199:125-126.

Farizo KM, Cochi SL, Patriarca PA. Poliomyelitis in the United States: a historical perspective and current vaccination policy. Journal of American College Health 1990;39:137-143.

Farkkila M, Kinnunen E, Weckstrom P. Survey of Guillain-Barre syndrome in southern Finland. Neuroepidemiology 1991;10:236-241.

Farwell JR, Dohrmann G J, Marrett LD, Meigs JW. Effect of SV40 virus-contaminated polio vaccine on the incidence and type of CNS neoplasms in children: a population-based study. Transactions of the American Neurological Association 1979;104:261-264.

Fasano MB, Wood RA, Cooke SK, Sampson HA. Egg hypersensitivity and adverse reactions to measles, mumps, and rubella vaccine. Journal of Pediatrics 1992;120:878-881.

FDA Drug Bulletin. Hib vaccine recommendations. FDA Drug Bulletin 1985;15:18-19.

Feasby TE, Gilbert JJ, Brown WF, Bolton CF, Hahn AF, Koopman WF et al. An acute axonal form of Guillain-Barre polyneuropathy. Brain 1986;109:1115-1126.

Feasby TE, Hahan AF, Brown WF, Bolton CF, Gilbert J. J., Koopman WJ. Severe axonal degeneration in acute Guillain-Barre syndrome: evidence of two different mechanisms? Journal of the Neurological Sciences 1993;116:185-192.

Feery BJ. Incidence and type of reactions to triple antigen (DTP) and DT (CDT) vaccines. Medical Journal of Australia 1982;2:511-515.

Feigin RD, Guggenheim MA, Johnsen SD. Vaccine-related paralytic poliomyelitis in an immunodeficient child. Journal of Pediatrics 1971;79:642-647.

Feldman R, Kamath D, Christopher S. Oral poliovaccine and paralysis. Indian Pediatrics 1968;5:475-478.

Feldman S, Gigliotti F, Shenep JL, Roberson PK, Lott L. Risk of Haemophilus influenzae type b disease in children with cancer and response of immunocompromised leukemic children to a conjugate vaccine. Journal of Infectious Diseases 1990;161:926-931.

Feldshon SD, Sampliner RE. Reaction to hepatitis B virus vaccine (letter). Annals of Internal Medicine 1984;100:156-157.

Fenichel GM. Neurological complications of immunization. Annals of Neurology 1982;12:119-128.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Fenichel GM. Neurologic complications of tetanus toxoid (letter). Archives of Neurology 1983;40:390.

Fenichel GM, Lane DA, Livengood JR, Horwitz SJ, Menkes JH, Schwartz JF. Adverse events following immunization: assessing probability of causation. Pediatric Neurology 1989;5:287-290.

Fenner F. Vaccination: its birth, death and resurrection; eighth Burnet lecture of the Australian Academy of Science, 1985. Australian Journal of Experimental Biology and Medical Science 1985;63((Pt. 6):607-622.

Fernandez de Castro J, Kumate J. [Vaccination against measles. The situation in Mexico and America. Advances in the method of aerosol immunization] La vacunacion contra el sarampion. Situacion en Mexico y America. Avances en el metodo de inmunizacion por aerosol. Boletin Medico del Hospital Infantil de Mexico 1990;47:449-461.

Fernandez Bracho JG, Roldan Fernandez SG. [Early reactions in pupils vaccinated with an aerosol measles vaccine] Reacciones tempranas en escolares vacunados con antisarampionosa en aerosol. Salud Publica de Mexico 1990;32:653-657.

Ferreccio C, Clemens J, Avendano A, Horwitz I, Flores C, Avila L et al. The clinical and immunologic response of Chilean infants to Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine coadministered in the same syringe with diphtheria-tetanus toxoids-pertussis vaccine at two, four and six months of age. Pediatric Infectious Disease Journal 1991;10:764-771.

Fescharek R, Quast U, Maass G, Merkle W, Schwarz S. Measles-mumps vaccination in the FRG: an empirical analysis after 14 years of use. I. Efficacy and analysis of vaccine failures . Vaccine 1990;8:333-336.

Fescharek R, Quast U, Maass G, Merkle W, Schwarz S. Measles-mumps vaccination in the FRG: an empirical analysis after 14 years of use. II. Tolerability and analysis of spontaneously reported side effects. Vaccine 1990;8:446-456.

Field EJ, Caspary EA, Shenton BK, Madgwick H. Lymphocyte sensitization after exposure to measles, and influenza: possible relevance to pathogenesis of multiple sclerosis. Journal of the Neurological Sciences 1973;19:179-187.

Fillastre C, Bregere P, Guerin N. [Tetravalent diphtheria, tetanus, pertussis and inactivated poliomyelitis vaccine] Vaccination tetravalente diphterique, tetanique, coquelucheuse et poliomyelitique inactivee. Archives Francaises de Pediatrie 1989;46:693-700.

Fine PM, Chen RT. Confounding in studies of adverse reactions to vaccines. American Journal of Epidemiology 1992;136:121-135.

Fischmeister M. [Acute reaction following injection with tetanus toxoid (letter).]. Akute Reaktion nach Tetanustoxoi-Injektion. Deutsche Medizinishe Wochenschrift 1974;99:850.

Fisher M. Anaphylaxis. Diseases of Man 1987;33:433-479.

Fishman PS, Carigan DR. Motoneuron uptake from the circulation of the binding fragment of tetanus toxin. Archives of Neurology 1988;45:558-561.

Flahaut A, Messiah A, Jougla E, Bouvet E, Perin J, Hatton F. Sudden infant death syndrome and diphtheria/tetanus toxoid/pertussis/poliomyelitis immunization (letter). Lancet 1988;1:582-583.

Floyd CB, Freeling P. Survey to establish the incidence of minor side effects in infants following protective immunization. Journal of the Royal College of General Practitioners 1989;39:359-363.

Foege WH, Eddins DL. Mass vaccination programs in developing countries. Progress in Medical Virology 1973;15:205-243.

Foege WH, Foster SO. Multiple antigen vaccine strategies in developing countries. American Journal of Tropical Medicine and Hygiene 1974;23:685-689.

Folie Pharmacother. Hypersensibilite aux vaccins contre l'hepatite B. Folie Pharmacother 1992;19: 31-32.

Food and Drug Administration. No AIDS risk from polio vaccines. FDA Talk Paper, No. T92-19, April 6, 1992.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Food and Drug Administration. Unapproved DTP vaccine vials. FDA Talk Paper, No. T92-17 , March 27, 1992.

Forsey T, Bentley ML, Minor PD, Begg N. Mumps vaccines and meningitis. Lancet 1992;340:980.

Forsey T, Mawn JA, Yates PJ, Bentley ML, Minor PD. Differentiation of vaccine and wild mumps viruses using the polymerase chain reaction and dideoxynucleotide sequencing. Journal of General Virology 1990;71(Pt. 4):987-990.

Forsey T, Minor PD. Mumps viruses and mumps, measles, and rubella vaccine (letter). British Medical Journal 1989;299:1340.

Forster J. Urbanek R. [Encephalitis following measles-mumps vaccination simultaneous to an EBV-infection] Encephalitis nach masern-mumps-impfung und gleichzeitiger EBV-infektion. Klinische Paediatrie 1982;194:29-30.

Forstrom L, Hannuksela M, Kousa M, Lehmuskallio E. Merthiolate hypersensitivity and vaccination. Contact Dermatitis 1980;6:241-245.

Fort P. Sekaran C, Stone P, Teichberg S, Wapnir RA, Lifshitz F. Mumps vaccine effects on glucose tolerance in genetically susceptible diabetes mellitus mice (DBA) (abstract no. 173). Diabetes 1977;26(Sup. 1):396.

Fothergill LD, Wright J. Influenzal meningitis: the relation of age incidence to the bactericidal power of blood against the causal organism. Journal of Immunology 1933;24:273-284.

Foulis AK. In type 1 diabetes, does a noncytopathic viral infection of insulin-secreting B-cells initiate the disease process leading to their autoimmune destruction. Diabetic Medicine 1989;6:666-674.

Fourrier A. Valet PM, Mouton Y. [Encephalitis due to viral vaccines] Les encephalites des vaccins a virus. Journal de Medicine de Montpellier 1974;9:39-46.

Francis DP, Feorino PM, McDougal S. The safety of the hepatitis B vaccine: inactivation of the AIDS virus during routine vaccine manufacture. Journal of the American Medical Association 1986;256:869-872.

Francis DP, Hadler SC, Thompson SE et al. The prevention of hepatitis B with vaccine: report of the Centers for Disease Control multi-center efficacy trial among homosexual men. Annals of Internal Medicine 1982;97:362-366.

Frank AL, Labotka RJ, Rao S, Frisone LR, McVerry PH, Samuelson JS et al. Haemophilus influenzae type b immunization of children with sickle cell diseases. Pediatrics 1988;82:571-575.

Frank J, Loh K. SSPE: but we thought measles was gone! Journal of Pediatric Nursing 1991;6:87-92.

Frantzidou-Adamopoulou F. Poliomyelitis cases in northern Greece during 1976-1990. European Journal of Epidemiology 1992;8:112-113.

Fra Sundhedsstyrelsen. [Complications in poliovaccination with Sabin vaccine in Spring, 1966] Komplikationer ved poliovaccinationen med Sabin-vaccine forangaret 1966. Fra Sundhedsstyrelsen 1967;4:201-208.

Frayha HH, Dent P, Shannon HS, Johnson SE, Gordon L. Safety and immunogenicity of subcutaneous H. influenzae vaccines in 15-17 month-old children. Clinical and Investigative Medicine [Medicine Clinique et Experimentale] 1991;14:379-387.

Freeman T. Erythema multiforme in children taking amoxicillin after vaccination. Canadian Medical Association Journal 1982;127:818-820.

Fried M, Conen D, Conzelmann M, Steinemann E. Uveitis after hepatitis B vaccination (letter). Lancet 1987;2:631-632.

Friedland IR, Snipelisky M. Contraindications to immunization. South African Medical Journal 1990;78:169-170.

Fritz RB, McFarlin DE. Encephalitogenic epitopes of myelin basic protein. Chemical Immunology 1989;46:101-125.

Fritzell B, Plotkin S. Efficacy and safety of a Haemophilus influenzae type b capsular polysaccharide-tetanus protein conjugate vaccine. Journal of Pediatrics 1992;121:355-362.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Froeschle JE, Connaught Laboratories. Presentation to the Institute of Medicine Vaccine Safety Committee. Public Meeting. Washington, DC, May 11, 1992.

Frontera Izquierdo P. [Should we modify antipoliomyelitis vaccination?] Debemos modificar la vacunacion antipoliomielitica? Anales Espanoles de Pediatria 1986;24:209-211.

Frosner GG. [Hepatitis B immunization: results of clinical trial and one year's use] Impfung gegen Hepatitis B: Ergebnisse der klinischen Prufung und der einjahrigen Anwendung. Monatsschrift fur Kinderheilkunde 1984;132:495-498.

Fujii H, Moriyama K, Sakamoto N, Kondo T, Yasuda K, Hiraizumi Y et al. Gly 145 to Arg substitution in HBs antigen of immune escape mutant of hepatitis B virus. Biochemical and Biophysical Research Communications 1992;184:1152-1157.

Fujinaga T, Motegi Y, Tamura H, Kuroume T. A prefecture-wide survey of mumps meningitis associated with measles, mumps and rubella vaccine. Pediatric Infectious Disease Journal 1991;10:204-209.

Fujinami RS. Molecular mimicry. In: The Autoimmune Diseases. Academic Press, Inc.; 1992.

Fujinami RS, Oldstone MB. Molecular mimicry as a mechanism for virus-induced autoimmunity. Immunologic Research 1989;8:3-15.

Fujiyama S. Yoshida K, Sato T, Shimada H, Deguchi T. Immunogenicity and safety of recombinant yeast-derived hepatitis B vaccine in haemodialysis patients. Hepatogastroenterology 1990;37(Suppl. 2):140-144.

Fukumi H. [Viral vaccine: immunity and vaccine]. [Japanese Journal of Clinical Medicine] Nippon Rinsho 1971;29:1218-1224.

Fukuyama Y, Shirki K. [Current problems of measles encephalitis]. Naika 1970;25:416-420.

Fukuyama Y, Tomori N, Sugitate M. Critical evaluation of the role of immunization as an etiological factor of infantile spasms. Neuropadiatrie 1977;8:224-237.

Fulginiti VA. The problems of poliovirus immunization. Hospital Practice 1980;15:61-67.

Fulginiti VA. How safe are pertussis and rubella vaccines? A commentary on the Institute of Medicine report. Pediatrics 1992;89:334-336.

Fulginiti VA, Kempe CH. Killed-measles-virus vaccine. Lancet 1967;2:468.

Fulginiti VA, Arthur JH, Pearlman DS, Kempe CH. Altered reactivity to measles virus: local reactions following attenuated measles virus immunization in children who previously received a combination of inactivated and attenuated vaccines. American Journal of Diseases of Children 1968;115:671-676.

Fulginiti VA, Nelson JD, McCracken GH Jr. Panel on immunizations. Pediatric Infectious Disease Journal 1983;2(3 Suppl.):S64-S69.

Furesz J. Serologic diagnosis of measles in subacute sclerosing panencephalitis (letter). New England Journal of Medicine 1971;284:729-730.

Furesz J, Contreras G. Vaccine-related mumps meningitis—Canda / Meningite ourlienne vaccinale—Canada. Canada Diseases Weekly Report / Rapport hebdomadaire des maladies au Canada 1990;16:253-254.

Furlow TW Jr. Neuropathy after influenza vaccination (letter). Lancet 1977;1:253-254.

Gaebler JW, Kleiman MB, French ML, Chastain G, Barrett C, Griffin C. Neurologic complications in oral polio vaccine recipients. Journal of Pediatrics 1986;108:878-881.

Galazka AM, Lauer BA, Henderson RH, Keja J. Indications and contraindications for vaccines used in the Expanded Programme on Immunization. Bulletin of the World Health Organization 1984;62:357-366.

Galazka AM, Lauer BA, Henderson RH, Keja J. [Indications and contraindications of vaccines used in the Extended Programme on Immunization] Indications et contre-indications des vaccins utilises dans le Programme elargi de vaccination. [Bulletin of the World Health Organization] Bulletin de l'Organisation mondiale de la Sante 1984;62:517-526.

Galazka AM, Lauer BA, Henderson RH, Keja J. [Indications and contraindications of vaccines used in the Expanded Programme on Immunization] Indications et contre-indications des

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

vaccins utilises dans le Programme elargi de vaccination. Medecine et Hygiene 1985;43:1718-1725.

Galbraith NS, Crosby G, Barnes JM, Fernandes R. Simultaneous immunization with B.C.G., diphtheria-tetanus, and oral poliomyelitis vaccines in children aged 13-14. British Medical Journal 1971;2:193-197.

Galbraith NS, Young SE, Pusey JJ, Crombie DL, Sparks JP. Mumps surveillance in England and Wales 1962-81. Lancet 1984;1:91-94.

Gale JL, Thapa PB, Bobo JK, Wassilak SG, Mendelman PM, Foy HM. Acute neurological illness and DTP: report of a case-control study in Washington and Oregon. Sixth International Symposium on Pertussis Abstracts. DHHS Publication No. (FDA) 90-1162. Bethesda, MD: U.S. Public Health Service, U.S. Department of Health and Human Services; 1990.

Galili S. A mild form of Stevens-Johnson syndrome following measles vaccination. Israel Journal of Medical Sciences 1967;3:903-905.

Gambia Hepatitis Study Group. Hepatitis B vaccine in the Expanded Program on Immunization: the Gambian experience. Lancet 1989;1:1057-1060.

Gamble DR. Relation of antecedent illness to development of diabetes in children. British Medical Journal 1980;281:99-101.

Gamboa ET, Cowen D, Eggers A, Cogan P, Ganti R, Brust JC. Delayed onset of postrabies vaccination encephalitis. Annals of Neurology 1983;13:676-678.

Ganguly R, Cusumano CL, Waldman RH. Suppression of cell-mediated immunity after infection with attenuated rubella virus. Infection and Immunity 1976;13:464-469.

Ganiats TG, Bowersox MT, Ralph LP. Universal neonatal hepatitis B immunization—are we jumping on the bandwagon too early? (editorial). Journal of Family Practice 1993;36:147-149.

Ganry O, Lerailler F, Vercelletto M, Chiffoleau A, Larousse C. [Peripheral facial paralysis following immunization for hepatitis b vaccine: a case report] Paralysie faciale peripherique faisant suite a une vaccination contre l'hepatite b: a propos d' un cas. Therapie 1992;47:437-438.

Garber HJ, Witte JJ, Tayback M, Latta R, Kelley E. Clinical reactions following vaccination with two types of live virus measles vaccines. Journal of the American Medical Association 1968;205:309-311.

Garenne M, Leroy O, Beau JP, Sene I. Child mortality after high-titre measles vaccines: prospective study in Senegal. Lancet 1991;338:903-907.

Gateff C, Relyveld EH, Le Gonidec G, Vincent J, McBean AM, Durand B et al. [A simplified tetanus immunization associated with live viral vaccines] Vaccination antitetanique simplifiee associee a des vaccins viraux vivants . Medecine Tropicale 1974;34:171-181.

Gathier JC, Bruyn GW. Peripheral neuropathies following the administration of heterologous immune sera: a critical evaluation. Psychiatria, Neurologia, Neurochirurgia 1968;71:351-371.

Gear MW. Immunization against tetanus. Postgraduate Medical Journal 1965;41:10-14.

Geffen T. Poliovaccination in the Gambia (letter). Lancet 1987;2:511-512.

Geier MR, Stanbro H, Merril CR. Endotoxins in commercial vaccines. Applied and Environmental Microbiology 1978;36:445-449.

Geissler E, Staneczek W. SV40 and human brain tumors. Archiv fur Geschwulstforschung 1988;58:129-134.

Gerber P. Patterns of antibodies to SV40 in children following the last booster with inactivated poliomyelitis vaccines. Proceedings of the Society for Experimental Biology and Medicine 1967;125:1284-1287.

Gerbrandy JL, Bienenstock J. Kinetics and localization of IgE tetanus antibody response in mice immunized by the intratracheal, intraperitoneal and subcutaneous routes. Immunology 1976;31:913-919.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Gerety RJ, Tabor E. Newly licensed hepatitis B vaccine: known safety and unknown risks. Journal of the American Medical Association 1983;249:745-746.

Gerichter C, Lasch E, Sever I, el-Massri M, Skalska P. Paralytic poliomyelitis in the Gaza Strip and West Bank during recent years. Developments in Biological Standardization 1978;41:173-177.

Gersbach P, Waridel D. [Paralysis after tetanus prevention] Paralysie apres preevention antitetanique. Schweizerische Medizinische Wochenschrift 1976;106:150-153.

Gershon AA. Immunization practices in children. Hospital Practice 1990;25:91-94, 97-103, 107.

Gerson K, Haslam RH A. Subtle immunologic abnormalities in four boys with subacute sclerosing panencephalitis. New England Journal of Medicine 1971;285:78-82.

Gervaix A, Caflisch M, Suter S, Haenggeli CA. Guillain-Barre syndrome following immunization with Haemophilus influenzae type b conjugate vaccine. European Journal of Pediatrics 1993;152:613-614.

Gezondheidsraad. Report on Hepatitis B. The Hague. The Netherlands: Gezondheidsraad [Health Council of the Netherlands]; 1983.

Gezondheidsraad. Adverse Reactions to Vaccines in the National Vaccination Programme in 1986. The Hague, The Netherlands: Gezondheidsraad [Health Council of the Netherlands]; 1987.

Gezondheidsraad. Adverse Reactions to Vaccines in the National Vaccination Programme in 1987. The Hague, The Netherlands: Gezondheidsraad [Health Council of the Netherlands]; 1988.

Gezondheidsraad. Adverse Reactions to Vaccines in the National Immunization Programme in 1988. The Hague, The Netherlands: Gezondheidsraad [Health Council of the Netherlands]; 1989.

Gezondheidsraad. Adverse Reactions to Vaccines in the National Vaccination Programme in 1989. The Hague, The Netherlands: Gezondheidsraad [Health Council of the Netherlands]; 1990.

Gezondheidsraad. Adverse Reactions to Vaccines in the National Vaccination Programme in 1990. The Hague, The Netherlands: Gezondheidsraad [Health Council of the Netherlands]; 1991.

Gezondheidsraad. Adverse Reactions to Vaccinations in the National Immunization Programme in 1991. The Hague, The Netherlands: Gezondheidsraad [Health Council of the Netherlands]; 1993.

Ghosh S, Kumari S, Bhargava SK. Antibody titres after measles vaccine. Indian Journal of Medical Research 1977;66:165-171.

Giammanco G, Li Volti S, Mauro L, Ciccia M, De Maria C, Patania S et al. Antibody responses of children to a measles mumps and rubella vaccine administered alone or simultaneously with booster doses of diphtheria-tetanus and oral poliovirus vaccines . Igiene Moderna 1989;92:1212-1218.

Giammanco G, Li Volti S, Mauro L, Giammanco Bilancia G, Salemi I, Barone P et al. Immune response to simultaneous administration of a recombinant DNA hepatitis B vaccine and multiple compulsory vaccines in infancy. Vaccine 1991;9:747-750.

Gigliotti F, Feldman S, Wang WC, Day SW, Brunson G. Immunization of young infants with sickle cell disease with a Haemophilus influenzae type b saccharide-diphtheria CRM197 protein conjugate vaccine. Journal of Pediatrics 1989;114:1006-1010.

Gigliotti F, Feldman S. Wang WC, Day SW, Brunson G. Serologic follow-up of children with sickle cell disease immunized with a Haemophilus influenzae type b conjugate vaccine during early infancy. Journal of Pediatrics 1991;118:917-919.

Gilbert GL. Haemophilus influenzae type b vaccines in Australia. Australian Paediatric Journal 1989;25:185-186.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Gill D. Measles: going, going, gone? (editorial). Irish Medical Journal 1986;79:174-175.

Gillie C, Hodgkin K. An effective measles immunization programme in a general practice . Journal of the Royal College of General Practitioners 1968;15:258-260.

Gillum JE, Garrison MW, Crossley KB, Rotschafer JC. Current immunization practices. 1. Polio, diphtheria, tetanus, pertussis, measles, mumps, rubella, and influenza. Postgraduate Medicine 1989;85:183-186, 188-190, 195, 198.

Gilmartin RC, Ch'ien LT. Guillain-Barre syndrome with hydrocephalus in early infancy. Archives of Neurology 1977;34:567-569.

Gilsdorf JR. Haemophilus influenzae type b vaccine. Indian Journal of Pediatrics 1988;55:218-224.

Gimeno de Sande A, Najera R, Najera E, Ortiz Berrocal A, Perez Gallardo F. [Results of the 1968 measles vaccination campaign] Resultados de la Campana de Vacunacion antisarampion 1968. Revista de Sanidad e Higiene Publica 1972;46:805-821.

Ginting R, Schilling G, Eis-Hubinger AM, Gerritzen A. [Hepatitis B vaccines: protective action and side effects] Hepatitis-B-Impfstoffe: Schutzwirkung und Nebenwirkungen. Arbeitsmedizin, Sozialmedizin, Praventivmedizin 1990;25:517-519.

Giroud M, Page G, Genelle B, Lacroix X. Les thrombopenies postvaccinales avec purpura [Postvaccinal thrombopenia with purpura]. Journal de Medecine de Lyon 1983;64:97-100.

Girsh LS. Current neurological trends with allergic implications. Immunology and Allergy Practice 1981;3:19-28.

Gladisch R., Hofmann W, Waldherr R. Myokarditis und insulitis nach Coxsackie virus infekt. Zeitschrift fur Kardiologie 1976;65:837-849.

Gladwell M. It's possible, but not likely: this theory leaves even more mysterious questions. Washington Post. April 5, 1992:C3.

Glenn MP, McKendrick DW. Varicella bullosa associated with measles vaccine. British Journal of Dermatology 1970;83:595-596.

Gluck R, Hoskins IM, Wegmann A, Just M, Germanier R. Rubini. a new live attenuated mumps vaccine virus strain for human diploid cells. Developments in Biological Standardization 1986;65:29-35.

Gocke DJ. Extrahepatic manifestations of viral hepatitis. American Journal of Medical Science 1975;270:49-52.

Gocke JD. Immune complex phenomena associated with hepatitis. In: Vyas GN, Cohen SN, Schmid R, eds. Viral Hepatitis: A Contemporary Assessment of Etiology, Epidemiology, Pathogenesis and Prevention. Philadelphia: Franklin Institute Press: 1977.

Goepp JG, Hohenboken M, Almeidohill J, Santosham M. Persistent urinary antigen excretion in infants vaccinated with Haemophilus influenzae type b capsular polysaccharide conjugated with outer membrane protein from Neisseria meningitidis. Pediatric Infectious Disease Journal 1992;11:2-5.

Goetz O. [Preventive vaccination against measles and rubella] Masernschutzimpfung und Rotelnschutzimpfung. Medizinische Klinik 1972;67:217-221.

Gogolin J. [A study to determine the neuropathogenicity of mumps vaccine on dwarf pigs] Untersuchungen zur Neuropathogenitatsbestimmung von Mumps-Impfstoff an Zwergschweinen. Zeitschrift fur die Gesamte Hygiene Ihre Grenzgebiete 1981;27:239-241.

Gold H. Sensitization induced by tetanus toxoid, alum precipitated. Journal of Laboratory and Clinical Medicine 1941;27:26-36.

Gold R. Scheifele D, Fast M, Contreras G, Gagnon A. Sidorowicz E et al. Evaluation of poliovirus-related cases occurring in Canada in 1989 / Etude des cas lies a des poliovirus survenus au Canada en 1989. Canada Diseases Weekly Report / Rapport hebdomadaire des maladies au Canada 1991;17:75-78.

Goldblatt D, Turner MW, Levinsky RJ. Branhamella catarrhalis: antigenic determinants and

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

the development of the IgG subclass response in childhood. Journal of Infectious Diseases 1990;162:1128-1135.

Golden JA. No increased incidence of AIDS in recipients of hepatitis B vaccine (letter). New England Journal of Medicine 1983;308:1163-1164.

Goldsmith MF. Vaccine information pamphlets here, but some physicians react strongly. Journal of the American Medical Association 1992;267:2005-2007.

Goldwater PN. The cost of hepatitis B vaccine: money or morbidity? (letter). New Zealand Medical Journal 1983;96:588.

Goldwater PN. Hypersensitivity to intradermal hepatitis B vaccine (letter). Lancet 1984;2:1156.

Golub N, Bogdanov I, Vashchenko M. [Possibility of diseases affecting the central nervous system caused by vaccine strains of poliovirus, type 3] O vozmozhnosti zabolevanii s porazheniem tsentral'noi nervnoi sistemy, vyzvannykh vaktsinopodobnymi shtammami poliovirusa tipa 3. Zhurnal Mikrobiologii, Epidemiologii. i Immunobiologii 1972;49:134-136.

Gonzalez E, Cordero J. [Poliomyelitis associated with a vaccine: two clinical cases] Poliomielitis asociada a vacuna: dos casos clinicos. Revista Medica de Chile 1988;116:461-464.

Goolsby PL. Erythema nodosum after Recombivax HB hepatitis B vaccine (letter). New England Journal of Medicine 1989;321:1198-1199.

Gordon EH, Krouse HA, Kinney JL, Stiehm JR, Klaustermeyer WB. Delayed cutaneous hypersensitivity in normals: choice of antigens and comparison to in vitro assays of cell-mediated immunity. Journal of Allergy and Clinical Immunology 1983;72:487-494.

Gordon LK. Characterization of a hapten-carrier conjugate vaccine: H. influenzae-diphtheria conjugate vaccine. In: Chanock RM, Lerner RA, eds. Modern Approaches to Vaccines. Cold Spring Harbor. NY: Cold Spring Harbor Laboratory; 1984.

Gorshunova LP, Mikhailova GR. [Effect of viral vaccines on animal bone marrow cell chromosomes] Issledovanie vliianiia protivovirusnykh vaktsin na khromosomy kletok kostnogo mozga zhivotnykh. Voprosy Virusologii 1976;5:521-526.

Gorshunova LP, Bektemirov TA, Koshtoyan SE. [On production of interferon and nonspecific protective reactions in the central nervous systems of animals vaccinated with live measles vaccine] O produktsii interferona i nespetsificheskikh zashchitnykh reaktsiiakh v tsentralnoi nervnoi sisteme zhivotnykh pri vaktsinatsii zhivoi protivokorevoi vaktsinoi. Voprosy Virusologii 1970;16:735-739.

Gorshunova LP, Mikhailova GR, Cherkezia SE. [Effect of mice immunization with live antiviral vaccines on bone marrow cell chromosomes in the first generation progeny] Vliianie immunizatsii myshei zhivymi protivovirusnymi vaktsinami na khromosomy kletok kostnogo mozga potomstva pervogo pokoleniia. Tsitologiia i Genetika 1975;9:542-545.

Goubau P. Immunogenicity and safety of measles vaccine in ill African children (letter). International Journal of Epidemiology 1989;18:467.

Grabenstein ID. Delayed-hypersensitivity testing: guide to product selection . Hospital Pharmacy 1990;25:1102-1107.

Graham DY, Brown CH, Benrey J, Butel JS. Thrombocytopenia. Journal of the American Medical Association 1974;227:1161-1164.

Granoff DM, Cates KL. Haemophilus influenzae type b polysaccharide vaccines. Journal of Pediatrics 1985;107:330-336.

Granoff DM, Munson RS Jr. Prospects for prevention of Haemophilus influenzae type b disease by immunization. Journal of Infectious Diseases 1986;153:448-461.

Granoff DM, Osterholm MT. Safety and efficacy of Haemophilus influenzae type b polysaccharide vaccine. Pediatrics 1987;80:590-592.

Granoff DM, Anderson EL, Osterholm MT et al. Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants. Journal of Pediatrics 1992;121:187-194.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Granoff DM, Boies EG, Munson RS. Immunogenicity of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in adults. Journal of Pediatrics 1984;105:22-27.

Granoff DM, Chacko A, Lottenbach KR, Sheetz KE. Immunogenicity of Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine in patients who acquired Haemophilus disease despite previous vaccination with type b polysaccharide vaccine. Journal of Pediatrics 1989;114:925-933.

Granoff DM, Holmes SJ, Osterholm MT. Induction of immunologic memory in infants primed with Haemophilus influenzae type b conjugate vaccines. Journal of Infectious Diseases; in press.

Granoff DM. Pandey JP, Boies E et al. Response to immunization with Haemophilus influenzae type b polysaccharide-pertussis vaccine and risk of haemophilis meningitis in children with the km(1) immunoglobulin allotype. Journal of Clinical Investigation 1984;74:1708-1714.

Granoff DM, Shackelford PG, Suarez BK et al. Haemophilus influenzae type b disease in children vaccinated with type b polysaccharide vaccine. New England Journal of Medicine 1986;315:1584-1590.

Granoff DM, Weinberg GA, Shackelford PE. IgG subclass response to immunization with Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine. Pediatric Research 1988;24:180-185.

Grant KL. Recombinant hepatitis B vaccine-induced central nervous system demyelination. P & T 1992;17:297.

Grattan-Smith PJ, Procopis PG, Wise GA, Grigor WG. Serious neurological complications of measles: a continuing preventable problem. Medical Journal of Australia 1985 ;143:385-387.

Gray BM. Opsonophagocidal activity in sera from infants and children immunized with Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate). Pediatrics 1990;85(4 Pt 2):694-697.

Gray JA, Burns SM. Mumps meningitis after mumps, measles, and rubella vaccination (letter). British Medical Journal 1989;299:1464-1465.

Gray JA, Burns SM. Mumps meningitis following measles. mumps. and rubella immunization (letter). Lancet 1989;2:98.

Gray JA, Burns SM. Mumps vaccine meningitis (letter). Lancet 1989;2:927.

Grazhdanov NP, Popov VF, Sokhin AA, Salmin LV, Frolov AK, Ektova LK et al. [Safety, antigenic activity and epidemiologic effectiveness of live parotitis vaccine from strain Leningrad-3. I. Study of the reactogenic, allergenic and mutagenic properties of the vaccine and its effect on systemic resistance against intercurrent diseases] Bezvrednost, antigennaia aktivnost i epidemiologicheskaia effektivnost zhivoi parotitnoi vaktsiny iz shtamma Leningrad-3. Soobshchenie I. Reaktogennye, allergennye i mutagennye svoistva vaktsiny i ee vliianie na rezistentnost organizma k interkurrentnym zabolevaniiam. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii 1981;1:69-74.

Greco D. Case-control study on encephalopathy associated with diphtheria-tetanus immunization in Campania, Italy. Bulletin of the World Health Organization 1985;63:919-925.

Green A, Gale EA, Patterson CC. Incidence of childhood-onset insulin-dependent diabetes mellitus: the EURODIAB ACE study. Lancet 1992;339:905-909.

Green C, Lakshmipathi T. A case of hepatitis related to etretinate therapy and hepatitis B vaccine. Dermatologica 1991;182:119-120.

Green MS, Handsher R, Cohen D, Melnick JL, Slepon R, Mendelsohn E et al. Age differences in immunity against wild and vaccine strains of poliovirus prior to the 1988 outbreak in Israel and response to booster immunization. Vaccine 1993;11:75-81.

Green MS, Melnick JL, Cohen D, Slepon R, Danon YL. Response to trivalent oral poliovirus

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

vaccine with and without immune serum globulin in young adults in Israel in 1988. Journal of Infectious Diseases 1990;162:971-974.

Greenberg DP, Vadheim CM, March SM, Ward JI, Kaiser-UCLA Hib Vaccine Study Group. Evaluation of the safety, immunogenicity, and efficacy of Haemophilus b (Hib) PRP-T conjugate vaccine in a prospective, randomized. and placebo-controlled trial in young infants. Program Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. Abstract 65, p. 109. Washington, DC: American Society for Microbiology; 1991.

Greenberg DP, Ward JI, Burkart K et al. Factors influencing immunogenicity and safety of two Haemophilus influenzae type b polysaccharide vaccines in children 18 and 24 months of age. Pediatric Infectious Disease Journal 1987;6:660-665.

Greenberg MA, Birx DL. Safe administration of mumps-measles-rubella vaccine in egg-allergic children. Journal of Pediatrics 1988;113:504-506.

Greenstreet R. Adjustment of rates of Guillain-Barre syndrome among recipients of swine flu vaccine, 1976-1977 (letter). Journal of the Royal Society of Medicine 1983;76:620-621.

Greenwood BM, Greenwood AM, Bradley AK et al. Studies with combined meningococcal vaccines. I. A combined meningococcal. measles and tetanus vaccine. Annals of Tropical Medicine and Parasitology 1981;75:217-226.

Grenier B, Viarme F, Roumiantzeff M, Xueref C, Demont F. [Antipoliomyelitis vaccination of young children with a new inactivated vaccine: serological results] Vaccination antipoliomyelitique de jeunes enfants par un nouveau vaccin inactive: resultats serologiques. Archives Francaises de Pediatrie 1985;42:321-323.

Griffin DE. Monophasic autoimmune inflammatory diseases of the CNS and PNS. Research Publications—Association for Research in Nervous and Mental Disease 1990;68:91-104.

Griffin MR, Ray WA, Livengood JR, Schaffner W. Risk of sudden infant death syndrome after immunization with the diphtheria-tetanus-pertussis vaccine. New England Journal of Medicine 1988;319:618-623.

Griffin MR, Ray WA, Mortimer EA, Fenichel GM, Schaffner W. Risk of seizures and encephalopathy after immunization with the diphtheria-tetanus-pertussis vaccine. Journal of the American Medical Association 1990;263):1641-1645.

Griffin MR, Ray WA, Mortimer EA, Fenichel GM, Schaffner W. Risk of seizures after measles-mumps-rubella immunization. Pediatrics 1991;88:881-885.

Griffin MR, Taylor JA, Daugherty JR, Ray WA. No increased risk for invasive bacterial infection found following diphtheria-tetanus-pertussis immunization. Pediatrics 1992;89(4 Pt. 1):640-642.

Griffith RD, Miller OF III. Erythema multiforme following diphtheria and tetanus toxoid vaccination. Journal of the American Academy of Dermatology 1988;19:758-759.

Grilli G, Cimini D, Vacca F. [Antimeasles vaccine: incidence of side-effects using two different vaccine strains] Vaccinazione antimorbillo: incidenza di effetti collaterali utilizzando due diversi ceppi di vaccino. Giornale di Malattie Infettive e Parassitarie 1991;43:147-149.

Grilli G, Cimini D, Vacca F et al. [Vaccination against measles, mumps and rubella: incidence of side effects using different vaccine strains] Vaccinazione contro morbillo, parotite e rosolia: incidenza di effetti collaterali utilizzando vaccini di diversa composizione. Giornale di Malattie Infettive e Parassitarie 1992;44:38-42.

Gronski P, Seiler FR, Schwick HG. Discovery of antitoxins and development of antibody preparations for clinical uses from 1890 to 1990. Molecular Immunology 1991;28:1321-1332.

Grose C. Guillain-Barre syndrome (letter). American Journal of Diseases of Children 1974;127(3):444.

Grose C, Henle W, Henle G, Feorino PM. Primary Epstein-Barr-virus infections in acute neurologic diseases. New England Journal of Medicine 1975;292:392-395.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Grose C, Spigland I. Guillain-Barre syndrome following administration of live measles vaccine. American Journal of Medicine 1976;60:441-443.

Gross TP, Hayes SW. Haemophilus conjugate vaccine and Guillain-Barre syndrome (letter). Journal of Pediatrics 1991;118:161.

Gross TP, Khurana RK, Higgins T, Nkowane BS, Hirsch RL. Vaccine-associated poliomyelitis in a household contact with Netherton's syndrome receiving long-term steroid therapy . American Journal of Medicine 1987;83:797-800.

Gross TP, Milstien JB, Kuritsky JN. Bulging fontanelle after immunization with diphtheria-tetanus-pertussis vaccine and diphtheria-tetanus vaccine. Journal of Pediatrics 1989;114:423-425.

Guerin A, Buisson Y, Nutini MT, Saliou P, London G, Marchais S. Response to vaccination against tetanus in chronic haemodialysed patients. Nephrology, Dialysis, Transplantation 1992;7:323-326.

Guillain G, Barre JA, Strohl A. Sur un syndrome de radiculonevrite avec hyperalbuminose due liquide cephalo-rachidien sans reaction cellulaire: remarques sure les caracteres cliniques et graphiques des reflexes tendineux. Bulletins et Memoires Societe Medicale des Hopitaux de Paris 1916;40:1462-1470.

Gunby P. 'Atypical' mumps may occur after immunization. Journal of the American Medical Association 1980;243:2374-2375.

Gunby P. SSPE incidence, therapy receive renewed attention. Journal of the American Medical Association 1981;246:927, 931-932.

Gunderman JR. Guillain-Barre syndrome: occurrence following combined mumps-rubella vaccine. American Journal of Diseases of Children 1973;125:834-835.

Gunderson E. Is diabetes of infectious origin? Journal of Infectious Diseases 1927;41:197-202.

Gunn TR. Bosley A, Woodfield DG. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates. New Zealand Medical Journal 1989;102:1-3.

Gupta RK, Relyveld EH. Adverse reactions after injection of adsorbed diphtheria-pertussis-tetanus (DPT) vaccine are not due only to pertussis organisms or pertussis components in the vaccine. Vaccine 1991;9:699-702.

Gupte SC, Bhatia HM. Anti-A and anti-B titre response after tetanus toxoid injections in normal adults and pregnant women. Indian Journal of Medical Research 1979;70:221-228.

Gupte SC, Bhatia HM. Increased incidence of haemolytic disease of the new-born caused by ABO-incompatibility when tetanus toxoid is given during pregnancy. Vox Sanguinis 1980;38:22-28.

Gutierrez K, Abzug MJ. Vaccine-associated poliovirus meningitis in children with ventriculoperitoneal shunts. Journal of Pediatrics 1990;117:424-427.

Gutierrez-Lopez MD, Bertera S, Chantres MT, Vavassori C, Dorman JS, Trucco M et al. Susceptibility to Type 1 (insulin-dependent) diabetes mellitus in Spanish patients correlates quantitatively with expression of HLA-DQ(alpha) ARG 52 and HLA-DQ(beta) non-Asp 57 alleles. Diabetologia 1992;35:583-588.

Haas D, Krause-Wichmann D. [Important notice concerning information on damage caused by oral polio vaccination] Wichtige Hinweise zur Impfschaden-Aufklarung nach Polio-Schluckimpfung. Offentliche Gesundheitswesen 1968;30:291-293.

Hachulla E, Houvenagel E, Mingui A, Vincent G, Laine A. Reactive arthritis after hepatitis B vaccination. Journal of Rheumatology 1990;17:1250-1251.

Hadler SC, Margolis HS. Hepatitis B immunization: vaccine types, efficacy, and indications for immunization. Current Clinical Topics in Infectious Diseases 1992;12:282-308.

Hagen-Coenen J, Drinka PJ, Siewert M. Tetanus-diphtheria vaccinations in a veterans nursing home. Journal of the American Geriatric Society 1992;40:513-514.

Hagge W, Enders-Ruckle G, von Brenndorff AI. [Atypical measles following immunization with inactivated measles vaccine (split vaccine)] Atypische Masern nach Immunisierung

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

mit inaktiviertem Masernimpfstoff (Spaltvakzine). Monatsschrift fur Kinderheilkunde 1974;122:504-506.

Hajeri H. [Vaccinations and pregnancy] Vaccins et grossesse. Revue de Medecine 1978;19:947-950.

Hallam LA. Role of aluminium sensitivity in delayed persistent immunization reactions (letter). Journal of Clinical Pathology 1991;44:877.

Halliday ML, Kang LY, Rankin JG, Coates RA, Corey PN, Hu ZH et al. An efficacy trial of a mammalian cell-derived recombinant DNA hepatitis B vaccine in infants born to mothers positive for HBsAg. in Shanghai, China. International Journal of Epidemiology 1992;21:564-573.

Halsey NA. Risk of subacute sclerosing panencephalitis from measles vaccination. Pediatric Infectious Disease Journal 1990;9:857-858.

Halsey NA. Case material on subacute sclerosing panencephalitis. Submitted to the Institute of Medicine Vaccine Safety Committee, November 1992.

Halsey NA, Holt E. Confounders are always a problem. Pediatrics 1990;86:490-491.

Halsey NA, Boulos R, Mode F, Andre J, Bowman L, Yaeger RG et al. Response to measles vaccine in Haitian infants 6 to 12 months old: influence of maternal antibodies, malnutrition, and concurrent illnesses. New England Journal of Medicine 1985;313:544-549.

Halsey NA, Modlin JF, Dyken PR. Subacute sclerosing panencephalitis (letter). Pediatric Neurology 1991;7:151.

Halsey NA, Modlin JF, Jabbour JT, Dubey L, Eddins DL, Ludwig DD. Risk factors in subacute sclerosing panencephalitis: a case-control study. American Journal of Epidemiology 1980;111:415-424.

Halsey NA, Modlin JF, Jabbour JT. Subacute sclerosing panencephalitis (SSPE): an epidemiologic review. In: Stevens JG et al., eds. Persistent Viruses. New York: Academic Press; 1978:101-114.

Halsey NA, Schubert W, Jabbour JT, Preblud SR. Measles vaccine and the course of subacute sclerosing panencephalitis (letter). Lancet 1978;2:783.

Halsey NA. Weiner LB, Meyers MG, Herrmann KL, Hinman A. Clinical evaluation of a new live measles vaccine derived in chick chorioallantoic membranes. Journal of Biological Standardization 1981;9:507-511.

Hamilos DL, Young RM, Peter JB, Agopian MS. Ikle DN, Barka N. Hypogammaglobulinemia in asthmatic patients. Annals of Allergy 1992;68:472-481.

Hammon WM, Coriell LL, Stokes J. Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. Journal of the American Medical Association 1952;150:739-760.

Hammon WM, Coriell LL, Wehrle PF, Stokes J. Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. 4. Final report of results based on clinical diagnoses. Journal of the American Medical Association 1953;151:1272-1285.

Haneberg B, Matre R, Winsnes R, Dalen A, Vogt H, Finne PH. Acute hemolytic anemia related to diphtheria-pertussis-tetanus vaccination. Acta Paediatrica Scandinavica 1978;67:345-350.

Haneberg B, Orstavik I. Poliomyelitis associated with oral poliovaccine: report on two cases. Acta Paediatrica Scandinavica 1972;61:105-108.

Hankey GJ. Guillain-Barre syndrome in Western Australia, 1980-1985. Medical Journal of Australia 1987;146:130-133.

Hankins RW, Black FL. Western blot analyses of measles virus antibody in normal persons and in patients with multiple sclerosis, subacute sclerosing panencephalitis, or atypical measles. Journal of Clinical Microbiology 1986;24:324-329.

Hansen J, Lennarzt H. Die virusdiagnostik zur atiologischen klarung. Deutsche Zeitschrift fur Nervenheilkunde 1961;182:185-200.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Hansson H, Moller H. Cutaneous reactions to merthiolate and their relationship to vaccination with tetanus toxoid. Acta Allergologica 1971;26:150-156.

Hara M, Saito Y, Komatsu T, Kodama H, Abo W, Chiba S et al. Antigenic analysis of polioviruses isolated from a child with agammaglobulinemia and paralytic poliomyelitis after Sabin vaccine administration. Microbiology and Immunology 1981;25:905-913.

Harcus AW, Ward AE, Roberts JS, Bryett KA. An evaluation of diphtheria-tetanus (adult) vaccine in unselected human volunteers. Journal of International Medical Research 1989;17:262-267.

Harjulehto T, Aro T, Hovi T, Saxen L. Congenital malformations and oral poliovirus vaccination during pregnancy. Lancet 1989;1:771-772.

Harrer G, Melnizky U, Wendt H. [Accommodation paresis and swallowing paralysis following tetanus toxoid booster inoculation] Akkommodationsparese und Schlucklahmung nach Tetanus Toxoid-Auffrischungsimpfung. Wiener Medizinische Wochenschrift 1971;121:296-297.

Harris G. Can injection technique reduce vaccine reactions? Practitioner 1983;227:299-300.

Harris HF. A case of diabetes mellitus quickly following mumps. Boston Medical and Surgical Journal 1899;140:465-469.

Harris MF. The safety of measles vaccine in severe illness (letter). South African Medical Journal 1979;55:38.

Harris RW, Isacson P, Karzon DT. Vaccine-induced hypersensitivity: reactions to live measles and mumps vaccine in prior recipients of inactivated measles vaccine. Journal of Pediatrics 1969;74:552-563.

Harrison HR, Fulginiti VA. Bacterial immunizations. American Journal of Diseases of Children 1980;134:184-193.

Harrison LH, Broome CV, Hightower AW, Hoppe CC, Makintubee S, Sitze SL et al. A day care-based study of the efficacy of Haemophilus b polysaccharide vaccine. Journal of the American Medical Association 1988;260:1413-1418.

Hartman S. Convulsion associated with fever following hepatitis B vaccination (letter). Journal of Paediatrics and Child Health 1990;26:65.

Hartsock R. Postvaccinal lymphadenitis. Hyperplasia of lymphoid tissue that simulates malignant lymphomas. Cancer 1968;21:632-649.

Hartung HP, Toyka KV. T-cell and macrophage activation in experimental autoimmune neuritis and Guillain-Barre syndrome. Annals of Neurology 1990;27(Suppl.):S57-S63.

Hasselbacher P et al. Neuropathy after influenza vaccination. Lancet 1977;1:551-552.

Hassin H. Ophthalmoplegic migraine wrongly attributed to measles immunization. American Journal of Ophthalmology 1987;104:192-193.

Hatem J. Fallout from Washington: the IOM report continues to be misinterpreted. NVIC News (National Vaccine Information Center) 1992;2(1):4.

Hatem J. IOM given new contract to review remaining vaccines. NVIC News 1992;2(1):4.

Haun U, Ehrhardt G. [Postvaccinal complications following protective vaccination against measles]. Zur problematik postvakzinaler komplikationen nach Masernschutzimpfung. Deutsche Gesundheitswesen 1973;28:1306-1308.

Hauser P, Voet P, Simoen E. Immunological properties of recombinant HBsAg produced in yeast. Postgraduate Medical Journal 1987;63(Suppl. 2):83-91.

Hayward JC, Gillespie SM, Kaplan KM, Packer R, Pallansch M, Plotkin S et al. Outbreak of poliomyelitis-like paralysis associated with enterovirus 71. Pediatric Infectious Disease Journal 1989;8:611-616.

Healy CE. Mumps vaccine and nerve deafness. American Journal of Diseases of Children 1972;123:612.

Heaton KW. Measles inoculation. British Medical Journal 1968;2:435.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Hecht FM. H. influenzae vaccines in HIV (letter). New England Journal of Medicine 1992;326:1569-1571.

Hedges LV, Cooper H, Bushman BJ. Testing the null hypothesis in meta-analysis: a comparison of combined probability and confidence interval procedures. Psychological Bulletin 1992;111:188-194.

Heidel G, Demmler M. [Neurological syndromes as atypical courses of vaccination after protective influenza a vaccination] Neurologische syndrome als atypische impfverlaufe nach influenza-a-schutzimpfung. Zeitschrift fur die Gesamte Hygiene und Ihre Grenzgebiete 1985;31:218-220.

Heidel G, Olbricht H, Ely K, Henkler J. [Influence of measles vaccination using the live measles virus vaccine SSW-L 16 on the complication rate in measles] Der Einfluss der Masernimpfung mit Masern-Lebendvirus-Impfstoff SSW-L 16 auf die Komplikationsrate bei Masernerkrankungen. Zeitschrift fur Arztliche Fortbildung 1972;66:171-174.

Heinonen OP, Shapiro S, Monson RR. Hartz SC, Rosenberg L. Slone D. Immunization during pregnancy against poliomyelitis and influenza in relation to childhood malignancy. International Journal of Epidemiology 1973;2:229-235.

Held JR, Adaros HL. Neurological disease in man following administration of suckling mouse brain antirabies vaccine. Bulletin of the World Health Organization 1972;46:321-327.

Helle EP, Koskenvuo K, Heikkila J, Pikkarainen J, Weckstrom P. Myocardial complications of immunizations. Annals of Clinical Research 1978;10:280-287.

Helmke K, Otten A, Willems WR, Brockhaus R, Mueller-Eckhardt G, Stief T et al. Islet cell antibodies and the development of diabetes mellitus in relation to mumps infection and mumps vaccination. Diabetologia 1986;29:30-33.

Hemachudha T, Griffin DE, Chen WW, Johnson RT. Immunologic studies of rabies vaccination-induced Guillain-Barre syndrome. Neurology 1988;38:375-378.

Hemachudha T, Griffin DE, Giffels JJ, Johnson RT, Moser AB, Phanuphak P. Myelin basic protein as an encephalitogen in encephalomyelitis and polyneuritis following rabies vaccination. New England Journal of Medicine 1987;316:369-374.

Hemachudha T, Phanuphak P, Johnson RT, Griffin DE, Ratanavongsiri J, Siriprasomsup W. Neurologic complications of Semple-type rabies vaccine: clinical and immunologic studies. Neurology 1987;37:550-556.

Hempel HC, Grimm J. [Measles vaccination in children with brain damage] Masernschutzimpfung bei hirngeschadigten Kindern. Deutsche Gesundheitswesen 1968;23:2106-2107.

Henderson DA, Witte JJ, Morris L, Langmuir AD. Paralytic disease associated with oral polio vaccines. Journal of the American medical Association 1964;190:41-48.

Hendley JO, Wenzel JG, Ashe KM, Samuelson JS. Immunogenicity of Haemophilus influenzae type b capsular polysaccharide vaccines in 18-month-old infants. Pediatrics 1987;80:351-354.

Henry P, Vital C, Du Pasquier P, Loiseau P, Barat M. [Subacute anterior poliomyelitis after oral polio vaccination: anatomo-clinical study] Poliomyelite anterieure subaigue apres vaccination antipoliomyelitique par voie orale: etude anatomo-clinique . Revue Neurologique 1972;127:364-370.

Henson PM. Antibody and immune-complex-mediated allergic and inflammatory reactions. In: Lachmann PJ. Peters DK, eds. Clinical Aspects of Immunology, 4th edition. Oxford: Blackwell; 1982.

Hepsen LS, Thomsen AC. Profylaktisk hepatitis B vaccinaton af et hospitalspersonale. Ugeskrift for Laeger 1992;154:2421-2423.

Herman JH. Bradley J, Ziff M, Smiley JD. Response of the rheumatoid synovial membrane to exogenous immunization. Journal of Clinical Investigation 1971;50:266-273.

Herman JJ, Radin R, Schneiderman R. Allergic reactions to measles (rubeola) vaccine in patients hypersensitive to egg protein. Journal of Pediatrics 1983;102:196-199.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Herroelen L, De Keyser J, Ebinger G. Central-nervous-system demyelination after immunization with recombinant hepatitis B vaccine. Lancet 1991;338:1174-1175.

Hersch BS, Fine PE, Kent WK, Cochi SL, Kahn LH, Zell ER et al. Mumps outbreak in a highly vaccinated population. Journal of Pediatrics 1991;119:187-193.

Hess G, Hingst V, Cseke J, Bock HL, Clemens R. Influence of vaccination schedules and host factors on antibody response following hepatitis B vaccination. European Journal of Clinical Microbiology and Infectious Diseases 1992;11:334-340.

Hetherington SB, Lepow ML. Correlation between antibody affinity and serum bactericidal activity in infants. Journal of Infectious Diseases 1992;165:753-756.

Heyne K. [Paralytic poliomyelitis following vaccination contact in the 1st trimester of an infant] Paralytische Impfkontakt-Poliomyelitis im 1. Trimenon eines Sauglings. Medizinische Welt 1977;28:1439-1441.

Heywood JL. Clinical observations following the introduction of a mass immunization programme for hepatitis B. Submitted to the National Institutes of Health, April 4, 1992. Unpublished.

Hickling S. Tetanus immunization. New Zealand Medical Journal 1977;86:529-530.

Hill A. Measles, mumps, and rubella vaccination (letter). British Medical Journal 1992;304:779.

Hill AB. Inoculation and Poliomyelitis. In: Statistical Methods in Clinical and Preventive Medicine. Edinburgh: E. & S. Livingstone Ltd.; 1962.

Hill AB. The environment and disease: association or causation. Proceedings of the Royal Society of Medicine 1965;58:295-300.

Hill JC. Summary of a workshop on Haemophilus influenzae type b vaccines. Journal of Infectious Diseases 1983;148:167-175.

Hilleman MR. Past, present, and future of measles, mumps, and rubella virus vaccines. Pediatrics 1992;90(1 Pt 2):149-153.

Hilleman MR, Buynak EB, Weibel RE, Stokes JJ, Whitman JE Jr, Leagus MB. Development and evaluation of the Moraten measles virus vaccine. Journal of the American Medical Association 1968;206:587-590.

Hilleman MR, Buynak EB, Weibel RE et al. Live attenuated mumps-virus vaccine. New England Journal of Medicine 1968;278:227-232.

Hinden E. Mumps followed by diabetes. Lancet 1962;1:1381.

Hiner EE, Frasch CE. Spectrum of disease due to Haemophilus influenzae type b occurring in vaccinated children. Journal of Infectious Diseases 1988;158:343-348.

Hinman AR. Landmark perspective: mass vaccination against polio. Journal of the American Medical Association 1984;251:2994-2996.

Hinman AR, Koplan JP, Orenstein WA, Brink EW, Nkowane BM. Live or inactivated poliomyelitis vaccine: an analysis of benefits and risks. American Journal of Public Health 1988;78:291-295.

Hinman AR, Koplan JP, Orenstein WA, Brink EW. Decision analysis and polio immunization policy. American Journal of Public Health 1988;78:301-303.

Hinton GG, Duncan IB, Rathbun JC. Paralysis after oral poliomyelitis vaccine. Canadian Medical Association Journal 1962;87:915-916.

Hirayama M. Measles vaccines used in Japan. Reviews of Infectious Diseases 1983;5:495-503.

Hirsch RL, Mokhtarian F, Griffin DE, Brooks BR, Hess J, Johnson RT. Measles virus vaccination of measles seropositive individuals suppresses lymphocyte proliferation and chemotactic factor production. Clinical Immunology and Immunopathology 1981;21:341-350.

Hirtz DG, Nelson KB, Ellenberg JH. Seizures following childhood immunizations. Journal of Pediatrics 1983;102:14-18.

Hisano S, Miyazaki C, Hatae K, Kaku Y, Yamane I, Ueda K et al. Immune status of children on continuous ambulatory peritoneal dialysis. Pediatric Nephrology 1992;6:179-181.

Hitsch RL, Griffin DE, Johnson RT, Cooper SJ, Lindo de Soriano I, Roedenbeck S et al.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Cellular immune responses during complicated and uncomplicated measles virus infections of man. Clinical Immunology and Immunopathology 1984;31:1-12.

Ho MS, Floyd RL, Glass RI, Pallansch MA, Jones B, Hamby B et al. Simultaneous administration of rhesus rotavirus vaccine and oral poliovirus vaccine: immunogenicity and reactogenicity. Pediatric Infectious Disease Journal 1989;8:692-696.

Hoffman HJ, Hunter JC, Damus K, Pakter J, Peterson DR, van Belle G et al. Diphtheriatetanus-pertussis immunization and sudden infant death: results of the National Institute of Child Health and Human Development Cooperative Epidemiological Study of Sudden Infant Death Syndrome Risk Factors. Pediatrics 1987;79:598-611.

Hofmann F, Sydow B. [Considering the question of mumps-immunity of hospital personnel] Zur Frage der Mumps-Immunitat bei Krankenhausbeschaftigen. Arbeitsmed Sozialmed Praventivmed 1989;24:115-117.

Holden JM, Strang DU. Reactions to tetanus toxoid: comparison of fluid and adsorbed toxoids. New Zealand Medical Journal 1965;64:574-577.

Holland P, Hutchinson CE. Uptake of hepatitis B vaccination amongst West Midlands radiologists. Clinical Radiology 1992;45:335-337.

Holliday PL, Bauer RB. Polyradiculoneuritis secondary to immunization with tetanus and diphtheria toxoids. Archives of Neurology 1983;40:56-57.

Holmes SJ, Lucas AH, Osterholm MT, Froeschle JE, Granoff DM, Collaborative Study Group. Immunoglobulin deficiency and idiotype expression in children developing Haemophilus influenzae type b disease after vaccination with conjugate vaccine. Journal of the American Medical Association 1991;266:1960-1965.

Holmes SJ, Murphy TV, Anderson RS, Kaplan SL, Rothstein EP, Gan VN et al. Immunogenicity of four Haemophilus influenzae type b conjugate vaccines in 17- to 19-month old children. Journal of Pediatrics 1991;118:364-371.

Holmes WH. Diphtheria: History. Bacillary and Rickettsial Infections. New York: Macmillan; 1940.

Holt S. Hudgins D, Krisnan KR, Critchley EM. Diffuse myelitis associated with rubella vaccination. British Medical Journal 1976;2:1037-1038.

Hong R, Gilbert EF, Opitz JM. Omenn disease: termination in lymphoma. Pediatric Pathology 1985;3:143-154.

Honovar M, Tharakan JK, Hughes RA, Leibowitz S, Winer JB. A clinicopathological study of the Guillain-Barre syndrome: nine cases and literature review. Brain 1991;114:1245-1269.

Hopf HC. [Guillain-Barre syndrome following tetanus toxoid administration: survey and report of a case.]. Guillain-Barre-Syndrom nach Tetanus-Schutzimpfung: Ubersicht und Fallmitteilung. Aktuelle Neurologie 1980;7:195-200.

Hopkins CC. Dismukes WE, Glick TH, Warren RJ. Surveillance of paralytic poliomyelitis in the United States: 1966 and 1967 cases, and 1965-1967 cases associated with oral poliovirus vaccine. Journal of the American Medical Association 1969;210:694-700.

Horowitz SD, Nagatani MS, Bowen GS, Holloway AW, St. Geme JW Jr. The acquisition of delayed hypersensitivity following attenuated mumps virus infection . Pediatrics 1970;45:77-82.

Horstmann DM. The Sabin live poliovirus vaccination trials in the USSR, 1959. Yale Journal of Biology and Medicine 1991;64:499-512.

Horta-Barbosa L, Fuccillo DA, Sever JL. Subacute sclerosing panencephalitis: isolation of measles virus from a brain biopsy. Nature 1969;221:974.

Horta-Barbosa L, Hamilton R, Wittig B, Fuccillo DA, Sever JL. Subacute sclerosing panencephalitis: isolation of suppressed measles virus from lymph node biopsies. Science 1971;173:840-841.

Hospital Employee Health. Hepatitis B: anaphylactic shock after Recombivax underscores need to question staff. Hospital Employee Health, December 1987.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

House A. Alleged link between hepatitis B vaccine and chronic fatigue syndrome. Canadian Medical Association Journal 1992;146:1145.

Hovi T, Cantell K, Huovilainen A, Kinnunen E, Kuronen T, Lapinleimu K et al. Outbreak of paralytic poliomyelitis in Finland: widespread circulation of antigenically altered poliovirus type 3 in a vaccinated population. Lancet 1986;1:1427-1432.

Howson CP, Fineberg HV. Adverse events following pertussis and rubella vaccines: summary of a report of the Institute of Medicine. Journal of the American Medical Association 1992;267:392-396.

Howson CP, Fineberg HV. The ricochet of magic bullets: summary of the Institute of Medicine report, Adverse Effects of Pertussis and Rubella Vaccines. Pediatrics 1992;89:318-324.

Hoyeraal HM, Mellbye OJ. Humoral immunity in juvenile rheumatoid arthritis. Annals of the Rheumatic Diseases 1974;33:248-253.

Hu XM. [Recent advance in research on the incidence of paralysis following immunization with live oral polio vaccine]. Chung Hua Liu Hsing Ping Hsueh Tsa Chih 1985;6:125-127.

Huber EG, Rannon L, Galffy G. [Long-term-follow-up-study after measles-vaccination] Langzeitstudie nach Masernimpfung. Padiatrie und Padologie 1976;11:72-76.

Hudson JB, Weinstein L, Chang T. Thrombocytopenic purpura in measles. Journal of Pediatrics 1956;48:48-56.

Hudson TJ, Newkirk M, Gervais F, Shuster J. Adverse reaction to the recombinant hepatitis B vaccine. Journal of Allergy and Clinical Immunology 1991;88:821-822.

Hughes RA. Guillain-Barre Syndrome. London: Springer-Verlag; 1990.

Hughes WT, Smith JS, Kim MH. Suppression of the histoplasmin reaction with measles and smallpox vaccines. American Journal of Diseases of Children 1968;116:402-406.

Huisman J. [Adverse effects of the state vaccination program in 1986] Bijwerkingen van het rijksvaccinatieprogramma in 1986. Nederlands Tijdschrift voor Geneeskunde 1988;132:5-6.

Hulbert TV, Larsen RA, Davis CL, Holtom PD. Bilateral hearing loss after measles and rubella vaccination in an adult (letter). New England Journal of Medicine 1991;325:134.

Hunt A. Tuberous sclerosis: a survey of 97 cases. I. Seizures, pertussis immunization and handicap. Developmental Medicine and Child Neurology 1983;25:346-349.

Huovila R. Adverse reactions in children vaccinated with DPT and pertussis vaccine. Acta Paediatrica Scandinavica 1982;71(Suppl. 298):26-29.

Hurt RD, Hogan MJ, Hagmeier CH, Wright PF, Kim-Farley RJ. Robertson S et al. The eradication of poliomyelitis. New England Journal of Medicine 1992;326:1295.

Hurwitz ES, Holman RC, Nelson DB, Schonberger LB. National surveillance for Guillain-Barre syndrome: January 1978-March 1979. Neurology 1983;33:150-157.

Hurwitz ES. Schonberger LB, Nelson DB, Holman RC. Guillain-Barre syndrome and the 1978-1979 influenza vaccine. New England Journal of Medicine 1981;304:1557-1561.

Hutcheson R. DTP immunization and sudden infant death—Tennessee. Morbidity and Mortality Weekly Report 1979;28:131-132.

Hutcheson R. Follow-up on DTP immunization and sudden infant death—Tennessee. Morbidity and Mortality Weekly Report 1979;28:134-135.

Hutchinson TA, Lane DA. Assessing methods for causality assessment of suspected adverse drug reactions. Journal of Clinical Epidemiology 1989;42:5-16.

Hutteroth TH, Quast U. [Aluminum hydroxide-induced granulomas after hepatitis B vaccination] Aluminiumhydroxid-Granulome nach Hepatitis-B-Impfung. Deutsche Medizinische Wochenschrift 1990;115:476.

Ifekwunigwe AE, Grasset N, Glass R, Foster S. Immune response to measles and smallpox vaccinations in malnourished children. American Journal of Clinical Nutrition 1980;33:621-624.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Iglehart JK. Compensating children with vaccine-related injuries. New England Journal of Medicine 1987;316:1282-1288.

Ikic D, Jancikic B, Branica M, Manhalter T. The safety of human diploid cell strains for man: a controlled study of symptoms occurring after the administration of WM-3 living attenuated poliovirus vaccine prepared in the WI-38 human diploid cell strain. American Journal of Epidemiology 1968;87:411-418.

Ilinskikh NN. [Chromosome breaks and changes in the mitotic regime of human and animal cells under the influence of a measles virus vaccinal strain (L-16)] Khromosomnye narusheniia i izmenenie mitoticheskogo rezhima v kletkakh cheloveka i zhivotnykh pod vliianiem vaktsinogo shtamma virusa kori (L-16). Tsitologiia 1975;17:131-136.

Ilinskikh NN. [Chromosome disorders in the leukocytes of healthy children and children with Down's syndrome vaccinated and unvaccinated against measles] Khromosomnye narusheniia v leikotsitakh krovi zdorovykh detei i detei, bol'nykh sindromom Dauna, v norme i posle vaktsinatsii protiv kori. Tsitologiia 1981;23:67-73.

Ilinskikh NN. [Chronobiological studies of the antimutagenic action of methyluracil in cytogenetic lesions induced in mice by the vaccinal strain of the poliomyelitis virus] Khronobiologicheskie issledovaniia antimutagennoi aktivnosti metiluratsila pri tsitogeneticheskikh porazheniiakh, indutsirovannykh u myshei vaktsinnym shtammom virusa poliomielita. Biulletin Eksperimentalnoi Biologii i Meditsiny 1982;94:102-104.

Ilinskikh NN. [Human intraspecific genetic polymorphism and the sensitivity of the chromosome apparatus to the mutagenic action of vaccinal viral strains] Vnutrividovoi geneticheskii polimorfizm u cheloveka i chuvstvitel'nost' khromosomnogo apparata k mutagennomu deistviiu vaktsinnykh shtammov virusov. Izvestiia Akademii Nauk SSSR (Biol) 1984;1:31-39.

Illis LS, Taylor FM. Neurological and electroencephalographic sequelae of tetanus. Lancet 1971;1:826-830.

Immunization Practices Advisory Committee, Centers for Disease Control. Poliomyelitis prevention. Annals of Internal Medicine 1982;96:630-634.

Inami S. Appearance of enterovirus in the Takatsuki district. Nippon Shonika Gakkai Sasshi [Journal of the Japan Pediatric Society] 1966;70:539-553.

Ing DJ, Glass RI, Woods PA, Simonetti M, Pallansch MA, Wilcox WD et al. Immunogenicity of tetravalent rhesus rotavirus vaccine administered with buffer and oral polio vaccine. American Journal of Diseases of Children 1991;145:892-897.

Innis MD. Oncogenesis and poliomyelitis vaccine. Nature 1968;219:972-973.

Inoue A, Tsukada N, Koh C-S, Yanagisawa N. Chronic relapsing demyelinating polyneuropathy associated with hepatitis B infection. Neurology 1987;37:1663-1666.

Insel RA, Anderson PW. Response to oligosaccharide-protein conjugate vaccine against Haemophilus influenzae b in two patients with IgG2 deficiency unresponsive to capsular polysaccharide vaccine. New England Journal of Medicine 1986;315:499-503.

Institute of Medicine. Adverse Effects of Pertussis and Rubella Vaccines. Washington, DC: National Academy Press. 1991.

Institute of Medicine. Evaluation of Poliomyelitis Vaccines. Washington, DC: National Academy of Sciences; 1977.

Institute of Medicine. An Evaluation of Poliomyelitis Vaccine Policy Options. Washington, DC: National Academy of Sciences; 1988.

Institute of Medicine. New Vaccine Development: Establishing Priorities. Volume I. Diseases of Importance in the United States. Washington. DC: National Academy Press: 1985.

Institute of Medicine. Vaccine Supply and Innovation. Washington. DC: National Academy Press; 1985.

Interagency Committee to Improve Access to Immunization Services. The Public Health Service action plan to improve access to immunization services. Public Health Reports 1992;107:243-251.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Ipp MM, Gold R, Greenberg S, Goldbach M, Kupfert BB, Lloyd DD et al. Acetaminophen prophylaxis of adverse reactions following vaccination of infants with diphtheria-pertussistetanus toxoids-polio vaccine. Pediatric Infectious Disease Journal 1987;6:721-725.

Ipp MM, Gold R, Goldbach M, Maresky DC, Saunders N, Greenberg S et al. Adverse reactions to diphtheria, tetanus, pertussis-polio vaccination at 18 months of age: effect of injection site and needle length. Pediatrics 1989;83:679-682.

Ipp M, Goldbach M, Greenberg S, Gold R. Effect of needle change and air bubble in syringe on minor adverse reactions associated with diphtheria-tetanus toxoids-pertussis-polio vaccination in infants. Pediatric Infectious Disease Journal 1990;9:291-293.

Irtel Von Brenndorff A, Enders Ruckle G, Hagge W. [Atypical measles after immunization with inactivated measles vaccine (split vaccine)] Atypische masern nach immunisierung mit inaktiviertem masernimpfstoff (spaltvakzine). Medizinische Monatsschrift 1973;27:265-268.

Isaacs D, Menser M. Measles, mumps, rubella, and varicella. Lancet 1990;335:1384-1387.

Isacson P, Stone A. Allergic reactions associated with viral vaccines. Progress in Medical Virology 1971;13:239-270.

Ishitobi A. Studies on diphtheria-tetanus combined vaccine. Acta Paediatrica Japonica 1980;22:66-67.

Ishizaki A, Noda Y. [Neurological complications of immunization]. No To Hattatsu 1986;18:105-113.

Isomura S. Measles and measles vaccine in Japan. Acta Paediatrica Japonica 1988;30:154-162.

Isomura S. Asano Y, Hon AS et al. Studies on live attenuated mumps vaccine. I. Comparative field trials with two different live vaccines . Biken Journal 1973;16:39-42.

Isozaki M, Kuno-Sakai H, Hoshi N, Takesue R, Takakura I, Kimura M et al. Effects and side effects of a new trivalent combined measles-mumps-rubella (MMR) vaccine. Tokai Journal of Experimental and Clinical Medicine 1982;7:547-550.

Iwai T, Matumoto M, Kawana R. Unusual clinical reactions to live measles vaccine in a child previously immunized with killed measles vaccine. Japanese Journal of Experimental Medicine and Biology 1968;38:139-142.

Iwarson S. The main five types of viral hepatitis: an alphabetical update. Scandinavian Journal of Infectious Diseases 1992;24:129-135.

Izuora GI. Acute paralytic poliomyelitis among Nigerian children in Enugu. East Africa Medical Journal 1981;58:405-411.

Jabbour JT, Duenas DA, Sever JL, Krebs HM, Horta-Barbosa L. Epidemiology of subacute sclerosing panencephalitis (SSPE). Journal of the American Medical Association 1972;220:959-962.

Jabbour JT, Garcia JH, Lemmi H, Ragland J, Duenas DA, Sever JL. Subacute sclerosing panencephalitis. Journal of the American Medical Association 1969;207:2248-2254.

Jabbour JT, Roane JA, Sever JL. Studies of delayed dermal hypersensitivity in patients with subacute sclerosing panencephalitis. Neurology 1969;19:929-931.

Jaber L. Shohat M, Mimouni M. Infectious episodes following diphtheria-pertussis-tetanus vaccination: a preliminary observation in infants. Clinical Pediatrics 1988;27:491-494.

Jackson H. A fatal case of purpura with a few notes on the recent literature of this disease. Archives of Pediatrics 1890;7:951.

Jacobs RL, Lowe RS, Lanier BQ. Adverse reactions to tetanus toxoid. Journal of the American Medical Association 1982;247:40-42.

Jacquest D, Stout I. Reactions to Haemophilus influenzae type b vaccine. Canadian Journal of Public Health 1989;80:304-305.

Jagdis F, Langston C, Gurwith M. Encephalitis after administration of live measles vaccine. Canadian Medical Association Journal 1975;112:972-975.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Jahnke U, Fischer EH, Alvord EC Jr. Sequence homology between certain viral proteins and proteins related to encephalomyelitis and neuritis. Science 1985;229:282-284.

Jakacki R, Luery N, McVerry P, Lange B. Haemophilus influenzae diphtheria protein conjugate immunization after therapy in splenectomized patients with Hodgkin disease. Annals of Internal Medicine 1990;112:143-144.

James G, Longshore WA, Hendry JL. Diphtheria immunization studies of students in an urban high school. American Journal of Hygiene 1951;53:178-201.

Janzen R, Balzereit F, Jannakis C. [Is there a panoramic variation in inflammatory nerve diseases since the introduction of poliomyelitis vaccination? Observations on rare courses of virus induced encephalitis, myelitis and polyneuritis] Gibt es einen Panoramawandel bei entzundlichen Nervenkrank-heiten seit Einfuhrung der Poliomyelitis-Schutzimpfung? Beobachtungen uber ungewohnliche Verlaufsformen von virusbedingten Enzephalitiden, Myelitiden, Polyneuritiden. Deutsche Medizinische Wochenschrift 1968;93:860-867.

Japan Measles Vaccine Research Commission. A field trial of further attenuated live measles virus vaccines in Japan, 1968. Japanese Journal of Medical Science and Biology 1969;22:191-200.

Jawad AS, Scott DG. Immunization triggering rheumatoid arthritis? (letter). Annals of the Rheumatic Diseases 1989;48:174.

Jean-Joseph P, Sow S, Casey HL, Imperato PJ, Henderson RH, Noble JJ. A comparison of Edmonston-B and Schwarz measles vaccine in Malian children. Lancet 1969;1:665-667.

Jenson AB, Rosenberg HS, Notkins AL. Pancreatic islet cell damage in children with fatal viral infections. Lancet 1980;2:354-358.

Jilg W et al. [Vaccination for hepatitis B virus: unresolved questions] Hepatitis-B impfung: ungelöste probleme. Schweizerische Rundschau fur Medizin Praxis 1992;81:795-797.

Jimenez Puente A, Cejas Hermoso P, Luna del Castillo JD, Valles Casado LM, Benitez Bocanegra S, Cortes Martinez C et al. [Postvaccinal reactions to simultaneous administration of the triple viral, oral polio and diphtheria-tetanus vaccines compared with their administration in sequence] Reacciones posvacunales tras la administracion simultanea de vacunas triple virica y antipolio oral-difteria-tetanos, frente a su administracion secuencial. Atencion Primaria 1992;10:825-830.

Job JS, Halsey NA, Boulos R, Holt E, Farrell D, Albrecht P et al. Successful immunization of infants at 6 months of age with high dose Edmonston-Zagreb measles vaccine. Pediatric Infectious Disease Journal 1991;10:303-311.

Joffe LS, Glode MP, Gutierrez MK, Wiesenthal A, Luckey DW, Harken L . Diphtheria-tetanus toxoids-pertussis vaccination does not increase the risk of hospitalization with an infectious illness. Pediatric Infectious Disease Journal 1992;11:730-735.

John TJ, Moore R, Gibson JJ et al. Choice between inactivated and oral poliovirus vaccines in India. Lancet 1992;339:504.

John TJ, Nambiar A, Samuel BU, Rajasingh J. Ulnar nerve inoculation of poliovirus in bonnet monkey: a new primate model to investigate neurovirulence. Vaccine 1992;10:529-532.

Johnson DE. Guillain-Barre syndrome in the US Army. Archives of Neurology 1982;39:21-24.

Johnson DW, Fleming SJ. The use of vaccines in renal failure. Clinical Pharmacokinetics 1992;22:434-446.

Johnson RT. Neurologic diseases associated with viral infections. Postgraduate Medicine 1971;50:158-163.

Johnson RT. Viral aspects of multiple sclerosis. 3. Vinken PJ, Bruyn GW, Klawans HL, eds. Handbook of Clinical Neurology. New York: Elsevier Science Publishing Co., Inc.; 1985:319-336.

Johnson RT, Griffin DE, Gendelman HE. Postinfectious encephalomyelitis. Seminars in Neurology 1985;5:180-190.

Johnson RT, Griffin DE, Hirsch RL, Wolinsky JS, Roedenbeck S, Lindo de Soriano I, Vaisberg

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

A. Measles encephalomyelitis: clinical and immunologic studies. New England Journal of Medicine 1984;310:137-141.

Jones AE, Melville-Smith M, Watkins J. Adverse reactions in adolescents to reinforcing doses of plain and adsorbed tetanus vaccines. Community Medicine 1985;7:99-106.

Jones RG, Bass JW, Weisse ME, Vincent JM. Antigenuria after immunization with Haemophilus influenzae oligosaccharide CRM197 conjugate (HBOC) vaccine. Pediatric Infectious Disease Journal 1991;10:557-559.

Jorch G, Kleine M, Erwig H. [Coincidence of virus encephalitis and measles-mumps vaccination] Koinzidenz von Virusenzephalitis und Masern-Mumps-Impfung. Monatsschrift fur Kinderheilkunde 1984;132:299-300.

Joseph VJ, Yeshwanth M. Poliomyelitis and immunization status (letter). Indian Pediatrics 1992;29:241-244.

Journal of the American Medical Association. Evaluation of a new mumps vaccine: mumps virus vaccine, live, attenuated (Mumpsvax). Journal of the American Medical Association 1969;209:2042.

Journal of the American Medical Association. Update: prevention of Haemophilus influenzae type b disease. Journal of the American Medical Association 1988;259:798-804.

Journal of the American Medical Association. Paralytic poliomyelitis—Senegal, 1986-1987: update on the N-IPV efficacy study. Journal of the American Medical Association 1988;259:2974.

Journal of the American Medical Association. Update: Haemophilus influenzae type b vaccine. Journal of the American Medical Association 1989;261:1118.

Journal of the American Medical Association. Haemophilus influenzae declining among young? Journal of the American Medical Association 1991;266:3398-3399.

Journal of the Indian Medical Association. Paralytic poliomyelitis. Journal of the Indian Medical Association 1973;60:309-310.

Journal of Pediatrics. Neurologic complications of oral poliomyelitis vaccine (letter). Journal of Pediatrics 1987;110:996-998.

Jung S, Schluesener HJ, Toyka K, Hartung HP. T cell vaccination does not induce resistance to experimental autoimmune neuritis. Journal of Neuroimmunology 1991;35:1-11.

Jungkunz G, Kohler P, Holbach M, Schweisfurth H. [Case representation: two cases of strong local reaction after active hepatitis B-vaccination with sensitisation to thiomersal] Kasuistik: zwei falle mit heftiger lokaler reaktion nach aktiver hepatitis B-impfung bei sensibilisierung auf thiomersal. Hygiene + Medizin 1990;15:418-420.

Juntunen-Backman K, Peltola H, Backman A, Salo OP. Safe immunization of allergic children against measles, mumps, and rubella. American Journal of Diseases of Children 1987;141:1103-1105.

Just M, Berger R. [Immunogenicity of vaccines: a comparative study of a mumps-measles-rubella vaccine given with or without oral polio vaccine] Immunantwort auf impfstoffe: Vergleichende studie mit mumps-, masern-und rotein-impfstoff allein oder zusammen mit polio-impfstoff appliziert. Munchener Medizinische Wochenschrift 1987;129:78-82.

Just M, Berger R, Gluck R, Wegmann A. Evaluation of a combined vaccine against measles-mumps-rubella produced on human diploid cells. Developments in Biological Standardization 1986;65:25-27.

Just M, Berger R, Just V. Evaluation of a combined measles-mumps-rubella-chickenpox vaccine. Developments in Biological Standardization 1986;65:85-88.

Just M, Berger R, Just V. Reactogenicity and immunogenicity of a recombinant hepatitis B vaccine compared with a plasma-derived vaccine in young adults. Postgraduate Medical Journal 1987;63(Suppl. 2):121-123.

Kaaber K, Nielsen AO, Veien NK. Vaccination granulomas and aluminium allergy: course and prognostic factors. Contact Dermatitis 1992;26:304-306.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Kaaber K, Samuelsson IS, Larsen SO. [Reactions after MMR vaccination] Reaktioner efter MFR-vaccination. Ugeskrift for Laeger 1990;152:1672-1676.

Kabat EA, Wolf A, Bezer AE. The rapid production of acute disseminated encephalomyelitis in rhesus monkeys by injection of heterologous and homologous brain tissue with adjuvants. Journal of Experimental Medicine 1947;85:117-130.

Kafidi KT, Rotschafer JC. Bacterial vaccines for splenectomized patients. Drug Intelligence and Clinical Pharmacy 1988;22:192-197.

Kaiser GC, King RD, Lempke RE, Ruster MH. Delayed recall of active tetanus immunization. Journal of the American Medical Association 1961;178:914-916.

Kakakios AM, Burgess MA, Bransby RD, Quinn AA, Allars HM. Optimal age for measles and mumps vaccination in Australia. Medical Journal of Australia 1990;152:472-474.

Kalet A, Berger DK, Bateman WB, Dubitsky J, Covitz K. Allergic reactions to MMR vaccine (letter). Pediatrics 1992;89:168-169.

Kamin PB, Fein BT, Britton HA. Live, attenuated measles vaccine. Journal of the American Medical Association 1963;185:99-102.

Kamin PB, Fein BT, Britton HA. Use of live, attenuated measles virus vaccine in children allergic to egg protein. Journal of the American Medical Association 1965;193:143-144.

Kamin PB, Fein BT, Britton HA. Use of live, attenuated measles virus vaccine in children allergic to egg protein. Journal of the American Medical Association 1965;193:1125-1126.

Kanesaki T, Baba K, Tsuda N, Yabuuchi H, Yamanishi K, Takahashi M. Protection of mumps in children with various underlying diseases: application of a live attenuated mumps and trivalent measles-rubella-mumps (MRM) vaccines in these children. Biken Journal 1986;29:63-71.

Kantoch M, Naruszewicz LD, Polna I, Litynska J. Immunologic response and reactions to vaccination in children during the campaign of vaccinations against measles. II. Antibody levels and seroconversion after vaccination . Przeglad Epidemiologiczny 1974;28:325-331.

Kantoch M, Naruszewicz LD, Polna I, Litynska J. Immunologic response and reactions to vaccination in children vaccinated against measles. III. Persistence of measles antibodies in children vaccinated in 1972. Przeglad Epidemiologiczny 1976;30:235-241.

Kaplan BS, Proesmans W. The hemolytic uremic syndrome of childhood. Seminars in Hematology 1987;24:148-160.

Kaplan C, Morinet F, Cartron J. Virus-induced autoimmune thrombocytopenia and neutropenia. Seminars in Hematology 1992;29:34-44.

Kaplan JE, Katona P, Hurwitz ES, Schonberger LB. Guillain-Barre syndrome in the United States, 1979-1980 and 1980-1981: lack of an association with influenza vaccination. Journal of the American Medical Association 1982;248:698-700.

Kaplan JE, Schonberger LB, Hurwitz ES, Katona P. Guillain-Barre syndrome in the United States, 1978-1981: additional observations from the national surveillance system. Neurology 1983;33:633-637.

Kaplan KM, Marder DC, Cochi SL, Preblud SR. Mumps in the workplace: further evidence of the changing epidemiology of a childhood vaccine-preventable disease . Journal of the American Medical Association 1988;260:1434-1438.

Kaplan SA. Clinical Pediatric Endocrinology. Philadelphia: W. B. Saunders; 1990.

Kaplan SL, Duckett T, Mahoney DH Jr., Kennedy LL, Dukes CM, Schaffer DM et al. Immunogenicity of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in children with sickle hemoglobinopathy or malignancies, and after systemic Haemophilus influenzae type b infection. Journal of Pediatrics 1992;120:367-370.

Kaplan SL, Zahradnik JM, Mason EO Jr., Dukes CM. Immunogenicity of the Haemophilus

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

influenzae type b capsular polysaccharide conjugate vaccine in children after systemic Haemophilus influenzae type b infections. Journal of Pediatrics 1988;113:272-277.

Karchmer AW, Friedman JP, Casey HL, Shope TC, Riker JB, Kappelman MM et al. Simultaneous administration of live virus vaccines: measles, mumps, poliomyelitis, and smallpox. American Journal of Diseases of Children 1971;121:382-388.

Karjalainen J, Martin JM, Knip M, Ilonen J, Robinson B, Savilahti E et al. A bovine albumin peptide as a possible trigger of insulin-dependent diabetes mellitus. New England Journal of Medicine 1992;327:302-307.

Karzon D, Edwards K. Diphtheria outbreaks in immunized populations. New England Journal of Medicine 1988;318:41-43.

Kaslow RA, Sullivan-Bolyai JZ, Hafkin B, Schonberger LB, Kraus L, Moore MJ et al. HLA antigens in Guillain-Barre syndrome. Neurology 1984;34:240-242.

Kaslow RA, Sullivan-Bolyai JZ, Holman RC, Hafkin B, Dicker RC, Schonberger LB. Risk factors for Guillain-Barre syndrome. Neurology 1987;37:685-688.

Kasper JM, Waesser ST. [Value of EEG studies in connection with vaccinations] Uber den Wert von EEG-Untersuchungen im zusammenhang mit Schutzimpfungen. Zeitschrift fur Aerztliche Fortbildung 1978;72:457-461.

Kass B, Nyberg-Hansen R. Acute brachial neuropathy. Tidsskrift for den Norske Laegeforening 1983;103:7-9, 26.

Katz M, Oyanagi S, Koprowski H et al. Structures resembling myxovirus nucleocapsids in cells cultures from brains . Nature 1969;222:888-890.

Katz SL. Immunization with live attenuated measles virus vaccine: five years' experience. Archiv Fur Die Gesamte Virusforschung 1965;16:222-230.

Katz SL. How does measles virus cause subacute sclerosing panencephalitis? New England Journal of Medicine 1969;281:615-616.

Katz SL. International Symposium on Measles Immunization: summary and recommendations. Pediatrics 1983;71:653-654.

Kaufman DL, Erlander MG, Slare-Salzler M, Atkinson MA, Maclaren NK, Tobin AJ. Autoimmunity to two forms of flutamate decarboxylase in insulin-dependent diabetes mellitus. Journal of Clinical Investigation 1992;89:283-292.

Kawamura S. [An analytical study on the clinical reactions to measles vaccine]. Nippon Eiseigaku Zasshi 1968;23:406-411.

Kawanishi K. [Clinical and serological studies of live attenuated mumps virus vaccine—inoculation of mumps vaccine singly and in combination with measles vaccine]. Kansenshogaku Zasshi 1971;45:54-66.

Kayhty H, Eskola J, Peltola H, Ronnberg PR, Kela E, Karanko V et al. Antibody responses to four Haemophilus influenzae type b conjugate vaccines. American Journal of Diseases of Children 1991;145:223-227.

Kayhty H, Peltola H, Eskola J. Immunogenicity and reactogenicity for four Haemophilus influenzae type b capsular polysaccharide vaccines in Finnish 24-month-old children. Pediatric Infectious Disease Journal 1988;7:574-577.

Kayhty H, Peltola H, Eskola J, Ronnberg PR, Kela E, Karanko V et al. Immunogenicity of Haemophilus influenzae oligosaccharide-protein and polysaccharide-protein conjugate vaccination of children at 4, 6, and 14 months of age. Pediatrics 1989;84:995-999.

Kazarian EL, Gager WE. Optic neuritis complicating measles, mumps, and rubella vaccination. American Journal of Ophthalmology 1978;86:544-547.

Kekomaki R, Nieminen U, Peltola H. Acute idiopathic thrombocytopenic purpura following measles, mumps and rubella vaccination (abstract). 13th Congress of the International Society on Thrombosis and Haemostatis, Amsterdam. The Netherlands, Abstract No. 600, p. 866.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Kellaway P, Krachoby RA, Frost JD, Zion T. Precise characterization and quantification of infantile spasms. Annals of Neurology 1979;6:214-218.

Kelton JG. Vaccination-associated relapse of immune thrombocytopenia. Journal of the American Medical Association 1981;245:369-371.

Kelton JG, Neame PB, Gauldie J, Hirsch J. Elevated platelet-associated IgG in the thrombocytopenia of septicemia. New England Journal of Medicine 1979;300:760-764.

Kemp A, Van Asperen P, Mukhi A. Measles immunization in children with clinical reactions to egg protein. American Journal of Diseases of Children 1990;144:33-35.

Kernbaum S. [Acute myelitis and vaccination] Myelite aigue et vaccination. Concours Medical 1991;113:1760.

Kernbaum S. [Meningoencephalitis after DTP vaccination] Meningo-encephalite apres DT-polio. Concours Medical 1992;114:156.

Keuth U. [Cerebral damage caused by enteritis (so-called toxicosis) following oral poliomyelitis vaccination, recognized as vaccination damage (letter)] Zerebralschaden durch Enteritis (sogenannte Toxikose) nach oraler Poliomyelitis-Impfung als Impfschaden anerkannt. Deutsche Medizinische Wochenschrift 1974;99:110.

Kibel MA et al. Guillain-Barre syndrome in childhood. South African Medical Journal 1983;63:715.

Kibel MA, Hay I, Donald P. Contraindications to immunization. South African Medical Journal 1990;77:537-538.

Kiefaber RW. Thrombocytopenic purpura after measles vaccination (letter). New England Journal of Medicine 1981;305:225.

Kim KS, Wong VK, Adler R, Steinberg EA. Comparative immune responses to Haemophilus influenzae type b polysaccharide and a polysaccharide-protein conjugate vaccine. Pediatrics 1990:85(4 Pt 2):648-650.

Kim-Farley R. Global immunization. Annual Reviews of Public Health 1992:13:223-237.

Kim-Farley R, Bart S, Stetler H, Orenstein W, Bart K, Sullivan K et al. Clinical mumps vaccine efficacy. American Journal of Epidemiology 1985;121:593-597.

Kinder J, Teare L, Rao M, Bridgman G, Kurian A. False contraindications to childhood immunization. British Journal of General Practice 1992;42:160-161.

King SD, Ramlal A, Wynter H, Moodie K, Castle D, Kuo JS et al. Safety and immunogenicity of a new Haemophilus influenzae type b vaccine in infants under one year of age. Lancet 1981:2:705-709.

Kinnunen E. Farkkila M, Hovi T, Juntunen J, Weckstrom P. Incidence of Guillain-Barre syndrome during a nationwide oral poliovirus vaccine campaign. Neurology 1989;39:1034-1036.

Kinnunen E, Farkkila M, Hovi T, Juntunen J, Weckstrom P. Polio vaccine and GBS. Neurology 1990;40:729.

Kirkland LR. Ocular sensitivity to thimerosal: a problem with hepatitis B vaccine? Southern Medical Journal 1990;83:497-499.

Kitamura I, Hirai S, Kurashige T. Poliomyelitis from a vaccine. Lancet 1969;1:465.

Kitsiou S, Saxoni-Papageorgiou P, Haidemenaki T, Gala A, Koukoutsakis P, Stavrinadis C et al. Sister chromatid exchanges in peripheral lymphocytes of children vaccinated against rubella and measles-mumps-rubella. Acta Paediatrica Scandinavica 1988;77:879-884.

Kittler FJ. Smith PJ, Hefley BF, Cazort AG. Reactions to tetanus toxoid . Southern Medical Journal 1966;59:149-153.

Kiwit JC. Neuralgic amyotrophy after administration of tetanus toxoid. Journal of Neurology, Neurosurgery and Psychiatry 1984;47:320.

Klajman A, Sternbach M, Ranon L, Drucker M, Geminder D, Sadan N. Impaired delayed hypersensitivity in subacute sclerosing panencephalitis. Acta Paediatrica Scandinavica 1973;62:523-526.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Kletz MR, Holland CL, Mendelson JS, Bielory L. Administration of egg-derived vaccines in patients with history of egg sensitivity. Annals of Allergy 1990;64:527-529.

Kniker WT. Anaphylaxis in children and adults. In: Bierman CW, Pearlman DW, eds. Allergic Diseases from Infancy to Adulthood. Philadelphia: W. B. Saunders Co.; 1988.

Koch J, Leet C, McCarthy R, Carter A, Cuff W. Adverse events temporally associated with immunizing agents—1987 report/Manifestations facheuses associees dans le temps a des agents immunisants—rapport de 1987. Canada Diseases Weekly Report/Rapport hebdomadaire des maladies au Canada 1989;15:151-158.

Kok PW, Leeuwenburg J, Tukei P, van Wezel AL, Kapsenberg JG, van Steenis G et al. Serological and virological assessment of oral and inactivated poliovirus vaccines in a rural population in Kenya. Bulletin of the World Health Organization 1992;70:93-103.

Kolmer JA. Vaccination against acute anterior poliomyelitis. American Journal of Public Health and the Nations Health 1936;26:126-135.

Koplan JP, Preblud SR. A benefit-cost analysis of mumps vaccine. American Journal of Diseases of Children 1982;136:362-364.

Koprowski H, Jervis GA, Norton TW. Immune responses in human volunteers upon oral administration of a rodent-adapted strain of poliomyelitis virus. American Journal of Hygiene 1952;55:108-126.

Korger G, Quast U, Dechert G. [Tetanus vaccination: tolerance and avoidance of adverse reactions] Tetanusimpfung: Vertraglichkeit und Vermeidung von Nebenreaktionen. Klinische Wochenschrift 1986;64:767-775.

Korman SH. Thrombocytopenic purpura during the incubation of hepatitis B. Acta Pediatrica Scandinavica 1991;80:975-976.

Kostrzewski JM. [Case of poliomyelitis in unvaccinated children in contact with persons vaccinated with attenuated virus] Zachorowania na poliomyelitis w otoczeniu szczepionych wirusem atenuowanym. Przeglad Epidemiologiczny 1973;27:259-265.

Kostrzewski J, Kantoch M. [Reactions to vaccination and measles antibody levels in children inoculated with vaccine prepared from the L-16 strain from Japanese quail embryonic fibroblast cultures] Odczyny i poziom przeciwcial odrowych u dzieci po podaniu szczepionki ze szczepu L-16 przygotowanej w hodowli fibroblastow zarodka przepiorki Japonskiej. Przeglad Epidemiologiczny 1975;29:291-300.

Kovalskaya SI. [The anaphylactogenic properties of absorbed and nonabsorbed pertussis-diphtheria-tetanus vaccines] Anafilaktogennye svoistva adsorbipovannoi i neadsorbirovannoi kokliusnodifterino-stolbniachnoi vaktsin. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii 1967;44:105-109.

Kovalskaya SI. [Anaphylactogenic properties of ADT, PDT- and APDT vaccines under experimental conditions] Anafilaktogennye svoistva ADS, KDS-i AKDS-baktsin v eksperimente. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii 1969;46:65-71.

Kovel A, Wald ER, Guerra N, Serdy C, Meschievitz CK. Safety and immunogenicity of acellular diphtheria-tetanus-pertussis and haemophilus conjugate vaccines given in combination or at separate injection sites. Journal of Pediatrics 1992;120:84-87.

Kramer MS. Assessing causality of adverse drug reactions: global introspection and its limitations. Drug Information Journal 1986;20:433-437.

Kramer MS. A Bayesian approach to assessment of adverse drug reactions: evaluation of a case of fatal anaphylaxis. Drug Information Journal 1986;20:505-517.

Kramer MS. Difficulties in assessing the adverse effects of drugs. British Journal of Clinical Pharmacology 1981;11:105S-110S.

Kramer MS, Lane DA. Causal propositions in clinical research and practice. Journal of Clinical Epidemiology 1992;45:639-649.

Kramer MS, Leventhal JM, Hutchinson TA, Feinstein AR. An algorithm for the operational assessment of adverse drug reactions. I. Background, description, and instructions for use. Journal of the American Medical Association 1979;242:623-632.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Krasinski K, Borkowsky W. Measles and measles immunity in children infected with human immunodeficiency virus. Journal of the American Medical Association 1989;261:2512-2516.

Krause DS, Cook L. Prevalence of hepatitis B in pregnant women (letter). Journal of the American Medical Association 1992;267:1919-1920.

Krause PJ, Cherry JD, Deseda-Tous J, Champion JG, Strassburg M, Sullivan C et al. Epidemic measles in young adults: clinical, epidemiologic, and serologic studies. Annals of Internal Medicine 1979;90:873-876.

Kremer HU. Juvenile diabetes as a sequel to mumps. American Journal of Medicine 1947;3:257-258.

Kringelbach J, Senstius J. [Hypsarrhythmia after triple vaccination] Hypsarrhytmia efter tripelvakcination. Nordisk Medicin 1966;76:1433-1436.

Krober MS, Stracener CE, Bass JW. Decreased measles antibody response after measles-mumps-rubella vaccine in infants with colds. Journal of the American Medical Association 1991;265:2095-2096.

Krugman S. Hepatitis B vaccine. In: Plotkin SA, Mortimer EA, eds. Vaccines. Philadelphia: W.B. Saunders Co.; 1988.

Krugman S, Giles JP. Viral hepatitis type B(MS-2 strain): further observations on natural history and prevention. New England Journal of Medicine 1973;288:755-760.

Krugman S, Giles JP, Friedman H, Stone S. Studies on immunity to measles. Journal of Pediatrics 1965;66:471-488.

Krugman S, Giles JP, Hammond J. Hepatitis virus: effect of heat on the infectivity and antigenicity of the MS-1 and MS-2 strains. Journal of Infectious Diseases 1970;122:432-436.

Krugman S, Giles JP, Hammond J. Viral hepatitis, type B(MS-2 strain): studies on active immunization. Journal of the American Medical Association 1971;217:41-45.

Krugman S, Giles JP, Jacobs AM, Friedman H. Studies with live attenuated measles-virus vaccine. American Journal of Diseases of Children 1962;103:353-363.

Kruppenbacher JP, Mertens T, Adrian M, Smolenski S, Leidel J, Eggers HJ. [Vaccine poliomyelitis as a complication of oral vaccination] Die Impfpoliomyelitis als Komplikation der Oralvakzination. Offentliche Gesundheitswesen 1983;45:528-531.

Kucharska Z, Sramova H, Zdrazilek J. Excretion of attenuated polioviruses in children vaccinated with live oral poliovirus vaccine. Journal of Hygiene, Epidemiology, Microbiology and Immunology 1982;26:74-82.

Kuhns WJ, Pappenheimer AM Jr. Immunochemical studies of antitoxin produced in normal and allergic individuals hyperimmunized with Diphtheria toxoid. Journal of Experimental Medicine 1952;95:363-374, 375-392.

Kulhanjian J. The decline in invasive Haemophilus Influenzae type b (Hib) disease in a large pediatric referral hospital following introduction to Hib conjugate vaccines. Program Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. Abstract 1727, p. 398. Washington, DC: American Society for Microbiology; 1992.

Kumar A. New vaccines for prevention of Hemophilus influenzae type b diseases. Drugs Today 1986;22(9):469-472.

Kumar R, Chandra R, Bhushan V, Srivastava BC. Adverse reaction after measles immunization in a rural population. Indian Pediatrics 1982;19:605-610.

Kupers TA, Petrich JM, Holloway AW, St, Geme JW Jr. Depression of tuberculin delayed hypersensitivity by live attenuated mumps virus. Journal of Pediatrics 1970;76:716-721.

Kurokawa T, Mizuno Y, Tomita S, Ueda K, Mitsudome A, Yokota K et al. [Neurological complications related to immunization]. No To Hattatsu 1986;18:98-104.

Kurz VM. Zwei falle von kurzfristiger diplopie nach poliomyelitis-schluckimpfung bei kindern. Wiener Medizinische Wochenschrift 1966;116:135.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Kuwert E, Thraenhart O, Hoher PG, Dorndorf W, Voit D, Blumenthal W. [Spinal poliomyelitis due to contact with polio vaccine virus] Spinale Kinderlahmung nach Kontakt mit Polioimpfvirus. Deutsche Medizinische Wochenschrift 1971;96:1562-1568.

Kwiatkowska E, Pajor Z. [Remarks on the preventive vaccination in children with damaged central nervous system] Uwagi o stosowaniu szczepien ochronnych u dzieci z uszkodzeniem osrodkowego ukladu nerwowego. Neurologia, Neurochirurgia i Psychiatria Polska 1965;15:635-637.

Kwittken PL, Rosen S, Sweinberg SK. MMR vaccine and neomycin allergy (letter). American Journal of Diseases of Children 1993;147:128-129.

Kyle WS. Simian retrovirus, poliovaccine, and origin of AIDS. Lancet 1992;339:600-601.

Labauge R, Marty-Double C, Pages M, Boukobza M, Monstrey J. [Postvaccinal encephalitis in an adult: a case with anatomo-clinical report] Encephalite postvaccinale de l'adulte: etude anatomo-clinique d'une observation. Revue Neurologique 1979;135:803-813.

Label LS, Batts DH. Transverse myelitis caused by duck embryo rabies vaccine. Archives of Neurology 1982;39:426-430.

LaForce FM. Poliomyelitis vaccines: success and controversy. Infectious Disease Clinics of North America 1990;4:75-83.

Lahelle O. [Vaccination against poliomyelitis] Vaksinasjon mot poliomyelitt. Tidsskrift for den Norske Laegeforening 1973;93:598-600.

Lahrech MT, Caudrelier P. Immunological response of Moroccan children and newborns to oral poliovirus vaccine prepared on Vero cells. Vaccine 1990;8:306-307.

Lancet. N.Z. and S.S.P.E (editorial). Lancet 1973;2:772-773.

Lancet. Identification of the origin of poliovirus isolates: report of World Health Organisation informal meetings 1979—80. Lancet 1981;2:968-970.

Lancet. Correction: mumps meningitis following measles, mumps, and rubella immunization. Lancet 1989;2:696.

Lancet. Mumps meningitis and MMR vaccination. Lancet 1989;2:1015-1016.

Landay AL, Jessop C, Lennette ET, Levy JA. Chronic fatigue syndrome: clinical condition associated with immune activation. Lancet 1991;338:707-712.

Lancet. Safety of high-titre measles vaccine (editorial). Lancet 1991;338:920.

Landrigan PJ, Witte JJ. Neurologic disorders following live measles-virus vaccination. Journal of the American Medical Association 1973;223:1459-1462.

Lane DA. A probabilist's view of causality assessment. Drug Information Journal 1984;18:323-330.

Lane DA, Kramer MS, Hutchinson TA, Jones JK, Naranjo C. The causality assessment of adverse drug reactions using a Bayesian approach . Pharmaceutical Medicine 1987;2:265-283.

Langholz E, Nielsen OH. Induction of endogenous Arachidonic acid metabolism in human neutrophils with snake venom phospholipase A2, immune complexes, and A23187. Prostaglandins, Leukotrienes and Essential Fatty Acids 1990;39:227-229.

Langmuir AD, Bregman DJ, Kurland LT, Nathanson N, Victor M. An epidemiologic and clinical evaluation of Guillain-Barre syndrome reported in association with the administration of swine influenza vaccines. American Journal of Epidemiology 1984;119:841-879.

Langsjoen PH, Stinson JC. Acute fatal allergic myocarditis: report of a case. Diseases of the Chest 1965;48:440-441.

Langue J, Preziosi MP, Boutitie F, Langue S, Schulz D, Hessel L et al. Vaccination of 3-month-old children with the capsular polysaccharide Haemophilus influenzae type b (Hib) combined with tetanus proteins (PRP-T). Medecine et Hygiene 1991;49:422-429.

Lasch EE, Livni E, Englander T, el-Massri M, Marcus O, Joshua H. The cell mediated immune response in acute poliomyelitis and its use in early diagnosis. Developments in Biological Standardization 1978;41:179-182.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Last JM, ed. A Dictionary of Epidemiology, 2nd edition. New York: Oxford University Press; 1988.

Last JM, Wallace RB, eds. Maxcy-Rosenau-Last Public Health and Preventive Medicine, 13th ed. Norwalk, CT: Appleton & Lange; 1992.

Lau YL, Tam AY, Ng KW, Tsoi NS, Lam B, Yeung CY. Response to preterm infants to hepatitis B vaccine. Journal of Pediatrics 1992;121:962-965.

Lavi S, Zimmerman B, Koren G, Gold R. Administration of measles, mumps, and rubella virus vaccine (live) to egg-allergic children. Journal of the American Medical Association 1990;263:269-271.

Lazzari G. [Postvaccinal encephalopathy] Sullencefalopatia postvaccinale. Minerva Pediatrica 1970;22:581-584.

Leake JP. Poliomyelitis following vaccination against this disease. Journal of the American Medical Association 1935;105:2152.

Lederle-Praxis Biologicals. Oral poliovirus vaccine. Report to the Institute of Medicine Vaccine Safety Committee. May 4, 1992.

Lee CT. Parental knowledge of their own immunization to poliomyelitis. Journal of the American Medical Association 1985;254:608-609.

Lee DA, Eby WC, Molinaro GA. HIV false positivity after hepatitis B vaccination (letter). Lancet 1992;339:1060.

Lee GR, Foerster J, Athens JW, Lukens JN, eds. Wintrobe's Clinical Hematology, 9th edition. London: Lea & Febiger; 1993.

Leen CL, Barclay GR, McClelland DB et al. Double-blind comparative trial of standard (commercial) and antibody-affinity-purified tetanus toxoid vaccines. Journal of Infection 1987;14:119-124.

Le Goff P, Fauquert P, Youinou P, Hoang S. [Periarteritis nodosa following vaccination against hepatitis B (letter)] Periarterite noueuse apres vaccination contre I'hepatite B. Presse Medicale 1988;17:1763.

Le Goff P, Fauquert P, Youinou P, Hoang S. [Periarteritis nodosa (PAN) following vaccine against B hepatitis]. Rhumatologie 1991;43:79.

Lemaire V. No risk of seizures or encephalopathy after DTP vaccination. Concours Medical 1991;113:177.

LeMay M. Infection after Haemophilus vaccine (letter). Pediatric Infectious Disease Journal 1986;5:387.

Leneman F. The Guillain-Barre syndrome. Archives of Internal Medicine 1966;118:139-144.

Lennartz H. [Enterovirus infections] Die Infektion mit Enteroviren. Ergebnisse der Inneren Medizin und Kinderheilkunde 1963;20:89-126.

Lenoir AA, Granoff PD, Granoff DM. Immunogenicity of Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine in 2- to 6-month-old infants. Pediatrics 1987;80:283-287.

Lenz TR. Foreign body granuloma caused by jet injection of tetanus toxoid. Rocky Mountain Medical Journal 1966;63:48.

Lepage P, Dabis F, Msellati P, Hitimana DG, Stevens AM, Mukamabano B et al. Safety and immunogenicity of high-dose Edmonston-Zagreb measles vaccine in children with HIV-1 infection: a cohort study in Kigali, Rwanda. American Journal of Diseases of Children 1992;146:550-555.

Lepow M. Clinical trials of the Haemophilus influenzae type b capsular polysaccharide-diphtheria toxoid conjugate vaccine. Pediatric Infectious Disease Journal 1987;6:804-807.

Lepow ML. Pediatric immunizations and adverse events. Current Opinion in Infectious Disease 1991;4:463-468.

Lepow ML, Barkin RM, Berkowitz CD, Brunell PA, James D, Meier K et al. Safety and immunogenicity of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine (PRP-D) in infants. Journal of Infectious Diseases 1987;156:591-596.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Lepow ML, Peter G, Glode MP et al. Response of infants to Haemophilus influenzae type b polysaccharide and diphtheria-tetanus-pertussis vaccines in combination. Journal of Infectious Diseases 1984;149:950-955.

Lepow M, Randolph M, Cimma R et al. Persistence of antibody and response to booster dose of Haemophilus influenzae type b polysaccharide diphtheria toxoid conjugate vaccine in infants immunized at 9 to 15 months of age. Journal of Pediatrics 1986;108:882-886.

Lepow ML. Samuelson JS, Gordon LK. Safety and immunogenicity of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in adults. Journal of Infectious Diseases 1984;150:402-406.

Lepow ML, Samuelson JS, Gordon LK. Safety and immunogenicity of Haemophilus influenzae type b-polysaccharide diphtheria toxoid conjugate vaccine in infants 9 to 15 months of age. Journal of Pediatrics 1985;106:185-189.

Lerman SJ, Bollinger M, Brunken JM. Clinical and serologic evaluation of measles, mumps, and rubella (HPV-77;DE-5 and RA 27/3) virus vaccines, singly and in combination. Pediatrics 1981;68:18-22.

Lerner S. Overdose of tetanus toxoid (letter). Journal of the American Medical Association 1974;228:159.

Lernmark A, Freedman ZR, Hofmann C, Rubinstein AH, Steiner DF, Jackson RL et al. Isletcell-surface antibodies in juvenile diabetes mellitus. New England Journal of Medicine 1978;299:375-380.

Lesser RP, Hauser WA, Kurland LT, Mulder DW et al. Epidemiologic features of the Guillain-Barre syndrome: Experience in Olmsted County, Minnesota, 1935 through 1968. Neurology 1973;23:1269-1272.

Leung A. Anaphylaxis to tetanus toxoid. Irish Medical Journal 1984;77:306.

Leung AK. Congenital heart disease and DPT vaccination (letter). Canadian Medical Association Journal 1984;131:541.

Leung AK. Erythema multiforme following DPT vaccination. Journal of the Royal Society of Medicine 1984;77:1066-1067.

Leung AK. Anaphylaxis to DPT vaccine (letter). Journal of the Royal Society of Medicine 1985;78:175.

Leung AK, Jadavji T. Polysaccharide vaccine for prevention of Haemophilus influenzae type b disease. Journal of the Royal Society of Health 1988;108:180-181.

Leung AK, Szabo TF. Erythema multiforme following diphtheria-pertussis-tetanus vaccination. Kobe Journal of Medical Science 1987;33:121-124.

Levin M, Walter MD S., Barratt TM. Hemolytic uremic syndrome. Advances in Pediatric Infectious Disease 1989;4:51-81.

Levine BE, Lavi S. Perils of childhood immunization against measles, mumps, and rubella. Pediatric Nursing 1991;17:159-161, 215.

Levine L, Edsall G. Tetanus toxoid: what determines reaction proneness? Journal of Infectious Diseases 1981;144:376.

Levine L, Ibsen J, McComb JA. Adult immunization: preparation and evaluation of combined fluid tetanus and diphtheria toxoids for adult use. American Journal of Hygiene 1961;73:20-35.

Levy M, Koren G. Hepatitis B vaccine in pregnancy: maternal and fetal safety. American Journal of Perinatology 1991;8:227-232.

Levy NL, Notkins AL. Viral infections and diseases of the endocrine system. Journal of Infectious Diseases 1971;124:94-103.

Lewis JE, Chernesky MA, Rawls ML, Rawls WE. Epidemic of mumps in a partially immune population. Canadian Medical Association Journal 1979;121:751-754.

Lewis K, Jordan SC, Cherry JD et al. Petechiae and urticaria after DTP vaccination: detection of circulating immune complexes containing vaccine-specific antigens. Journal of Pediatrics 1986;109:1009-1012.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Lhuillier M, Mazzariol MJ, Zadi S, Le Cam N, Bentejac MC, Adamowicz L et al. Study of combined vaccination against yellow fever and measles in infants from six to nine months. Journal of Biological Standardization 1989;17:9-15.

Libbey MA. New vaccination: measles, mumps, rubella (letter). British Dental Journal 1988;165:160.

Lidin-Janson G, Strannegard O. Two cases of Guillain-Barre syndrome and encephalitis after measles. British Medical Journal 1972;2:572.

Liebenau JM. Public health and the production and use of diphtheria antitoxin in Philadelphia. Bulletin of the History of Medicine 1987;61:216-236.

Light RJ, Pillemer DB. Summing up: the science of reviewing research. Cambridge, Mass.: Harvard University Press; 1984.

Lightsey AL. Thrombocytopenia in children. Pediatric Clinics of North America 1980;27:293-308.

Limongi JC, Machado LR, Spina-Franca A. [Demyelinating diseases and the cerebrospinal fluid cytoproteinogram] Afeccoes desmielinizantes e citoproteinograma do liquido cefalorraqueano. Arquivos de Neuropsiquiatria 1981;39:296-300.

Lin JJ, Chang MK, Hsu CT, Tang HS. A rare association between hepatitis B virus vaccination and Guillain-Barre syndrome: a case report. Chinese Journal of Gastroenterology 1989;6:229-232.

Ling CM, Loong SC. Injection injury of the radial nerve. Injury 1976;8:60-62.

Lingam S, Miller CL, Clarke M, Pateman J. Antibody response and clinical reactions in children given measles vaccine with immunoglobulin. British Medical Journal 1986;292:1044-1045.

Linnemann CC Jr, May DB, Schubert WK, Caraway CT, Schiff GM. Fatal viral encephalitis in children with X-linked hypogammaglobulinemia. American Journal of Diseases of Children 1973;126:100-103.

Lione A. More on aluminum in infants. New England Journal of Medicine 1986;314:923.

Lipton et al. Autoimmunity and genetics contribute to the risk of insulin-dependent diabetes mellitus in families: islet cell antibodies and HLA DQ heterodimers. American Journal of Epidemiology 1992;136:503-512.

Little RE, Peterson DR. Sudden infant death syndrome epidemiology: a review and update. Epidemiologic Reviews 1990;12:241-246.

Livengood JR, Mullen JR, White JW, Brink EW, Orenstein WA. Family history of convulsions and use of pertussis vaccine. Journal of Pediatrics 1989;115:527-531.

Lleonart-Bellfill R, Cistero-Bahima A, Cerda-Trias MT, Olive-Perez A. Tetanus toxoid anaphylaxis. DICP Annals of Pharmacotherapy 1991;25:870.

Loffel M, Meienberg O, Diem P, Mombelli G. [Vaccine poliomyelitis in an adult undergoing chemotherapy for non-Hodgkin Iymphoma] Impfpoliomyelitis bei einem Erwachsenen unter Chemotherapie wegen Non-Hodgkin-Lymphoms. Schweizerische Medizinische Wochenschrift 1982;112:419-421.

Lohiya G. Asthma and urticaria after hepatitis B vaccination (letter). Western Journal of Medicine 1987;147:341.

Lohr JM, Oldstone MB A. Detection of cytomegalovirus nucleic acid sequences in pancreas in type 2 diabetes. Lancet 1990;336:644-648.

Lokietz H, Fulginiti VA. Diphtheria and tetanus toxoids and pertussis vaccine litigation. American Journal of Diseases of Children 1991;145:425.

Long AP, Sartwell PE. Tetanus in the U.S. Army in World War II. Bulletin of the U.S. Army Medical Department 1947;7:371-385.

Lopez C, Biggar WD, Park BH, Good RA. Nonparalytic poliovirus infections in patients with severe combined immunodeficiency disease. Journal of Pediatrics 1974;84:497-502.

Lopez Adaros H, Held JR. Guillain-Barre syndrome associated with immunization against rabies: epidemiological aspects. Research Publications—Association for Research in Nervous and Mental Disease 1971;49:178-186.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Lorentz IT, McLeod JG. Postvaccinial sensory polyneuropathy with myoclonus. Proceedings of the Australian Association of Neurologists 1969;6:81-86.

Louchet E, Tamalet J, Dufour Y, Chippaux. [Fleeting paralysis after oral anti-poliomyelitic agent: role of Echo 11 virus isolated in the patient] Paralysie fugace apres anti-poliomyelitique par voie buccale: role d'un virus Echo 11 isole chez le malade. Marseille Medical 1969;106:701-703.

Loughlin AM, Marchant CD, Lett S, Shapiro ED. Efficacy of Haemophilus influenzae type b vaccines in Massachusetts children 18 to 59 months of age. Pediatric Infectious Disease Journal 1992;11:374-379.

Lu WL, Zhao BX. Postvaccinal neurological complication: report of 12 cases. Chinese Medical Journal 1984;97:447-50.

Luby JP, Jones SR, Wohl AJ. Toben HR. Adverse reaction to duck embryo rabies vaccine (letter). Annals of Internal Medicine 1974;81:400-401.

Lumbiganon P, Kowsuwan P, Lumbiganon P, Taksaphan S, Panamonta M, Assateerawatts A. Comparison of immunogenicity of hepatitis B vaccine between low and normal birth weight infants. Asian Pacific Journal of Allergy and Immunology 1992;10:61-63.

Lynch TP, Cherry JD, Fulginiti VA. Vaccine myth and physician handouts. American Journal of Diseases of Children 1991;145:426-427.

Lyons R, Howell F. Pain and measles, mumps. and rubella vaccination. Archives of Disease in Childhood 1991;66:346-347.

Maass G, Quast U. Acute spinal paralysis after the administration of oral poliomyelitis vaccine in the Federal Republic of Germany (1963-1984). Journal of Biological Standardization 1987;15:185-191.

Macchia P, Terrosi F. [On an unusual case of encephalitis in a Sabin vaccinated infant] Su di un particolare caso di encefalite in bambino vaccinato secondo Sabin. Rivista di Clinica Pediatrica 1967;80:22-26.

Macko MB, Powell CE. Comparison of the morbidity of tetanus toxoid boosters with tetanusdiphtheria toxoid boosters. Annals of Emergency Medicine 1985;14:33-35.

Maclaren N, Atkinson M. Is insulin-dependent diabetes mellitus environmentally induced? New England Journal of Medicine 1992;327:348-349.

MacLennan R, Schoefield FD, Pittman M, Hardegree MC, Barile MF. Immunization against neonatal tetanus in New Guinea. Bulletin of the World Health Organization 1965;32:683-697.

Madden DL, Fuccillo DA, Traub RG, Ley AC, Sever JL, Beadle EL. Juvenile onset diabetes mellitus in pregnant women: failure to associate with Coxsackie B1-6, mumps, or respiratory syncytial virus infections. Journal of Pediatrics 1978;92:959-960.

Madore DV, Johnson CL, Phipps DC, Pennridge Pediatric Associates, Popejoy LA, Eby R et al. Safety and immunologic response to Haemophilus influenzae type b oligosaccharide-CRM197 conjugate vaccine in 1-to 6-month-old infants. Pediatrics 1990;85:331-337.

Madore DV, Johnson CL, Phipps DC, Pennridge Pediatric Associates, Myers MG, Eby R et al. Safety and immunogenicity of Haemophilus influenzae type b oligosaccharide-CRM197 conjugate vaccine in infants aged 15 to 23 months. Pediatrics 1990;86:527-534.

Madsen T, Jensen C, Ipsen J et al. Problems in active and passive immunity. Bulletin of the Johns Hopkins Hospital 1937;61:221-245.

Magdzik W. [Surveillance of adverse effects following immunization (AEFI)] Surveillance niepoangzadanych odczynow poszczepiennych (AEFI). Przeglad Epidemiologiczny 1992;46:27-33.

Mahmoud Abdel Azeem M, Imam ZE, Sohair SA. A study of a case of acute paralytic poliomyelitis. Journal of the Egyptian Public Health Association 1973 ;47:198-209.

Mahnke PF. [On the pathogenesis of vaccination damage in childhood] Zur Pathogenese des Impfschadens im Kindesalter. Zeitschrift fur die Gesamte Innere Medizin und Ihre Grenzgebiete 1967;22:806-811.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Mair IW, Elverland HH. Sudden deafness and vaccination. Journal of Laryngology and Otolaryngology 1977;91:323-329.

Majeron MA, Salvatores U. [Neuritic complications of antitetanus seroprophylaxis] Complicanze neuritiche della sieroprofilassi antitetanica. Rivista Sperimentale di Freniatria e Medicina Legale delle Alienazioni Mentali 1968;92:1904-1915.

Makela H, Eskola J, Peltola H, Takala AK, Kayhty H. Clinical experience with Haemophilus influenzae type b conjugate vaccines. Pediatrics 1990;85(4 Pt 2):651-653.

Makela PH, Peltola H, Kayhty H, Jousimies H, Perray O, Ruoslahti E et al. Polysaccharide vaccines of group A Neisseria meningitidis and Haemophilus influenzae type b: a field trial in Finland. Journal of Infectious Diseases 1977;136(Supplement):S43-S50.

Makino S, Sasaki K, Nakayama T, Oka S, Urano T, Kimura M et al. A new combined trivalent live measles (AIK-C strain), mumps (Hoshino strain), and rubella (Takahashi strain) vaccine. Findings in clinical and laboratory studies. American Journal of Diseases of Children 1990;144:905-910.

Mandal GS, Mukhopadhyay M, Bhattacharya AR. Adverse reactions following tetanus toxoid injection. Journal of the Indian Medical Association 1980;74:35-37.

Manfredi M. [A fatal case following antitetanic serum prophylaxis] Su un caso mortale da sieroprofilassi antitetanica. Bollettino Societa Medico Chirurgica Cremona 1968;22:19-35.

Mansfield LE, Ting S, Rawls DO, Frederick R. Systemic reactions during cutaneous testing for tetanus toxoid hypersensitivity. Annals of Allergy 57;:135-137.

Mantel N. Re: An epidemiologic and clinical evaluation of Guillain-Barre syndrome reported in association with the administration of swine influenza vaccines. American Journal of Epidemiology 1985;121:620-623.

Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute 1959;22:719-748.

Marchant CD, Band E, Froeschle JE, McVerry PH. Depression of anticapsular antibody after immunization with Haemophilus influenzae type b polysaccharide-diphtheria conjugate vaccine. Pediatric Infectious Disease Journal 1989;8:508-511.

Marchand JC. [The anti-measles vaccination] La vaccination antirougeoleuse. Cahiers du Medecine 1970;11:1105-1108.

Marcinak JF, Frank AL, Labotka RL, Fao S, Frisone LR, Yogev R et al. Haemophilus influenzae after vaccination at age one and one-half to six years. Pediatric Infectious Disease Journal 1991;10:157-159.

Marcuse EK, Wentz KR. The NCES reconsidered: summary of a 1989 workshop. Vaccine 1990;8:531-535.

Margileth AM, Mella GW, Di Moia F. Live measles vaccine: effect of age and preservative upon seroconversion. Medical Annals of the District of Columbia 1966;35:297-301.

Margileth AM, Mella GW, Di Moia F. Live mumps virus vaccine: clinical reactions and serological response in 615 children. Medical Annals of the District of Columbia 1968;37:197-201.

Mariner WK. The National Vaccine Injury Compensation Program: update. Health Affairs 1992;(Spring):255-265.

Mark A, Christenson B, Granstrom M, Strandell A, Wickbom B, Bottiger M . Immunity and immunization of children against diphtheria in Sweden. European Journal of Clinical Microbiology and Infectious Disease 1989;8:214-219.

Markland LD, Riley HD. The Guillain-Barre syndrome in childhood: a comprehensive review, including observations on 19 additional cases. Clinical Pediatrics 1967;6:162-170.

Markowitz LE, Sepulveda J, Diaz-Ortega JL, Valdespino JL, Albrecht P, Zell ER et al. Immunization of six-month-old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines. New England Journal of Medicine 1990;322:580-587.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Marks JS, Halpin TJ. Guillain-Barre syndrome in recipients of A/New Jersey influenza vaccine. Journal of the American Medical Association 1980;243:2490-2494.

Marshall GS, Wright PF, Fenichel GM, Karzon DT. Diffuse retinopathy following measles, mumps, and rubella vaccination. Pediatrics 1985;76:989-991.

Marti-Masso JF, Obeso JA, Cosme A. Guillain-Barre syndrome associated with a type B acute hepatitis. Medicina Clinica (Barcelona) 1979;73:447.

Martin GI, Weintraub MI. Brachial neuritis and seventh nerve palsy: a rare hazard of DPT vaccination . Clinical Pediatrics 1973;12:506-507.

Martin R, McFarland H, McFarlin D. Immunological aspects of demyelinating diseases. Annual Review of Immunology 1992;10:153-183.

Martinez E, Domingo P. Evans's syndrome triggered by recombinant hepatitis B vaccine. Clinical Infectious Diseases 1992;15:1051.

Marwick C. Expert panel convened by FDA recommends Haemophilus influenzae type b vaccine should continue in use for children older than 2 years. Journal of the American Medical Association 1987;257:3182-3183.

Marwick C. H. influenzae vaccines gain favor. Journal of the American Medical Association 1990;264:1375.

Marwick C. Haemophilus influenzae declining among young? Journal of the American Medical Association 1991;266:3398-3399.

Marzetti G, Bertolini L, Midulla M. [Virological and clinical study of morbid manifestations connected with anti-poliomyelitis vaccination with the oral Sabin vaccine] Studio virologico-clinico delle manifestazioni morbose in rapporto con la vaccinazione antipoliomielitica orale di Sabin. Minerva Pediatrica 1967;19:2236-2245.

Mason JO. From the Assistant Secretary for Health, US Public Health Service: protecting physicians from vaccine liability. Journal of the American Medical Association 1991;266:2951.

Mason JO. Addressing the measles epidemic (editorial). Public Health Reports 1992;107:241-242.

Maspero A, Cancellieri V, Della Rosa C. [Adverse reactions to measles vaccine] Reazioni secondarie alla vaccinazione contro il morbillo. Giornale di Malattie Infettive e Parassitarie 1991;43:499-503.

Maspero A, Sesana B, Ferrante P. Adverse reactions to measles vaccine. Bollettino dell Istituto Sieroterapico Milanese 1984;63:125-129.

Mastaglia FL, Ojeda VJ. Inflammatory myopathies: part 1. Annals of Neurology 1985;17:215-227.

Mastaglia FL, Ojeda VJ. Inflammatory myopathies: part 2. Annals of Neurology 1985;17:317-323.

Mastaglia FL, Walton JN. Inflammatory myopathies. In: Mastaglia FL, Walton JN, eds. Skeletal Muscle Pathology. Edinburgh: Churchill; 1982.

Mathias RG, Routley JV. Paralysis in an immunocompromised adult following oral polio vaccination (letter). Canadian Medical Association Journal 1985;132:738-739.

Matuhasi T, Ikegami H. Elevation of levels of IgE antibody to tetanus toxin in individuals vaccinated with diphtheria-pertussis-tetanus vaccine. Journal of Infectious Diseases 1982;146:290.

Mawhinney H, Allen IV, Beare JM, Bridges JM, Connolly HH, Haire M et al. Dysgammaglobulinaemia complicated by disseminated measles. British Medical Journal 1971;2:380-381.

Maynard JE. Viral hepatitis as an occupational hazard in the health care profession. In: Vyas GN, Cohen SN, Schmid R, eds. Viral Hepatitis. Philadelphia: Franklin Institute Press; 1978.

McBean AM, Thoms ML, Albrecht P, Cuthie JC, Bernier R. Serologic response to oral polio vaccine and enhanced-potency inactivated polio vaccines. American Journal of Epidemiology 1988;128:615-628.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

McBean AM, Thoms ML, Johnson RH, Gadless BR, MacDonald B, Nerhood L et al. A comparison of the serologic responses to oral and injectable trivalent poliovirus vaccines. Reviews of Infectious Diseases 1984;6(Suppl. 2):S552-S555.

McChesney MB, Oldstone MBA. Viruses perturb lymphocyte functions: selected principles characterizing virus-induced immunosuppression. Annual Review of Immunology 1987;5:279-304.

McChesney MB, Oldstone MBA. Virus-induced immunosuppression: infections with measles virus and human immunodeficiency virus. Advances in Immunology 1989;45:335-380.

McComb J, Levine L. Adult immunization. II. Dosage reduction as a solution to increasing reactions to tetanus toxoid. New England Journal of Medicine 1961;265:1152.

McCrae WM. Diabetes mellitus following mumps. Lancet 1963;1:1300-1301.

McDonald JC, Moore DL, Quennec P. Clinical and epidemiologic features of mumps meningoencephalitis and possible vaccine-related disease. Pediatric Infectious Disease Journal 1989;8:751-755.

McDonald R. SSPE (subacute sclerosing panencephalitis): is measles vaccination promotive or preventive? Clinical Pediatrics 1977;16:124-127.

McEwen J. Early-onset reaction after measles vaccination: further Australian reports. Medical Journal of Australia 1983;2:503-505.

McFarlin DE. Immunological parameters in Guillain-Barre syndrome. Annals of Neurology 1990;27(Suppl.):S25-S29.

McIntosh K. Feasible improvements in vaccines in the Expanded Programme on Immunization. Reviews of Infectious Diseases 1989;11(Suppl. 3):S530-S537.

McKendrick GD W., Nishtar T. Mumps orchitis and sterility. Public Health 1966;80:277-278.

McKhann GM, Cornblath DR, Griffin JW, Ho TW, Li CY, Jiang Z et al. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Annals of Neurology 1993;33:in press.

McKhann GM, Cornblath DR, Ho TL, Li CY, Bai AY, Wu HS, Yei QF et al. Clinical and electrophysiological aspects of acute paralytic disease of children and young adults in northern China. Lancet 1991;38:593-597.

McKhann GM, Griffin JW, Cornblath DR, Mellits ED, Fisher RS, Quaskey SA. Plasmapheresis and Guillain-Barre syndrome: analysis of prognostic factors and the effect of plasmapheresis. Annals of Neurology 1988;23:347-353.

McLaughlin M, Thomas P, Onorato I, Rubinstein A, Oleske J. Nicholas S et al. Live virus vaccines in human immunodeficiency virus-infected children: a retrospective survey. Pediatrics 1988;82:229-233.

McLean AA, Hilleman MR, McAleer WJ, Buynak EB. Summary of world wide experience with HB-Vax. Journal of Infectious Diseases 1983;7(Suppl.):95-104.

McMahon B et al. Hepatitis B associated polyarteritis in Alaskan eskimos: clinical and epidemiologic features and long-term follow-up. Hepatology 1989;9:97-101.

McMahon BJ, Helminiak C, Wainwright RB, Bulkow L, Trimble BA, Wainwright K. Frequency of adverse reactions to hepatitis B vaccine in 43,618 persons. American Journal of Medicine 1992;92:254-256.

Medecine et Hygiene. [Compulsory immunizations: side effects and responsibility] Vaccinations obligatoires, effets secondaires et responsabilite. Medecine et Hygiene 1981;39:3501-3502.

Medical Journal of Australia. Vaccine-associated poliomyelitis (editorial). Medical Journal of Australia 1973;2:795-796.

Medical Journal of Australia. Measles vaccination: thrombocytopenia. Medical Journal of Australia 1980;1:561.

Medical Letter on Drugs and Therapeutics. Haemophilus influenzae type b vaccine. Medical Letter on Drugs and Therapeutics 1985;27:61-62.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Medical Letter on Drugs and Therapeutics. Conjugated Haemophilus influenzae type b vaccine. Medical Letter on Drugs and Therapeutics 1988;30:47-48.

Medical Letter on Drugs and Therapeutics. Routine immunization for adults. Medical Letter on Drugs and Therapeutics 1990;32:54-56.

Medical Letter on Drugs and Therapeutics. H. influenzae vaccine for infants. Medical Letter on Drugs and Therapeutics 1991;33:5-7.

Medical Research Council. Vaccination against measles: Clinical trial of live measles vaccine given alone and live vaccine preceded by killed vaccine. Practitioner 1971;206:458-466.

Medical Research Council, Measles Vaccines Committee. Vaccination against measles: a study of clinical reactions and serological responses of young children—a report to the Medical Research Council by the Measles Vaccines Committee. British Medical Journal 1965;1:817-863.

Medical Research Council, Measles Vaccines Committee. Vaccination against measles: a clinical trial of live measles vaccine given alone and live vaccine preceded by killed vaccine—a report to the Medical Research Council by the Measles Vaccines Committee. British Medical Journal 1966;1:441-446.

Medical Research Council, Measles Vaccines Committee. Vaccination against measles: a clinical trial of live measles vaccine given alone and live vaccine preceded by killed vaccine—second report to the Medical Research Council by the Measles Vaccines Committee. British Medical Journal 1968;2:449-452.

Mekler-Lupolover Y. [Uveitis and hepatitis B vaccination] Uveitis bei Hepatitis-B-Impfung. Klinische Monatsblatter fur Augenheilkunde 1987;190:297-298.

Melamed I, Romem Y, Shimoni T et al. Overdose of booster tetanus toxoid given in error: a clinical study. Scandinavian Journal of Infectious Diseases 1983;15:303-306.

Mellin H, Neff JM, Garber H, Lane JM. Complications of smallpox vaccination, Maryland 1968. Johns Hopkins Medical Journal 1970;126:160-168.

Melnick JL. Advantages and disadvantages of killed and live poliomyelitis vaccines. Bulletin of the World Health Organization 1978;56:21-38.

Melnick JL. Toward eradication of poliomyelitis by combined use of killed and live vaccines. Cardiovascular Research Center Bulletin 1982;20:49-60.

Melnick JL. Live attenuated poliovaccines. In: Plotkin SA, Mortimer EA, eds. Vaccines. Philadelphia: W.B. Saunders Co.; 1988.

Melnick JL. Vaccination against poliomyelitis: present possibilities and future prospects. American Journal of Public Health 1988;78:304-305.

Menser MA, Forrest JM, Bransby RD. Rubella infection and diabetes mellitus. Lancet 1978;1:57-60.

Meric AL. The safety of the hepatitis B vaccine (letter). Journal of the American Medical Association 1987;257:315-316.

Mertens T, Eggers HJ, Urteaga-Ballon O et al. Vaccine-associated poliomyelitis (letter). Lancet 1984;2:1390-1391.

Mertens T, Schurmann W, Kruppenbacher J, Rheingans K, Kellermann K, Maass G et al. Problems of live virus vaccine-associated poliomyelitis a paralytic case with isolation of all three poliovirus types. Medical Microbiology and Immunology 1983;172:13-21.

Mertens T, Schurmann W, Kruppenbacher JP, Eggers HJ, Rheingans K, Kellermann K et al. Two cases of vaccine-induced poliomyelitis. Acta Paediatrica Scandinavica 1984;73:133-134.

Messaritakis J. Toxic epidermal necrolysis in children. Annales Paediatrici 1966;207:236-246.

Messaritakis J. Diabetes following mumps in sibs. Archives of Disease in Childhood 1971;46:561.

Meyer JC, Trachsel H. Precipitating antibodies in sera of normal blood donors against some antigens related to type III allergy, detected by counterimmunoelectrophoresis. Allergologia et Immunopathologia 1979;7:205-210.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Meyer MB. An epidemiologic study of mumps: its spread in school and families. American Journal of Hygiene 1962;75:259.

Miadonna A. [Biological characteristics of specific IgE for tetanus toxoid] Caratteristiche biologiche delle IgE specifiche per il tossoide tetanico. Bollettino dell Istituto Sieroterapico Milanese 1980;59:554-559.

Miadonna A, Falagiani P. Determinazione delle IgE specifiche in 15 soggetti con sospetta allergia al tossoide tetanico. Folia Allergologica et Immunologica Clinica 1978;25:609-611.

Michielsen W. [Reactions to tetanus vaccination] Reacties bij tetanusvaccinatie. Tijdschrift voor Geneeskunde 1992;48:475-476.

Middaugh JP. Side effects of diphtheria-tetanus toxoid in adults. American Journal of Public Health 1979;69:246-249.

Mieli-Vergani G, Sutherland S, Mowat AP. Measles and autoimmune chronic active hepatitis (letter). Lancet 1989;2:688.

Miles RN, Hosking GP. Pertussis: should we immunise neurologically disabled and developmentally delayed children. British Medical Journal 1983;287:318-320.

Miller CL. Ten years of measles vaccinations: a review of the advantages and hazards of vaccination. Nursing Times 1978;74:2059-2060.

Miller CL. Surveillance after measles vaccination in children. Practitioner 1982;226:535-537.

Miller CL. Convulsions after measles vaccination. Lancet 1983;2:215.

Miller C, Farrington CP, Harbert K. The epidemiology of subacute sclerosing panencephalitis in England and Wales 1970-1989. International Journal of Epidemiology 1992;21:998-1006.

Miller C, Miller E, Rowe K, Bowie C, Judd M, Walker D. Surveillance of symptoms following MMR vaccine in children. Practitioner 1989;233:69-73.

Miller DL, Ross EM. ABC of 1 to 7: whooping cough. British Medical Journal 1982;284:1874.

Miller DL et al. Frequency of complications of measles, 1963. British Medical Journal 1964;2:75-78.

Miller DL, Alderslade R, Ross EM. Whooping cough and whooping cough vaccine: the risks and benefits debate. Epidemiologic Reviews 1982;4:1-24.

Miller DL, Reid D, Diamond JR. Poliomyelitis surveillance in England and Wales, 1965-8. Public Health 1970;84:265-285.

Miller DL, Ross EM, Alderslade R, Bellman MH, Rawson NS B. Pertussis immunization and serious acute neurological illness in children. British Medical Journal 1981;282:1595-1599.

Miller DL, Wadsworth J, Diamond J, Ross E. Pertussis vaccine and whooping cough as risk factors in acute neurological illness and death in young children. Developments in Biological Standardization 1985;61:389-394.

Miller DL, Wadsworth MJH, Ross EM. Pertussis vaccine and severe acute neurological illnesses: response to a recent review by members of the NCES team. Vaccine 1989;7:487-489.

Miller DL, Wadsworth J, Ross E. Severe neurological illness: further analyses of the British National Childhood Encephalopathy Study. Tokai Journal of Experimental and Clinical Medicine 1988;13(Suppl.):145-155.

Miller E, Nokes DJ, Anderson RM. Measles, mumps, and rubella vaccination (letter). British Medical Journal 1992;304:1440-1441.

Miller G, Gale J, Villarejos V, James W, Arteaga CG, Casey H et al. Edmonston B and a further attenuated measles vaccine: a placebo controlled double blind comparison. American Journal of Public Health / Nations Health 1967;57:1333-1340.

Miller HG, Stanton JB. Neurological sequelae of prophylactic inoculation. Quarterly Journal of Medicine 1954;23:1-27.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Miller JE, Harding-Cox B. Measles vaccination in general practice. Practitioner 1969;203:352-354.

Miller JR, Orgel HA, Meltzer EO. The safety of egg-containing vaccines for egg-allergic patients. Journal of Allergy and Clinical Immunology 1983;71:568-573.

Miller NZ. Vaccines: Are They Really Safe and Effective? A Parents' Guide to Childhood Shots. Santa Fe, NM: New Atlantean Press; 1992.

Miller RG. Guillain-Barre syndrome: current methods of diagnosis and treatment. Postgraduate Medicine 1985;77:57-64.

Millson DS. Brother-to-sister transmission of measles after measles, mumps, and rubella immunization. Lancet 1989;1:271.

Milstien JB, Kuritsky JN. Erythema multiforme and hepatitis B immunization (letter). Archives of Dermatology 1986;122:511-512.

Milstien JB, Gross TP, Kuritsky JN. Adverse reactions reported following receipt of Haemophilus influenzae type b vaccine: an analysis after 1 year of marketing. Pediatrics 1987;80:270-274.

Mirchamsy H. Measles immunization in Iran. Reviews of Infectious Diseases 1983;5:491-494.

Mirchamsy H, Nilforoushan MA. Shafyi A, Razavi J, Ashtiani MP, Youssofi I et al. Comparative evaluation of two combined measles-mumps-rubella vaccines based on AIK and Edmonston-Zagreb strains of measles virus. Kitasato Archives of Experimental Medicine 1991;64:141-147.

Mittelmeier VH. Generalisierte anaphylaktisch-toxische Gefabwandschadigung mit sinusthrombose nach aktiver Diphtherie-Schutzimpfung. Monatsschrift fur Kinderheilkunde 1959;107:288-293.

Mitus A. Vaccination of college students with attenuated live measles vaccine (letter). New England Journal of Medicine 1985;312:1326.

Mitus A, Holloway A, Evans AE, Enders JF. Attenuated measles vaccine in children with acute leukemia. American Journal of Diseases of Children 1962;103:243-248.

Mizutani H, Gerson KL, Haslam RH. Skin-test reactions in patients with SSPE. New England Journal of Medicine 1972;286:48.

Mobius G, Wiedersberg H, Wunscher W, Backer F. [Pathological-anatomical findings in cases of death following poliomyelitis and diphtheria-pertussis-tetanus vaccination] Pathologisch-anatomische Befunde bei Todesfallen nach Poliomyelitis- und Dreifach-Schutzimpfung. Deutsche Gesundheitswesen 1972;27:1382-1386.

Modlin JF, Jabbour JT, Witte JJ, Halsey NA. Epidemiologic studies of measles, measles vaccine, and subacute sclerosing panencephalitis. Pediatrics 1977;59:505-512.

Modlin JF, Onorato IM, McBean AM, Albrecht P, Thoms ML, Nerhood L et al. The humoral immune response to type 1 oral poliovirus vaccine in children previously immunized with enhanced potency inactivated poliovirus vaccine or live oral poliovirus vaccine. American Journal of Diseases of Children 1990;144:480-484.

Mohle-Boetani J. Oropharyngeal carriage of Haemophilus influenzae type b (Hib) in a heavily vaccinated population of 2-5 year olds. Program Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. Abstract 1729, p. 399. Washington, DC: American Society for Microbiology; 1992.

Mok JQ, De Rossi A, Ades AE, Giaqunito C, Grosch-Wörner I, Peckham CS et al. Infants born to mothers seropositive for human immunodeficiency virus. Lancet 1987;1:1164-1168.

Monif GR. Can diabetes mellitus result from an infectious disease. Hospital Practice 1973;18:124-130.

Monif GR. Rubella virus and the pancreas. Medecine et Chirurgie Digestives 1974;3:195-197.

Monnet P. [Vaccinating children] Les vaccinations chez l'enfant. Rev Pediatr 1981;17:429-438.

Montanaro D, De Ruggiero N, Triassi M, D'Ambrosio R. [Reactions to required vaccinations:

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

a year of surveillance in Naples] Reazioni a vaccinazioni obbligatorie: un anno di sorveglianza in Napoli. Nuovi Annali Igiene e Microbiologia 1982;33:725-740.

Morens DM, Halsey NA, Schonberger LB, Baublis JV. Reye syndrome associated with vaccination with live virus vaccines: an exploration of possible etiologic relationships. Clinical Pediatrics 1979;18:42-44.

Morgan M, Nathwani D. Facial palsy and infection: the unfolding story. Clinical Infectious Diseases 1992;14:263-271.

Mori I, Torii S, Hamamoto Y, Kanda A, Tabata Y, Nagafuji H. [Virological evaluation of mumps meningitis following vaccination against mumps]. Kansenshogaku Zasshi [Journal of the Japanese Association for Infectious Diseases] 1991;65:226-283.

Mori I, Torii S, Mochida Y, Hatano Y, Nagafuji H. Poliovirus in cerebrospinal fluid from an infant with adenovirus infection. Clinical Infectious Diseases 1993;16:342-343.

Morley DC. Measles in the developing world. Proceedings of the Royal Society of Medicine 1974;67:1112-1115.

Morley D. Severe measles in the tropics. II. British Medical Journal 1969;1:363-365.

Morris JA, Butler H. Nature and frequency of adverse reactions following hepatitis B vaccine injection in children in New Zealand, 1985-1988. Submitted to Institute of Medicine Vaccine Safety Committee, May 4, 1992.

Morrison H, Mao Y, Semenciw R, Carter A, Davies J. Vaccine adverse reactions in young children in Ontario. Canadian Journal of Public Health 1988;79:459-460.

Morrow JI, Dowey KE, Swallow MW. Subacute sclerosing panencephalitis in Northern Ireland: twenty years' experience. Ulster Medical Journal 1986;55:124-130.

Morse LJ. Poliomyelitis from a vaccine. Lancet 1968;1:1312-1313.

Morse LJ, Rubin HE, Blount RE Jr. Vaccine-acquired paralytic poliomyelitis in an unvaccinated mother. Journal of the American Medical Association 1966;197:1034-1035.

Mortimer EA. Diphtheria toxoid. In: Plotkin SA, Mortimer EA, eds. Vaccines. Philadelphia: W.B. Saunders Co.; 1988.

Mortimer J, Melville-Smith M, Sheffield F. Diphtheria vaccine for adults. Lancet 1986;2:1182-1183.

Moss PD, Robertson L, Durbe NG, Cowburn GR. The Blackburn poliomyelitis epidemic: an analysis of the 109 cases admitted to hospital. Lancet 1968;2:555-558.

Mougrabi MM, Zarate AM, Alvarado GA, Reyes CA, Valdez DA. [Epidemiological field study of a poliomyelitis outbreak occurring in the state of Coahuila in 1977] Estudio epidemiologico de campo de un brote de poliomielitis ocurrido en el esdado de Coahuila duirante 1977 . Salud Publica de Mexico 1980;22:39-44.

Moulignier A, Richer A, Fritzell C, Foulon D, Khoubesserian P, De Recondo J. [Meningo-radiculitis after second injection of an anti-rabies vaccine 13 obtained from human diploid cell culture] Meningo-radiculite secondaire a une vaccination antirabique a partir d'un vaccin prepare sur culture de cellules diploides humaines. Presse Medicale 1991;20:1121-1123.

Moutard CML, Lejeune C. [Techniques, indications, contraindications and supervision of vaccination] Techniques, indications, contre-indications et surveillance des vaccinations. Revue du Praticien 1983;33:355-359.

Mouton Y, Chidiac C, Fourrier A. [Tetanus and diphtheria vaccinations in children] Vaccinations antitetanique et antidiphterique chez l'enfant. Semaine des Hopitaux de Paris 1985;61:1535-1538.

Moyner K. Specific IgE antibodies in sera from individuals with adverse reactions following diphtheria-tetanus-pertussis (DTP) or diphtheria-tetanus (DT) immunization. Allergy 1982;37(Suppl. 1):12.

Moynihan NH. Serum-sickness and local reactions in tetanus prophylaxis. Lancet 1955;2:264-266.

Mueller-Eckhardt G, Stief T, Otten A, Helmke K, Willems WR, Mueller-Eckhardt C. Compli-

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

cations of mumps infection, islet-cell antibodies, and HLA. Immunobiology 1984;167:338-344.

Mullen J. Centers for Disease Control. Questions and answers about vaccine safety and large-linked databases (LLDB). Submission to the Institute of Medicine Vaccine Safety Committee. Public Meeting, Washington, DC, May 11, 1992.

Mullen J, Centers for Disease Control. The Vaccine Adverse Events Reporting System (VAERS). Presentation to the Institute of Medicine Vaccine Safety Committee. Public Meeting, Washington, DC, May 11, 1992.

Mullen JR, Chen RT, Swint E, Hayes SW, Rastogi S, Knapp G. The Vaccine Adverse Event Reporting System (VAERS): A single postmarketing surveillance system for vaccines in the United States. Presented at the 7th International Conference on Pharmacoepidemiology, Basel, Switzerland, August 26-29, 1991.

Muller HE. [Local reactions after tetanus vaccination] Lokalreaktion nach tetanus-schutzimpfung. Deutsche Medizinische Wochenschrift 1990;115:235.

Muller HE. [Tetanus vaccination] Tetanus-schutzimpfung. Deutsche Medizinische Wochenschrift 1990;115:998.

Muller K. [Endangering of children with brain damage by measles vaccination] Zur Frage der Gefahrdung von hirngeschadigten Kindern durch Masernschutzimpfung. Deutsche Gesundheitswesen 1968;23:2104-2105.

Muller K, Eckoldt G. [Measles vaccination and EEG: evaluation of measles vaccination from the electroencephalographic point] Masern-Schutzimpfung und EEG: die Beurteilung der Masernimpfungen aus elektrencephalographischer Sicht. Zeitschrift fur Kinderheilkunde 1966;96:172-180.

Munoz O, Benitez-Diaz L, Martinez MC, Guiscafre H. Hearing loss after Hemophilus influenzae meningitis: follow-up study with auditory brainstem potentials. Annals of Otolaryngology Rhinology and Laryngology 1983;92:272-275.

Munoz JJ, Peacock MG, Hadlow WJ. Anaphylaxis or so-called encephalopathy in mice sensitized to an antigen with the aid of pertussigen (pertussis toxin). Infection and Immunity 1987;55:1004-1008.

Munyer TP, Mange RJ, Dolan T, Kantor FS. Depressed lymphocyte function after measles-mumps-rubella vaccination. Journal of Infectious Diseases 1975;134:75-78.

Murph JR, Grose C, McAndrew P, Mickiewicz C, Mento S, Cano F et al. Sabin inactivated trivalent poliovirus vaccine: first clinical trial and seroimmunity survey. Pediatric Infectious Disease Journal 1988;7:760-765.

Murphy TV. Haemophilus b polysaccharide vaccine: need for continuing assessment. Pediatric Infectious Disease Journal 1987;6:701-703.

Murphy TV. Is Haemophilus influenzae type b colonization of children in day care reduced by Hib conjugate (Conj) and plain polysaccharide (PPRP) vaccine (Vac)? Program Abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy. Abstract 66, p. 121. Washington, DC: American Society for Microbiology; 1991.

Murphy TV, Pastor P, Medley F, Osterholm MT, Granoff DM. Decreased Haemophilus colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine. Journal of Pediatrics 1993;122:517-523.

Murphy TV, White KE, Pastor P et al. Declining incidence of Haemophilus influenzae type b disease since introduction of vaccination. Journal of the American Medical Association 1993;269:246-248.

Murray MW, Lewis MJ. Mumps meningitis after measles, mumps, and rubella vaccination (letter). Lancet 1989;2:677.

Musgrove J. Measles vaccine. New Zealand Medical Journal 1971;73:309.

Musher DM, Watson DA, Lepow ML, McVerry P, Hamill R, Baughn RE. Vaccination of 18-month-old children with conjugated polyribosyl ribitol phosphate stimulates production

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

of functional antibody to Haemophilus influenzae type b. Pediatric Infectious Disease Journal 1988;7:156-159.

Myers MG, Beckman CW, Vosdingh RA, Hankins WA. Primary immunization with tetanus and diphtheria toxoids: reaction rates and immunogenicity in older children and adults. Journal of the American Medical Association 1982;248:2478-2480.

Nabe-Nielsen J, Walter B. Unilateral total deafness as a complication of the measles-mumps-rubella vaccination. Scandinavian Audiology, Supplementum 1988;30:69-70.

Nabe-Nielsen J, Walter B. Unilateral deafness as a complication of the mumps, measles, and rubella vaccination. British Medical Journal 1988;297:489.

Nader PR, Warren RJ. Reported neurologic disorders following live measles vaccine. Pediatrics 1968;41:997-1001.

Nagel J, Svec D, Waters T. Fireman P. IgE synthesis in man. I. Development of specific IgE antibodies after immunization with tetanus diphtheria (TD) toxoids. Journal of Immunology 1977;118:334-341.

Nakayama T, Oka S, Komase K, Mori T, Nakagawa M, Sasaki K et al. The relationship between the mumps vaccine strain and parotitis after vaccination. Journal of Infectious Diseases 1992;165:186-187.

Nalin DR. Evaluating mumps vaccine (letter). Lancet 1992;339:305.

Nalin DR. Mumps vaccine complications: which strain? (letter). Lancet 1989;2:1396.

Nalin DR. Mumps, measles, and rubella vaccination and encephalitis. British Medical Journal 1989;299:1219.

Naruszewicz-Lesiuk D, Kantoch M, Polna I. [Immunological responses and postvaccination reactions in children vaccinated against measles. I. Assessment of postvaccination reactions] Odpowiedz immunologiczna i odczyny poszczepienne u dzieci objetych akcja szczepien przeciw odrze. I. Ocena odczynow poszczepiennych. Przeglad Epidemiologiczny 1974;28:315-324.

Naruszewicz-Lesiuk D, Wieczorkiewicz M, Iwinska B, Kulczycki J, Gut W. [Subacute sclerosing panencephalitis (SSPE) in Poland 1984-1986. Stage III of epidemiologic studies] Podostre stwardniajace zapalenie mozgu (SSPE) w Polsce w latach 1984-1986. III. Etap badan epidemiologicznych. Przeglad Epidemiologiczny 1988;42:205-210.

Nassif X, Haroche G, Lafaix C. [Problems of measles vaccination] Problemes poses par la vaccination morbilleuse. Medecine et Hygiene 1985;43:1144-1150.

Nategh R, Naficy K, Shahriary M. Mass trivalent oral polio vaccination in primary school age children in Teheran. Tropical and Geographical Medicine 1970 ;22:303-306.

Nathanson N, Horn SD. Neurovirulence tests of type 3 oral poliovirus vaccine manufactured by Lederle Laboratories, 1964-1988. Vaccine 1992;10:469-474.

Nathanson N, Langmuir AD. The Cutter incident: poliomyelitis following formaldehyde-inactivated poliovirus vaccination in the United States during the spring of 1955. I. Background. American Journal of Hygiene 1963;78:16-28.

National Center for Health Statistics. Current Estimates from the National Health Interview Survey, United States, 1988. Vital and Health Statistics, Series 10, No. 173. Washington, DC: U.S. Government Printing Office; 1989.

National Library of Medicine. Vaccine-Preventable Diseases of Childhood: Current Bibliographies in Medicine, No. 88-12. Washington, DC: U.S. Department of Health and Human Services; 1988.

National Vaccine Information Center. Dissatisfied Parents Together. NVIC News 1992;2(1):1-12.

Navarrete-Navarro S, Alvarez-Munoz MT, Bustamante-Calvillo ME, Vallejo-Aguilar OJ, Munoz O, Santos-Preciado JI et al. [Protection of health personnel against hepatitis B by DNA recombinant vaccine] Proteccion contra hepatitis B en trabajadores de salud con vacuna de DNA recombinante. Boletin Medico del Hospital Infantil de Mexico 1992;49:739-742.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Nederlands Tijdschrift voor Geneeskunde. [Vaccination and the Guillain-Barre syndrome] Vaccinatie en het syndroom van Guillain-Barre. Nederlands Tijdschrift voor Geneeskunde 1978;122:1780.

Neiderud J. Thrombocytopenic purpura after a combined vaccine against morbilli. parotitis and rubella. Acta Paediatrica Scandinavica 1983;72:613-614.

Nelson PG, Pyke DA, Gamble DR. Viruses and the aetiology of diabetes: a study in identical twins. British Medical Journal 1975;4:249-251.

Neuman E. Vaccines and victims. Washington Times. April 5, 1992:(Insight)6-11, 26, 28.

Neumann-Haefelin D, Newmann-Haefelin C, Baumeister HG, Knocke KW, Petersen EE, Haas R. [Poliomyelitis in the Federal Republic of Germany: a retrospective study of 1973] Poliomyelitis in der Bundesrepublik Deutschland: Ruckblick auf das Jahr 1973. Deutsche Medizinische Wochenschrift 1974;99:2597-2602.

New Zealand Department of Health. Hepatitis B: why we have to immunize. Health Quarterly Magazine (New Zealand Department of Health) 1988;40(3):3-5.

Newell KW, Duenas Lehmann A, LeBlanc DR, Garces Osorio N. The use of toxoid for the prevention of tetanus neonatorum: final report of a double-blind controlled field trial. Bulletin of the World Health Organization 1966;35:863-871.

Newell KW, Leblanc DR, Edsall G, Levine L, Christensen H, Montouri MH et al. The serological assessment of a tetanus toxoid field trial. Bulletin of the World Health Organization 1971;45:773-785.

Newman SL, Waldo B, Johnston RB Jr. Separation of serum bactericidal and opsonizing activities for Haemophilus influenzae type b. Infection and Immunity 1973;8:488-490.

Newton NJ. Janati A. Guillain-Barre syndrome after vaccination with purified tetanus toxoid. Southern Medical Journal 1987;80:1053-1054.

Ng PL, Powell LW, Campbell CP. Guillain-Barre syndrome during the Preicteric phase of acute type B viral hepatitis. Australia and New Zealand Journal of Medicine 1975;5:367-369.

Nicholson JK A., Holman RC, Jones BM, McDougal SM A., Markowitz LE. The effect of measles-rubella vaccination on lymphocyte populations and subpopulations in HIV-infected and healthy individuals. Journal of Acquired Immune Deficiency Syndromes 1992;5:528-529.

Nicoll A. Vaccine related poliomyelitis in nonimmunised relatives and household contacts (letter). British Medical Journal 1987;294:374.

Nicoll A, Begg N. Immunizations in children. Current Opinion in Pediatrics 1993;5:60-67.

Nicolosi A, Hauser WA, Beghi E, Kurland LT. Epidemiology of central nervous system infections in Olmsted County, Minnesota, 1950-1981. Journal of Infectious Diseases 1986;154:399-408.

Nieminen U, Peltola H, Syrjala MT, Makipernaa A, Kekomaki R. Acute thrombocytopenic purpura following measles, mumps and rubella vaccination: a report on 23 patients. Acta Paediatrica 1993;82:267-270.

Niermeijer P, Gips CH. Guillain-Barre syndrome in acute HBs Ag-positive hepatitis. British Medical Journal 1975;4:732-733.

Nightingale SL. From the Food and Drug Administration. Journal of the American Medical Association 1990;264:2863.

Nishio O, Ishihara Y, Sakae K, Nonomura Y, Kuno A, Yasukawa W et al. The trend of acquired immunity with live poliovirus vaccine and the effect of revaccination: follow-up of vaccinees for ten years. Journal of Biological Standardization 1984;12:1-10.

Niv M. Mumps vaccine: possible reaction. Pediatrics 1969;44:146.

Nkowane BM, Wassilak SG, Orenstein WA, Bart KJ, Schonberger LB, Hinman AR et al. Vaccine-associated paralytic poliomyelitis, United States: 1973 through 1984. Journal of the American Medical Association 1987;257:1335-1340.

Noah ND. Vaccination today. British Journal of Hospital Medicine 1980;24:533-536.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Noel I, Galloway A, Ive FA. Hypersensitivity to thiomersal in hepatitis B vaccine (letter). Lancet 1991;338:705.

Nokes DJ, Anderson RM. Measles, mumps, and rubella vaccine: what coverage to block transmission? (letter). Lancet 1988;2:1374.

Nokes DJ, Anderson RM. Vaccine safety versus vaccine efficacy in mass immunization programmes. Lancet 1991;338:1309-1312.

Nokes DJ, Anderson RM. Evaluation of mumps vaccine (letter). Lancet 1992;339:1052-1053.

Norden CW, Michaels RH, Melish M. Serologic responses of children with meningitis due to Haemophilus influenzae type b. Journal of Infectious Diseases 1976;134:495-499.

Norrby R. Polyradiculitis in connection with vaccination against morbilli, parotitis and rubella. Lakartidningen 1984;81:1636-1637.

Novak M, Kvicalova E, Friedlanderova B. Reactions to merthiolate in infants. Contact Dermatitis 1986;15:309-310.

Novello F, Lombardi F, Amato C, Santoro R, Fiore L. Grandolfo ME et al. Paralytic poliomyelitis in Italy (1981-85). European Journal of Epidemiology 1987;3:54-60.

Nutini MT, Marie FN, Loucq C, Tron F. Hepatitis B vaccine: clinical experience and safety (letter). Lancet 1983;2:1301.

Nyerges G, Zimonyi I, Nyerges G et al. Efficiency of tetanus toxoid booster in leukaemic children. Acta Paediatrica Academiae Scientiarum Hungaricae 1981;22:237-241.

Obodowska-Zysk W. [Reaction after vaccination against poliomyelitis and discussion of 3 cases] Odczynypo szczepieniu przeciw poliomyelitis z omowieniem 3 przypadkow. Przeglad Epidemiologiczny 1970;24:249-254.

Ochsenfahrt H. [Adverse reactions of drugs: collection and evaluation of reported data by the committee on safety of medicines] Unerwunschte Arzneimittelwirkungen: Sammlung und Auswertung durch die Arzneimittelkommission. Fortschritte der Medizin 1984;102:355-360.

Office of Technology Assessment. Compensation for Vaccine-Related Injuries: A Technical Memorandum. Washington, DC: U.S. Government Printing Office; 1980.

Offor E, Obi JO. Paralytic poliomyelitis in Benin City in Nigeria. Public Health 1986;100:297-301.

Ogra PL, Faden HS. Poliovirus vaccines: live or dead. Journal of Pediatrics 1986;108:1031-1033.

Okuno Y, Nakao T, Ishida N, Konno T, Mizutani H, Sato T et al. An epidemiological study of subacute sclerosing panencephalitis in Japan, 1976. Biken Journal 1978;21(A):9-14.

Okuno Y, Nakao T, Ishida N, Konno T, Mizutani H, Fukuyama Y et al. Incidence of subacute sclerosing panencephalitis following measles and measles vaccination in Japan. International Journal of Epidemiology 1989;18:684-689.

Oldstone MB. Prevention of type I diabetes in nonobese diabetic mice by virus infection. Science 1988;239:500-502.

Oldstone MB. Viruses can cause disease in the absence of morphological evidence of cell injury: implication for uncovering new diseases in the future. Journal of Infectious Diseases 1989;159:384-389.

Oldstone MB, Ahmed R, Salvato M. Viruses as therapeutic agents II. Viral reassortants map prevention of insulin-dependent diabetes mellitus to the small RNA of lymphocytic choriomeningitis virus. Journal of Experimental Medicine 1990;171:2091-2100.

Oldstone MB, Nerenberg M, Southern P, Price J, Lewicki H. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 1991;65:319-331.

Oldstone MB, Tishon A, Schwimmbeck PL. Shyp S. Lewicki H, Dryberg T. Cytotoxic T lymphocytes do not control lymphocytic choriomeningitis virus infection of BB diabetesprone rats. Journal of General Virology 1990;71(Pt. 4):785-791.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Olivares M, Walter T, Osorio M, Chadud P, Schlesinger L. Anemia of a mild viral infection: the measles vaccine as a model. Pediatrics 1989;84:851-855.

Onisawa S, Sekine I, Ichimura T, Homma N. Guillain-Barre syndrome secondary to immunization with diphtheria toxoid. Dokkyo Journal of Medical Science 1985;12:227-229.

Onorato IM, Markowitz LE, Oxtoby MJ. Childhood immunization, vaccine-preventable diseases and infection with human immunodeficiency virus. Pediatric Infectious Disease Journal 1988;7:588-595.

Onorato IM, Modlin JF, McBean A. M., Thoms ML. Losonsky GA, Bernier RH. Mucosal immunity induced by enhanced-potency inactivated and oral polio vaccines. Journal of Infectious Diseases 1991;163:1-6.

Openshaw H, Lieberman JS. Vaccine-related poliomyelitis (editorial). Archives of Internal Medicine 1982;142:1617.

Openshaw H, Lieberman JS. Vaccine-related poliomyelitis: serum IgM and cerebrospinal fluid antibodies. Western Journal of Medicine 1983;138:420-422.

Oppenheimer DR. A case of so-called demyelinating encephalitis. Neuropatologia Polska 1966;4(Suppl.):717-21.

Orenstein WA. Safety of combined schedules of OPV and IPV. Prepared for Meeting of Immunization Practices Advisory Committee. October 24-25, 1985.

Orenstein WA, Markowitz LE, Hinman AR. Diseases controlled primarily by vaccination: measles. In: Last JM, Wallace RB, eds. Maxcy-Rosenau-Last Public Health and Preventive Medicine, 13th ed. Norwalk, CT: Appleton & Lange; 1992.

Orgel HA, Hamburger RN, Mendelson LM et al. Antibody responses in normal infants and in infants receiving chemotherapy for congenital neuroblastoma. Cancer 1977;40:994-997.

Ornoy A, Arnon J, Feingold M, Ben Ishai P. Spontaneous abortions following oral poliovirus vaccination in first trimester (letter). Lancet 1990;335:800.

Orzechowska-Wolczyk M, Szulc-Kuberska J, Zawadzki Z. [Case of poliomyelitis in the mother of a child vaccinated against poliomyelitis] Przypadek zapalenia rogow przednich rdzenia kregowego u matki dziecka szczepionego przeciw polio. Wiadomosci Lekarskie 1976;29:1007-1010.

Osawa J, Kitamura K, Ikezawa Z, Nakajima H. A probable role for vaccines containing thimerosal in thimerosal hypersensitivity. Contact Dermatitis 1991;24:178-182.

Osawa J, Kitamura K, Ikezawa Z, Nakajima H. A study on hypersensitivity reactions to piroxicam in experimentally induced thimerosal allergy . Skin Research 1991;33(Suppl. 10):154-159.

Osetowska E, Biernacki M, Pietrzyk J. ''Spontaneous'' changes in the brains of monkeys used for vaccine production. Polish Medical Journal 1966;5:1132-1151.

Oski FA, Naiman JL. Effect of live measles vaccine on the platelet count. New England Journal of Medicine 1966;275:352-356.

Osorio M, Olivares M, Chadud P, Schlesinger L, Arevalo M, Stekel A. [Clinical manifestations and leukocyte response induced by measles vaccination] Manifestaciones clinicas y respuesta leucocitaria producidas por la vacunacion antisarampion. Revista Chilena de Pediatria 1987;58:74-77.

Osterholm MT, Rambeck JH, White KE, Jacobs JL, Pierson LM, Neaton JD et al. Lack of efficacy of Haemophilus b polysaccharide vaccine in Minnesota. Journal of the American Medical Association 1988;260:1423-1428.

Osuntokun BO. The neurological complications of vaccination against smallpox and measles. West African Medical Journal and Nigerian Practitioner 1968;17:115-121.

Otsuki A. [Current status and problems of measles vaccine and vaccination]. Hokenfu Zasshi 1970;26:50-51.

Ott K. [Iatrogenic disease in the prevention of tetanus] Iatrogenie v prevenci tetanu. Rozhledy v Chirurgii 1967;46:493-495.

Otten A, Helmke K, Stief T, Mueller-Eckhard G, Willems WR, Federlin K. Mumps, mumps

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

vaccination, islet cell antibodies and the first manifestation of diabetes mellitus type I. Behring Institute Mitteilungen 1984;75:83-88.

Ovens H. Anaphylaxis due to vaccination in the office. Canadian Medical Association Journal 1986;134:369-370.

Ozaki T, Miwata H, Kodama H, Matsui Y, Asano Y. Henoch-Schonlein purpura after measles immunization. Acta Paediatrica Japonica 1989;31:484-486.

Ozeretskovskii NA, Gurvich EB. [The side effects of vaccines used in prophylactic inoculation schedules] Pobochnoe deistvie vaktsin kalendaria profilakticheskikh privivok. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii 1991;5:59-63.

Pachman DJ. Mumps occurring in previously vaccinated adolescents. American Journal of Diseases of Children 1988;142:478-479.

Palumbo P, Hoyt L, Demasio K, Oleske J, Connor E. Population-based study of measles and measles immunization in human immunodeficiency virus-infected children. Pediatric Infectious Disease Journal 1992;11:1008-1014.

Pampiglione G, Griffith AH, Bramwell EC. Transient cerebral changes after vaccination against measles. Lancet 1971;2:5-8.

Pappenheimer AM Jr. Diphtheria. In: Germanier R, ed. Bacterial Vaccines, Orlando: Academic Press; 1984.

Pappenheimer AM Jr. A study of reactions following administration of crude and purified diphtheria toxoid in an adult population. American Journal of Hygiene 1950;52:353-370.

Paradiso G, Micheli F, Fernandez Pardal M, Casas Parera I. [Multifocal demyelinating neuropathy after tetanus vaccine] Neuropatia desmielinizante multifocal siguiendo vacunacion antitetanica. Medicina 1990;50:52-54.

Parish HJ, Oakley CL. Anaphylaxis after injection of tetanus toxoid. British Medical Journal 1940;1:294-295.

Parish WE, Eosinophilia. I. Eosinophilia in guinea-pigs mediated by passive anaphylaxis and by antigen-antibody complexes containing homologous IgG1a and IgG1b. Immunology 1972;22:1087-1098.

Parke JC Jr, Schneerson R, Reimer C, Black C, Welfare S, Bryla D et al. Clinical and immunologic responses to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infants injected at 3, 5, 7, and 18 months of age. Journal of Pediatrics 1991;118:184-190.

Parker JC, Klintworth GK, Graham DG, Griffith JF. Uncommon morphologic features in subacute sclerosing panencephalities (SSPE). American Journal of Pathology 1970;61:275-291.

Parkkonen P, Hyoty H, Koskinen L, Leinikki P. Mumps virus infects beta cells in human fetal islet cell cultures upregulating the expression of HLA class I molecules. Diabetologia 1992;35:63-69.

Pasetto N. Problems of vaccinations in pregnancy. Clinica Terapeutica 1988;125:65-70.

Pataky L. [Late vaccination complications in the prevention of tetanus and rabies] Spate Impfkomplikationen bei der Prophylaxe gegen Tetanus und Tollwut. Zeitschrift fur die Gesamte Hygiene 1977;23:917-918.

Patan B. [Postvaccinal severe diabetes mellitus]. Posvaktsinoznyi tiazhelyi sakharnyi diabet. Terapevticheskii Arkhiv (Moskva) 1968;40:117-118.

Pathak UN, Dilawari JB, Chawla Y, Sokhey CS, Sharma BK, Ganguly NK. Immunogenicity and side effects of low dose intradermally administered hepatitis B vaccine. Indian Journal of Gastroenterology 1988;7:113-114.

Patriarca PA, Sutter RW. Diseases controlled primarily by vaccination: poliomyelitis. In: Last JM, Wallace RB, eds. Maxcy-Rosenau-Last Public Health and Preventive Medicine, 13th ed. Norwalk, CT: Appleton & Lange: 1992.

Patrick A. Acute diabetes following mumps. British Medical Journal 1924;2:802.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Patterson K, Chandra RS, Ienson AB. Congenital rubella, insulitis, and diabetes mellitus in an infant. Lancet 1981:1:1048-1049.

Pauksen K, Duraj V, Ljungman P, Sjolin J, Oberg G, Lonnerholm G et al. Immunity to and immunization again measles, rubella and mumps in patients after autologous bone marrow transplantation. Bone Marrow Transplantation 1992;9:427-432.

Paulson GW. The Landry-Guillain-Barre-Strohl syndrome in childhood. Developmental Medicine and Child Neurology 1970;12:604-607.

Paux G, Chretien P, Hermier C, Moore N, Boismare F. [Minor and major side-effects from vaccination: interest of a precise inquiry done by a pharmacovigilance center] Incidents et accidents vaccinaux: interet de l'enquete precise faite a l'initiative du centre de pharmacovigilance aupres des praticiens. Therapie 1983;38:583-585.

Pawlowski B, Gries FA. [Mumps vaccination and type-I diabetes]. Mumpsimpfung und Typ-I-Diabetes. Deutsche Medizinische Wochenschrift 1991;116:635.

Payne FE, Baublis JV, Itabashi HH. Isolation of measles virus from cell cultures of brain from a patient with subacute sclerosing panencephalitis. New England Journal of Medicine 1969;281:585-589.

Pearlman DS, Bierman CW. Allergic disorders. In: Stiehm ER, ed. Immunologic Disorders in Infants and Children, 3rd edition. Philadelphia: W. B. Saunders Co.; 1989.

Peebles TC, Levine L, Eldred ML. Tetanus toxoid emergency boosters: a reappraisal. New England Journal of Medicine 1969;280:575-581.

Peel MM, Edsall G, White WG, Barnes GM. Relationship between lymphocyte response to tetanus toxoid and age of lymphocyte donor. Journal of Hygiene 1978;80:259-265.

Peig M, Ercilla G, Millan M, Gomis R. Postmumps diabetes mellitus (letter). Lancet 1981:1:1007.

Peltola H. Rapid effect on endemic measles, mumps, and rubella of nationwide vaccination programme in Finland. Lancet 1986;1:137-139.

Peltola H. Clinical efficacy of the PRP-D versus HbOC conjugate vaccine Haemophilus influenzae type b (Hib). Program Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. Abstract 975, p. 273. Washington, DC: American Society for Microbiology: 1992.

Peltola H, Heinonen OP. Frequency of true adverse reactions to measles-mumps-rubella vaccine: a double-blind placebo-controlled trial in twins. Lancet 1986;1:939-942.

Peltola H, Kayhty H, Sivonen A, Makela PH. Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland. Pediatrics 1977;60:730-737.

Peltola H, Kayhty H, Virtanen M, Makela PH. Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine. New England Journal of Medicine 1984;310:1561-1566.

Penner E, Maida E, Mamoli B, Gangl A. Serum and cerebrospinal fluid immune complexes containing hepatitis B surface antigen in Guillain-Barre syndrome. Gastroenterology 1982;82:576-580.

Pennie RA, O'Connor AM, Dulberg CS, Bottiglia A, Manga P, Kang CY. Low-cost hepatitis B vaccine improves uptake among self-paying health-care students. Journal of Medical Virology 1992;37:48-53.

Penttinen K. Benefits and risks of killed polio vaccine. Experiences in Finland. Developments in Biological Standardization 1979;43:159-163.

Penttinen K, Cantell K, Somer P, Poikolainen A. Mumps vaccination in the Finnish defense forces. American Journal of Epidemiology 1968;88:234-244.

Pere JC. Estimation du numerateur en notification spontanee. In: Begaud B, ed. Analyse d'Incidence en Pharmacovigilance: Application a la Notification Spontanee. Bordeaux, France: ARME-Pharmacovigilance Editions: 1991.

Perez-Martin R. Reactions to booster doses of tetanus vaccine. Pediatrics 1968;42:711-712.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Perkins LD. Complying with the National Childhood Vaccine Injury Act. American Journal of Hospital Pharmacy 1990;47:1260, 1262, 1266.

Perlman EC. Purpuric and cerebral manifestations following measles. Archives of Pediatrics 1934;51:596-604.

Peter G. Vaccine crisis: an emerging societal problem. Journal of Infectious Diseases 1985;151:981-983.

Peter G. Measles immunization: recommendations, challenges, and more information (editorial). Journal of the American Medical Association 1991;265:2111-2112.

Peterson JC, Christie A. Immunization in the young infant. American Journal of Diseases of Children 1951;81:518-529.

Pharmacy International. Vaccination and drug interactions. Pharmacy International 1985;6:291-292.

Philip RN, Reinhard KR, Lackman DB. Observations on a mumps epidemic in a "virgin" population. American Journal of Hygiene 1959;69:91-111.

Physicians' Desk Reference, 46th edition. Montvale, NJ: Medical Economics Company Inc.; 1992.

Piazza M, Picciotto L, Villari R et al. Hepatitis B immunization with a reduced number of doses in newborn babies and children. Lancet 1985 ;1:949-951.

Pichichero ME, Barkin RM, Samuelson JS. Pediatric diphtheria and tetanus toxoids-adsorbed vaccine: immune response to the first booster following the diphtheria and tetanus toxoids vaccine primary series. Pediatric Infectious Disease 1986;5:428-430.

Pierce EJ, Davison MD, Parton RG, Habig WH, Critchley DR. Characterization of tetanus toxin binding to rat brain membranes. Biochemical Journal 1986;236:845-852.

Pierchalla P, Petri H, Ruping KW, Stary A. [Urticaria after H-B-vax injection due to hypersensitivity to thiomersal (merthiolate)] Urtikarielle Reaktion nach Injektion von H-B-Vax bei Sensibilisierung auf Thiomersal (Merthiolat). Allergologie 1987;10:97-99.

Pietroski N. Viral hepatitis: advances in pharmacy therapy. American Druggist 1992;206:71-85.

Pilotti G. [Thrombopenia and acute hemolytic anemia in the course of poliomyelitis vaccination] Piastrinopenia ed anemia emolitica acuta in corso di vaccinazione antipoliomielitica. Minerva Pediatrica 1975;27:637-639.

Pincus DJ, Morrison D, Andrews C, Lawrence E, Sell SH, Wright PF. Age-related response to two Haemophilus influenzae type b vaccines. Journal of Pediatrics 1982;100:197-201.

Pineau A, Durand C, Guillard O, Bureau B, Stalder JF. Role of aluminium in skin reactions after diphtheria-tetanus-pertussis-poliomyelitis vaccination: an experimental study in rabbits. Toxicology 1992;73:117-125.

Pinson JB, Weart CW. New considerations for Haemophilus influenzae type b vaccination. Clinical Pharmacy 1992;11:332-336.

Piriev GG, Liashchenko VA. [Possibilities of measles vaccination in children with counterindications and duration of preservation of postvaccinal immunity] Izuchenie vozmozhnosti vaktsinatsii protiv kori detei s nekotorymi protivopokazaniiami i prodolzhitel'nost' sokhraneniia postvaktsinal'nogo immuniteta. Pediatriia 1990;12:27-30.

Plotkin SA, Mortimer EA, eds. Vaccines. Philadelphia: W.B. Saunders Co.; 1988.

Plotkin SL, Plotkin SA. A short history of vaccination. In: Plotkin SA, Mortimer EA, eds. Vaccines. Philadelphia: W.B. Saunders Co.; 1988.

Pohl KR, Farley JD. Jan JE, Junker AK. Ataxia-telangiectasia in a child with vaccine-associated paralytic poliomyelitis. Journal of Pediatrics 1992;121:405-407.

Pokrovskii VI, Bolotovskii VM, Titova NS, Pokrovskaia NI. [Subacute sclerosing panencephalitis] Podostryi skleroziruiushchii panentsefalit. Sovetskaia Meditsina 1982;7:53-59.

Pol KM. Measles: the epidemiology and control of an outbreak. Journal of the American College Health Association 1983;31:158-161.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Polakoff S. Immunization of infants at high risk of hepatitis B. British Medical Journal 1982;285:1294-1295.

Poland GA, Love KR, Hughes CE. Routine immunization of the HIV-positive asymptomatic patient. Journal of General Internal Medicine 1990;5:147-152.

Pollard JD, Selby G. Relapsing allergic neuritis. Proceedings of the Australian Association of Neurologists 1977;14:133-136.

Pollard JD, Selby G. Relapsing neuropathy due to tetanus toxoid: report of a case. Journal of Neurological Science 1978;37:113-125.

Pollard JD, Selby G, McLeod JG. Chronic relapsing polyneuritis (abstract). Electroencephalography and Clinical Neurophysiology 1977;43:617.

Pollock TM. Measles control in the United Kingdom. Reviews of Infectious Diseases 1983;5:574-576.

Pollock TM, Morris J. A 7-year survey of disorders attributed to vaccination in North West Thames region. Lancet 1983;1:753-757.

Pollock TM, Morris J. Vaccine reactions. Lancet 1983;1:1380-1381.

Pollock TM, Miller E, Mortimer JY, Smith G. Symptoms after primary immunization with DTP and with DT vaccine. Lancet 1984;2:146-149.

Pollock TM, Miller E, Mortimer JY, Smith G. Postvaccination symptoms following DTP and DT vaccination. Developments in Biological Standardization 1985;61:407-410.

Poole FT. Abnormal result of treatment. Occupational Health 1974;26:55-57.

Pope RM, Pahlavani MA, LaCour E. Antigenic specificity of rheumatoid synovial fluid lymphocytes. Arthritis and Rheumatism 1989;32:1371-1380.

Popejoy LA, Rivera AI, Gonzales-Torres I. Side-effects and immunogenicity of Haemophilus influenzae type b polysaccharide vaccine in a multi-ethnic pediatric population. Military Medicine 1989;154:25-29.

Popow-Kraupp T, Kundi M, Ambrosch F, Vanura H, Kunz C. A controlled trial for evaluating two live attenuated mumps-measles vaccines (Urabe Am 9-Schwarz and Jeryl Lynn-Moraten) in young children. Journal of Medical Virology 1986;18:69-79.

Porter D, Porter R. The politics of prevention: anti-vaccinationism and public health in nineteenth-century England. Medical History 1988;32:231-252.

Poser CM. Disseminated vasculomyelinopathy: a review of the clinical and pathologic reactions of the nervous system in hyperergic diseases. Acta Neurologica Scandinavica 1969;37(Suppl.):3-44.

Poser CM. Postvaccinal encephalitis (letter). Annals of Neurology 1983;13:341-342.

Poser CM. Neurological complications of infections and vaccinations. Saudi Medical Journal 1992;13:379-386.

Pounder DJ. Sudden, unexpected death following typhoid-cholera vaccination. Forensic Science International 1984;24:95-98.

Pozzetto B, Genin C, Gaudin OG, Berthoux FC, Alloin B, Laurent B et al. Live poliovirus vaccine in patients with chronic glomerulonephritis: effects on renal function and specific antibody response. Clinical Nephrology 1987;28:194-198.

Preblud SR, Katz SL. Measles vaccine. In: Plotkin SA, Mortimer EA, eds. Vaccines. Philadelphia: W.B. Saunders Co.; 1988.

Press E. Desirability of the routine use of tetanus toxoid. New England Journal of Medicine 1948;239:50-56.

Price DL, Griffin JW. Immunocytochemical localization of tetanus toxin to synapses of spinal cord. Neuroscience Letters 1981;23:149-155.

Prilutskaya AF, Feldman EV, Votyakov VI, Protas II. [Diagnosis of poliomyelitis and polio like paralysis in children under conditions of mass vaccination with live poliovaccine in Byelorussia]. Zdravookhr Beloruss 1974;20:73-76.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Prince GA, Jenson AB, Billups LC, Notkins AL. Infection of human pancreatic beta cell cultures with mumps virus. Nature 1978;271:158-161.

Profeta ML. [Characteristics of the virus and of measles vaccines] Generalita sul virus del morbillo e sui relativi vaccini. Annali Sclavo 1979;21(Suppl. 1):377-383.

Prost J. [Remarks on 10,000 anti-poliomyelitis vaccinations made in the factories of a business] Remarques sur 10,000 vaccinations anti-poliomyelitiques effectuees dans les ateliers d'une entreprise. Archives des Maladies Professionnelles de Medecine du Travail et de Securite Sociale 1967;28:871-875.

Purcell RH, Gerin JL. Hepatitis B subunit vaccine: a preliminary report of safety and efficacy tests in chimpanzees. American Journal of Medical Science 1975;270:395-399.

Puvvada L, Silverman B. Bassett C, Chiaramonte LT. Systemic reactions to measles-mumps-rubella vaccine skin testing. Pediatrics 1993;91:835-836.

Quagliarello V, Scheld WM. Bacterial meningitis: pathogenesis, pathophysiology, and progress. New England Journal of Medicine 1992;327:864-872.

Quast U, Hennessen W, Widmark RM. Mono- and polyneuritis after tetanus vaccination (1970-1977). Developments in Biological Standardization 1979;43:25-32.

Quast U, Hennessen W, Widmark RM. Vaccine induced mumps-like diseases. Developments in Biological Standardization 1979;43:269-272.

Quast U, Herder C, Zwisler O. Vaccination of patients with encephalomyelitis disseminata. Vaccine 1991;9:228-230.

Querfurth H, Swanson PD. Vaccine-associated paralytic poliomyelitis: regional case series and review. Archives of Neurology 1990;47:541-544.


Racaniello VR. Poliovirus vaccines. Biotechnology 1992;20:205-222.

Radl H. [Virus meningitis: newer clinical and epidemiological observations] Virus-Meningitiden: neuere klinische und epidemiologische Beobachtungen. Munchener Medizinische Wochenschrift 1967;109:1900-1904.

Raettig H. Provokation einer infektion durch Schutzimpfung. Zentralblatt fur Bakteriologie, Parasitendunde. Infektionskrankheiten und Hygiene 1959;174:192-217.

Raj B, Dubey YD. A study of sensitivity induced by certain drugs by intradermal skin tests. Indian Journal of Medical Research 1969;57:1769-1775.

Ramon G. Medecine experimentale: sur le pouvoir floculant et sur les proprietes immunisantes d'une toxine diphtherique rendue anatoxique (anatoxine). Comptes Rendus Hebdomadaires des Seances de I'Academie des Sciences 1923;177:1338-1340.

Ramon G, Zoeller C. Medecine experimentale: de la valeur antigene de I'anatoxine tetanique chez l'homme. Comptes Rendues Hebdomadaires des Seances de I'Academie des Sciences 1926;182:245-247.

Ramon G, Zoeller C. L'anatoxine tetanique et I'immunization active de l'homme vis-a-vis du tetanos. Annales Institut Pasteur 1927;41:803-833.

Ramsay ME, Rao M. Meningoencephalitis after measles-mumps-rubella vaccine (letter). Archives of Disease in Childhood 1991;66:1365.

Ramsay ME, Rao M, Begg NT. Symptoms after accelerated immunization. British Medical Journal 1992;304:1543-1536.

Ramsey M, Rao M, Symons J, Virdee S, Gogarty M, Ryan J et al. Vaccine reaction: "guilty until proven innocent". Commun Dis Rep 1990;90:3.

Ranieri R, Passaretti B, Vecchi L, Milella AM. Hepatitis B vaccination in a group of 50 Italian prisoners. Medical Science Research 1992;20:115-116.

Rantala H, Uhari M, Niemela M et al. Occurrence, clinical manifestations, and prognosis of Guillain-Barre syndrome. Archives of Disease in Childhood 1991;66:706-709.

Rantala H, Uhari M, Tuokko H, Stenvik M, Kinnunen L. Poliovaccine virus in the cerebrospinal fluid after oral polio vaccination. Journal of Infection 1989 ;19:173-176.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Rapicetta M. Hepatitis B vaccination in dialysis centres: advantages and limits. Nephron 1992;61:284-286.

Rappouli R, Perugini M, Falsen E. Molecular epidemiology of the 1984-1986 outbreak of diphtheria in Sweden. New England Journal of Medicine 1988;318:12-14.

Rasmussen JE. Erythema multiforme in children: response to treatment with systemic corticosteroids. British Journal of Dermatology 1976;95:181-186.

Ratliff DA, Burns-Cox CJ. Anaphylaxis to tetanus toxoid. British Medical Journal 1984;288:114.

Ratzmann KP, Strese J, Witt S. Berling H, Keilacker H, Michaelis D. Mumps infection and insulin-dependent diabetes mellitus (IDDM). Diabetes Care 1984;7:170173.

Rau R. Karger T, Herborn G. Zwei falle chronischer polyarthritis nach Hepatitis B impfung. Zeitschrift fur Rheumatologie (Tagung der Deutschen Gesellschraft fur Rheumatologie) 1984;43:213.

Rayfield EJ, Kelly KJ, Yoon JW. Rubella virus-induced diabetes in the hamster. Diabetes 1986;35:1278-1281.

Rayfield EJ, Seto Y. Viruses and the pathogenesis of diabetes mellitus. Diabetes 1978;27:1126-1139.

Read SJ, Schapel GJ, Pender MP. Acute transverse myelitis after tetanus toxoid vaccination (letter). Lancet 1992;339:1111-1112.

Reed D, Brown G, Merrick R, Sever J, Feltz E. A mumps epidemic on St. George Island, Alaska. Journal of the American Medical Association 1967;199:113-117.

Regamey RH. Die Tetanus-Schutzimpfung. In: Herrlick A, ed. Handbuch der Schutzimpfungen. Berlin-Heidelberg-New York: Springer; 1965.

Reinstein L, Pargament JM, Goodman JS. Peripheral neuropathy after multiple tetanus toxoid injections. Archives of Physical Medicine and Rehabilitation 1982;63:332-334.

Reisman RE. Rose NR, Witebsky E, Arbesman CE. Serum sickness: II. Demonstration and characteristics of antibodies. Journal of Allergy 1961 ;32:531-543.

Relihan M. Reactions to tetanus toxoid. Journal of the Irish Medical Association 1969;62:430-434.

Relyveld EH. Current developments in production and testing of tetanus and diphtheria vaccines. Progress in Clinical and Biological Research 1980;47:51-76.

Relyveld EH. Preparation and use of calcium phosphate adsorbed vaccines. Developments in Biological Standardization 1986;65:131-136.

Relyveld EH, Henocq E, Bizzini B. Studies on untoward reactions to diphtheria and tetanus toxoids. Developments in Biological Standardization 1979;43:33-37.

Reutens DC, Dunne JW, Leather H. Neuralgic amyotrophy following recombinant DNA hepatitis B vaccination (letter). Muscle and Nerve 1990;13:461.

Revista de Igiena. [The national program to eliminate poliomyelitis (NPEP)] Programul national pentru eliminarea poliomielitei (PNEP). Revista de Igiena (Bacteriol) 1988;33:372-380.

Reviews of Infectious Diseases. Seroconversion rates and measles antibody titers induced by measles vaccination in Latin American children six to 12 months of age. Reviews of Infectious Diseases 1983;5:596-605.

Revue du Practicien—Medecine Generale. [Haemophilus vaccine] Vaccination anti-haemophilus. Revue du Practicien—Medecine Generale 1992;6:1231.

Rhoads JL, Birx DL, Wright DC, Brundage JF, Brandt BL, Redfield RR et al. Safety and immunogenicity of multiple conventional immunizations administered during early HIV infection. Journal of Acquired Immune Deficiency Syndrome 1991;4:724-731.

Ribera EF, Dutka AJ. Polyneuropathy associated with administration of hepatitis B vaccine (letter). New England Journal of Medicine 1983;309:614-615.

Ricciardi G, Graziano G. [Safety and immunogenicity of an anti-hepatitis-B vaccine obtained using the recombinant DNA technique: results of a longitudinal study in hospital person-

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

nel] Sicurezza ed immunogenicita di un vaccino anti-epatite B ottenuto con la tecnica del DNA-ricombinante: risultati di un'indagine longitudinale su personale ospedaliero. Bollettino dell Istituto Sieroterapico Milanese 1990;69:385-390.

Richens ER, Jones WG. Islet-cell antibodies and mumps. Lancet 1981;1:507-508.

Rietschel RL, Adams RM. Reactions to thimerosal in hepatitis B vaccines. Dermatologic Clinics 1990;8:161-164.

Riikonen R. The role of infection and vaccination in the genesis of optic neuritis and multiple sclerosis in children. Acta Neurologica Scandinavica 1989;80:425-431.

Riikonen R, Donner M. Incidence and aetiology of infantile spasms from 1960 to 1976: a population study in Finland. Developmental Medicine and Child Neurology 1979;21:333-343.

Riker JB, Brandt CD, Chandra R, Arrobio JO, Nakano JH. Vaccine-associated poliomyelitis in a child with thymic abnormality. Pediatrics 1971;48:923-929.

Riley HD Jr. Immunization against measles (rubeola). Journal of the Oklahoma State Medical Association 1969;62:107-110.

Ring J. Exacerbation of eczema by formalin-containing hepatitis B vaccine in formaldehydeallergic patient (letter). Lancet 1986;2:522-523.

Rivers TM, Schwenker FF. Encephalomyelitis accompanied by myelin destruction experimentally produced in monkeys. Journal of Experimental Medicine 1935;61:689-702.

Rizzuto N, Napoleone-Capra A, Ferrari G. [Atonic diplegia caused by antipoliomyelitic oral vaccination: anatomo-clinical study] Diplegia atonica insorta dopo vaccinazione antipoliomielitica per via orale: studio anatomo-clincio. Acta Neurologica 1969;24:248-258.

Robbins FC. Measles: clinical features, pathogenesis, pathology, and complications. American Journal of Diseases of Children 1962;103:266-273.

Robbins FC, Robbins JB. Current status and prospects for some improved and new bacterial vaccines . Annual Review of Public Health 1986;7:105-125.

Robbins JB, Parke JC Jr., Schneerson R, Whisnant JK. Quantitative measurement of "natural" and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies. Pediatric Research 1973;7:103-110.

Robbins JB, Schneerson R. Evaluating the Haemophilus influenzae type b conjugate vaccine PRP-D (editorial). New England Journal of Medicine 1990;323:1415-1416.

Robbins JB, Schneerson R. Polysaccharide-protein conjugates: a new generation of vaccines. Journal of Infectious Diseases 1990;161:821-832.

Robertson CM, Bennett VJ, Jefferson N, Mayon-White RT. Serological evaluation of a measles, mumps, and rubella vaccine. Archives of Disease in Childhood 1988;63:612-616.

Robinson IG. Unusual reaction to tetanus toxoid (letter). New Zealand Medical Journal 1981;94:359.

Rocchi G, Giannini V, Provvidenza G, Andreoni G. [Poliomyelitis due to poliovirus 3, with fatal outcome in an infant vaccinated with Sabin vaccine] Poliomielite da virus polio 3 ad esito letale in vaccinazto con vaccino Sabin. Giornale di Malattie Infettive e Parassitarie 1967;19:463-465.

Roden A. Convulsive disorders in young children. Proceedings of the Royal Society of Medicine 1974;67:380.

Roedenbeck SD, Diaz C. [Poliomyelitis and oral vaccine] Poliomielitis y vacuna oral. Revista de Neuropsiquiatria 1967;30:38-56.

Rogerson SJ, Nye FJ. Hepatitis B vaccine associated with erythema nodosum and polyarthritis. British Medical Journal 1990;301:345.

Rohde W. [Possibilities of reactions and complications from the part of CNS in vaccinations] Reaktionsmiglichkeiten und Komplikationen von seiten des ZNS bei Schutzimpfungen. Zeitschrift fur Arztliche Fortbildung 1974;68:202-208.

Ronne T. Measles virus infection without rash in childhood is related to disease in adult life. Lancet 1985;1:1-5.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Ropper AH. The Guillain-Barre syndrome: New England Journal of Medicine 1992;326:1130-1136.

Ropper AG, Wijdicks EF, Truax BT. Guillain-Barre syndrome. Philadelphia: F. A. Davis; 1991.

Roscelli JD, Bass JW, Pang L. Guillain-Barre syndrome and influenza vaccination in the US Army, 1980-1988. American Journal of Epidemiology 1991 ;133:952-955.

Rose I. Adverse reactions to tetanus toxoid. Lancet 1973;1:380.

Rosen HR, Stierer M, Wolf HM, Eibl MM. Impaired primary antibody responses after vaccination against hepatitis B in patients with breast cancer. Breast Cancer Research and Treatment 1992;23:233-240.

Ross JS, Smith NP, White IR. Role of aluminium sensitivity in delayed persistent immunization reactions (letter). Journal of Clinical Pathology 1991;44:876-877.

Rothstein RJ. Tetanus toxoid boosters (letter). Journal of the American Medical Association 1978;239:1133.

Rousseau SA. Symptomatic reaction to hepatitis B vaccine with abnormal liver function values (letter). British Medical Journal 1985;290:1989.

Rowe JE, Messinger IK, Schwendeman CA, Popejoy LA. Three-dose vaccination of infants under 8 months of age with a conjugate Haemophilus influenzae type b vaccine. Military Medicine 1990;155:483-486.

Rowe PC, Orrbine E, Wells GA, McLaine PN. Epidemiology of hemolytic-uremic syndrome in Canadian children from 1986 to 1988 . Journal of Pediatrics 1991:119:218-224.

Rowe PC, Orrbine E, Wells GA, McLaine PN, and the members of the Canadian Pediatric Kidney Disease Reference Centre. Epidemiology of hemolytic-uremic syndrome in Canadian children from 1986 to 1988. Journal of Pediatrics 1991;119:218-224.

Rowland A. Vaccination against measles. Community Health 1971;2:235-239.

Rozina EE, Hilgenfeldt M. Comparative study on the neurovirulence of different vaccine strains of parotitis virus in monkeys. Acta Virologica 1985;29:225-230.

Ruben FL, Nagel J, Fireman P. Antitoxin responses in the elderly to tetanus-diphtheria (TD) immunization. American Journal of Epidemiology 1978;108:145-149.

Rubin LG, Voulalas D, Carmody L. Immunization of children with sickle cell disease with Haemophilus influenzae type b polysaccharide vaccine. Pediatrics 1989;84:509-513.

Rubin LG, Voulalas D, Carmody L. Immunogenicity of Haemophilus influenzae type b conjugate vaccine in children with sickle cell disease. American Journal of Diseases of Children 1992;146:340-342.

Rubinstein P, Walker ME, Fedun B, Witt ME, Cooper LZ, Ginsberg-Fellner F. The HLA system in congenital rubella patients with and without diabetes. Diabetes 1982;31:1088-1091.

Ruddock DG, Dickson A. Intradermal hepatitis B vaccine: pilot study. Canadian Family Physician 1992:38:59-64.

Rumke HC. Contraindications for vaccinations in the state vaccination program. Nederlands Tijdschrift voor Geneeskunde 1989; 133:1975-1977.

Rutledge SL, Snead OC. Neurologic complications of immunizations. Journal of Pediatrics 1986;109:917-924.

Ruuskanen O, Salmi TT, Stenvik M, Lapinleimu K. Inactivated poliovaccine: adverse reactions and antibody responses. Acta Paediatrica Scandinavica 1980;69:397-401.

Saballus MK, Lake KD, Wager GP. Immunizing the pregnant woman: risks versus benefits. Postgraduate Medicine 1987;81:103-113.

Sabin AB. Immunization of chimpanzees and human beings with avirulent strains of poliomyelitis virus. Annals of the New York Academy Sciences 1956;61:1050-1056.

Sabin AB. Oral poliovirus vaccine: history of its development and prospects for eradication of poliomyelitis. Journal of the American Medical Association 1965;194:872-876.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Sabin AB. Oral poliomyelitis vaccine: achievements and problems in worldwide use. Bulletin of the International Pediatric Association 1977;2:6-18.

Sabin AB. Poliomyelitis vaccination. Evaluation and direction in continuing application. American Journal of Clinical Pathology 1978;70(1 Suppl.):136-140.

Sabin AB. Oral poliovirus vaccine: history of its development and use and current challenge to eliminate poliomyelitis from the world. Journal of Infectious Diseases 1985;151:420-436.

Saez-Llorens X, Ramilo O, Mustafa MM, Mertsola J. Molecular pathophysiology of bacterial meningitis: current concepts and therapeutic implications. Journal of Pediatrics 1990;116:671-684.

Safranek TJ, Lawrence DN, Kurland LT, Culver DH, Wiederholt WC, Hayner NS et al. Reassessment of the association between Guillain-Barre syndrome and receipt of swine influenza vaccine in 1976-1977: results of a two-state study. Expert Neurology Group. American Journal of Epidemiology 1991;133:940-951.

Saggese G, Federico G, Carzelli C, Toniolo A. Insulin-dependent diabetes: a possible viral disease. Pediatrician 1985;12:179-193.

Sagman D. Guillain-Barre Syndrome. Journal of the American Medical Association 1972;221:301.

Saisbren BA. Swine-influenza vaccine (letter). Annals of Internal Medicine 1982;97:149.

Sakano T, Kittaka E, Tanaka Y, Yamaoka H, Kobayashi Y, Usui T. Vaccine-associated poliomyelitis in an infant with agammaglobulinemia. Acta Paediatrica Scandinavica 1980;69:549-551.

Salk D. Eradication of poliomyelitis in the United States. III. Poliovaccines—practical considerations. Reviews of Infectious Diseases 1980;2:258-273.

Salk D. Polio immunization policy in the United States: a new challenge for a new generation. American Journal of Public Health 1988;78:296-300.

Salk D, Salk J. Vaccinology of poliomyelitis. Vaccine 1984;2:59-74.

Salk J. The virus of poliomyelitis: from discovery to extinction. Journal of the American Medical Association 1983:250:808-810.

Salk J, Drucker J. Noninfectious poliovirus vaccine. In: Plotkin SA, Mortimer EA, eds. Vaccines. Philadelphia: W.B. Saunders Co.; 1988.

Salk JE. The logic of the magic of vaccination. Allergy Proceedings 1988;9:689-692.

Salk JE. Recent studies on immunization against poliomyelitis. Pediatrics 1953;12:471-482.

Salk JE, Bennett BL, Lewis LJ, Ward EN, Youngner JS. Studies in human subjects on active immunization against poliomyelitis 1. A preliminary report of experiments in progress. Journal of the American Medical Association 1953:151:1081-1098.

Salomonsen CJ, Madsen TH. Bulletin de I'Academie de Sciences et des Lettres de Danemark. 1896.

Sanchez-Lanier M, Guerin P, McLaren LC, Bankhurst AD. Measles virus-induced suppression of lymphocyte proliferation. Cellular Immunology 1988;116:367-381.

Sandler B. Recovery from sterility after mumps orchitis. British Medical Journal 1954:11:795.

Santosham M, Hill J, Wolff M, Reid R, Lukacs L. Ahonkhai V. Safety and immunogenicity of a Haemophilus influenzae type b conjugate vaccine in a high risk American Indian population. Pediatric Infectious Disease Journal 1991;10:113-117.

Santosham M, Reid R, Letson GW, Wolff MC, Siber G. Passive immunization for infection with Haemophilus influenzae type b. Pediatrics 1990;85(4 Pt 2):662-666.

Santosham M, Rivin B, Wolff M, Reid R, Newcomer W, Letson GW et al. Prevention of Haemophilus influenzae type b infections in Apache and Navajo children. Journal of Infectious Diseases 1992;165(Suppl. 1):S144-S151.

Santosham M, Wolff M. Reid R, Hohenboken M, Bateman M, Goepp J et al. The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex. New England Journal of Medicine 1991:324:1767-1772.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Sarnaik S, Kaplan J, Schiffman G, Bryla D, Robbins JB, Schneerson R. Studies on pneumococcus vaccine alone or mixed with DTP and on pneumococcus type 6b and Haemophilis influenzae type b capsular polysaccharide-tetanus toxoid conjugates in two- to five-year-old children with sickle cell anemia. Pediatric Infectious Disease Journal 1990;9:181-186.

Sassini A, Mirchamsy H, Ahourai SP, Razavi J, Gholami MR, Mohammadi A et al. Development of a new live attenuated mumps virus vaccine in human diploid cells. Biologicals 1991;19:203-211.

Satar M, Savas N, Kozanoglu MN. Prophylaxis of babies born to HBsAg+ mothers. Mikrobiyoloji Bulteni 1992;26:37-40.

Saulsbury FT, Winkelstein JA, Davis LE, Hsu SH, D'Souza BJ, Gutcher GR et al. Combined immunodeficiency and vaccine-related poliomyelitis in a child with cartilage-hair hypoplasia. Journal of Pediatrics 1975;86:868-872.

Saxonhouse WJ. Hepatitis vaccine (letter). Journal of the American Dental Association 1985;110:670.

Saxton NL. Thrombocytopenic purpura following the administration of attenuated live measles vaccine. Journal of the Iowa Medical Society 1967;57:1017-1018.

Schacher SA. An epidemiological approach to subacute sclerosing panencephalitis. Neurology 1968;18(1 Pt. 2):76-77.

Schaltenbrand G, Hopf HC. Neurologische komplikationen nach schluckimpfung. Nervenarzt 1964;35:120-132.

Schattner A, Ben-Chetrit E, Schmilovitz H. Poliovaccines and the course of systemic lupus erythematosus—a retrospective study of 73 patients. Vaccine 1992;10:98-100.

Scheifele DW. Postmarketing surveillance of adverse reactions to ProHIBit vaccine in British Columbia. Canadian Medical Association Journal 1989;141:927-929.

Scheifele D, Bjornson G, Barreto L, Meekison W, Guasparini R. Controlled trial of Haemophilus influenzae type b diphtheria toxoid conjugate combined with diphtheria, tetanus and pertussis vaccines, in 18-month-old children, including comparison of arm versus thigh injection. Vaccine 1992;10:455-460.

Scheinberg L, Allensworth M. Sciatic neuropathy in infants related to antibiotic injections. Pediatrics 1957;19:261-265.

Scherer RW, Dickersin K, Kaplan E. The accessible biomedical literature represents a fraction of all studies in a field. Unpublished manuscript.

Schettini F, Manzionna MM, De MD, Amendola F, Di BG. Clinical and immunological evaluation of a bivalent vaccine against measles and rubella . Minerva Pediatrica 1990;42:531-536.

Schick B. Die diphtherietoxin-Hautreaktion des menschen als vorprobe der prophylaktischen diphtherieheilseruimnektion. Munchener Medizinische Wochenschrift 1913;60:2606.

Schlech WF, Ward JI, Bard JD et al. Bacterial meningitis in the United States, 1978-81: the National Bacterial Meningitis Surveillance Study. Journal of the American Medical Association 1985;253:1749-1754.

Schlenska GK. Unusual neurological complications following tetanus toxoid administration. Journal of Neurology 1977;215:299-302.

Schlesinger Y, Granoff DM. Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. Journal of the American Medical Association 1992;267:1489-1494.

Schneck SA. Vaccination with measles and central nervous system disease. Neurology 1968;18(Part 2):79-82.

Schneerson R, Barrera O, Sutton A, Robbins JB. Preparation, characterization, and immunogenicity of H. influenzae type b polysaccharide-protein conjugates. Journal of Experimental Medicine 1980;152:361-376.

Schneerson R, Rodrigues LP, Parke JC Jr., Robbins JB. Immunity to disease caused by Hemophilus influenzae type b. II. Specificity and some biologic characteristics of ''natural,'' infection-

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

acquired, and immunization-induced antibodies to the capsular polysaccharide of Hemophilus influenzae type b. Journal of Immunology 1971;107:1081-1089.

Schneider CH. Reactions to tetanus toxoid: a report of five cases. Medical Journal of Australia 1964;1:303-305.

Schonberger LB, Bregman D, Sullivan-Bolyai JZ, Bryan L, Noble GR. Guillain-Barre syndrome after administration of killed vaccines. Developments in Biological Standardization 1977;39:295-296.

Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, Keenlyside RA, Ziegler DW, Retailliau HF et al. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977. American Journal of Epidemiology 1979;110:105-123.

Schonberger LB, McGowan JE Jr., Gregg MB. Vaccine-associated poliomyelitis in the United States, 1961-1972. American Journal of Epidemiology 1976;104:202-211.

Schoub BD, Johnson S. Contraindications to immunization (letter). South African Medical Journal 1990;78:169.

Schreiber JR, Barrus V, Cates KL, Siber GR. Functional characterization of human IgG, IgM, and IgA antibody directed to the capsule of Haemophilus influenzae type b. Journal of Infectious Diseases 1986;153:8-16.

Schreurs AJ, Terpstra GK, Raaijmakers JA, Nijkamp FP. The effects of Haemophilus influenzae vaccination on anaphylactic mediator release and isoprenaline-induced inhibition of mediator release. European Journal of Pharmacology 1980;62:261-268.

Schroder JP. [Complications of tetanus vaccinations in juveniles] Tetanus: Keine blindimpfungen bei jugendlichen. Therapiewoche 1992;42:202.

Schroder JP, Gessler M, Kuhlmann WD, Trendelenburg C. [Avoidance of hyperergic reactions after tetanus immunization by using a knowledge base system for questions concerning the necessity for vaccination] Vermeidung hyperergischer reaktionen bei tetanus-impfungen durch einsatz eines wissensbasierten systems bei fragen der impfnotwendigkeit. Klinisches Labor 1992;38:229-233.

Schulman SL, Deforest A, Kaiser BA, Polinsky MS, Baluarte HJ. Response to measles-mumps-rubella vaccine in children on dialysis. Pediatric Nephrology 1992;6:187-189.

Schulz TF, Hoad JG, Whitby D, Tizard EJ, Dillon MJ, Weiss RA. A measles virus isolate from a child with Kawasaki disease: sequence comparison with contemporaneous isolates from 'classical' cases. Journal of General Virology 1992;73(Pt 6):1581-1586.

Schumacher HR, Gall EP. Arthritis in acute hepatitis and chronic active hepatitis: pathology of the synovial membranes with evidence of Australian antigen in synovial membranes. American Journal of Medicine 1974;57:655-664.

Schwarz AJ. Immunization against measles: development and evaluation of a highly attenuated live measles vaccine. Annales de Paediatrie 1964;202:241-252.

Schwarz AJ, Anderson JT. Immunization with a further attenuated live measles virus vaccine. Archiv fur die Gesamte Virusforschung 1965;16:273-278.

Schwarz AJ, Jackson JE, Ehrenkranz NJ, Ventura A, Schiff GM, Walters VW. Clinical evaluation of a new measles-mumps-rubella trivalent vaccine. American Journal of Diseases of Children 1975;129:1408-1412.

Schwarz G, Lanzer G, List WF. Acute midbrain syndrome as an adverse reaction to tetanus immunization. Intensive Care Medicine 1988;15:53-54.

Schwimmbeck PL, Dyrberg T, Oldstone MB A. et al. Abrogation of diabetes in BB rats by acute virus infection. Journal of Immunology 1988;140:3394-3400.

Scott GB. HIV infection in children: clinical features and management. Journal of the Acquired Immune Deficiency Syndrome 1991;4:109-115.

Scottish Medical Journal. Clinico-pathological conference from the University of Aberdeen and the Grampian Health Board. Scottish Medical Journal 1982;27:343-350.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Seeff LB, Beebe GW, Hoofnagle JH, Norman JE, Buskell-Bales Z, Waggoner JG et al. A serologic follow-up of the 1942 epidemic of postvaccination hepatitis in the United States Army. New England Journal of Medicine 1987;316:965-970.

Seki T, Miyazaki Y, Chiba H, Fukazawa J. [Atypical measles accompanying radiculitis]. Nippon Shonika Gakkai Zasshi 1971;75:251-254.

Sell E, Katzmann GW. Reaktive arthritis und immunvasculitis mit cardiovascularem Schock nach Dreifach-(Diphtherie-Pertussis-Tetanus) Schutzimpfund? Kinderarztliche Praxis 1990;58:547-549.

Senecal J, Roussey M. [Combined vaccination against measles, mumps and rubella] Vaccination associee contre la rougeole, les oreillons et la rubeole (R.O.R.). Bulletin de l'Academie Nationale de Medecine 1987;171:325-332.

Serdaru M, Lacomblez L, Danze F, Agid Y. [Meningo-myelitis with a favorable course after measles vaccination] Meningo-myelite d'evolution favorable apres vaccination antirubeolique. Revue Neurologique 1984;140:226-227.

Settergren B, Broholm KA, Norrby SR, Christenson B. Schick test as a predictor of immunity to diphtheria and of side effects after revaccination with diphtheria vaccine. British Medical Journal 1986;292:524-525.

Seyal M, Ziegler DK, Couch JR. Recurrent Guillain-Barre syndrome following influenza vaccine. Neurology 1978;28:725-726.

Shackelford PG, Granoff DM. IgG subclass composition of the antibody response of healthy adults, and normal or IgG2-deficient children to immunization with H. influenzae type b polysaccharide vaccine or Hib PS-protein conjugate vaccines. Monographs in Allergy 1988;23:269-281.

Shaikh N, Raut SK, Bedekar SS, Phadke MA, Banerjee K. Experience with a measles vaccine manufactured in India. Indian Pediatrics 1992;29:883-887.

Shapiro ED. New vaccines against Haemophilus influenzae type b. Pediatric Clinics of North America 1990;37:567-583.

Shapiro ED, Berg AT. Protective efficacy of Haemophilus influenzae type b polysaccharide vaccine. Pediatrics 1990;85(4 Pt 2):643-647.

Shapiro ED, Dobyns WB. Polio vaccine and GBS (letter). Neurology 1990;40:729.

Shapiro ED, Murphy TV, Wald ER, Brady CA. The protective efficacy of Haemophilus b polysaccharide vaccine. Journal of the American Medical Association 1988;260:1419-1422.

Shaw EB, Cesario TC. Vaccine-derived poliomyelitis. American Journal of Diseases of Children 1970;119:546.

Shaw FE Jr, Graham DJ, Guess HA, Milstien JB, Johnson JM, Schatz GC et al. Postmarketing surveillance for neurologic adverse events reported after hepatitis B vaccination: experience of the first three years. American Journal of Epidemiology 1988;127:337-352.

Shaw FE, Guess HA, Roets JM. The effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination. Vaccine 1989;7:425-430.

Sheffield FW, Ironside AG, Abbott JD. Immunization of adults against diphtheria. British Medical Journal 1978;2:249-250.

Shelley WB. Bacterial endotoxin (lipopolysaccharide) as a cause of erythema multiforme. Journal of the American Medical Association 1980;243:58-60.

Shimizu H, Baba K, Abe J et al. Vaccination to the handicapped children. Brain and Development 1981;13:329-336.

Shimojo H. Poliomyelitis control in Japan. Reviews of Infectious Diseases 1984;6(Suppl. 2):S427-S430.

Shoss RG, Rayhanzadeh S. Toxic epidermal necrolysis following measles vaccination. Archives of Dermatology 1974;110:766-770.

Shyamalan NC, Singh SS, Bisht DB. Transverse myelitis after vaccination. British Medical Journal 1964;1:434-435.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Siber GR, Santosham M, Reid GR, Thompson C, Almeido-Hill J, Morell A et al. Impaired antibody response to Haemophilus influenzae type b polysaccharide and low IgG2 and IgG4 concentrations in Apache children. New England Journal of Medicine 1990;323:1387-1392.

Sibley WA, Bamford CA, Clark K. Clinical viral infections and multiple sclerosis. Lancet 1985;1:1313-1315.

Sicot C. Urticaire apres hevac B. Concours Medical 1988;110:4083-4084.

Sigmund J, Guggenbichler JP. [Flaccid paralysis following oral poliomyelitis vaccination] Schlaffe Parese nach oraler Poliomyelitisimpfung. Padiatrie und Padologie 1985;20:77-82.

Silva CA, Sa MJ, Cruz C. Tetanus antibody production in serum and cerebrospinal fluid in the rabbit and correlated histopathological features of the central nervous system. Journal of Neurological Science 1977;33:213-227.

Simoes EA, Balraj V, Selvakumar R, John TJ. Antibody response of children to measles vaccine mixed with diphtheria-pertussis-tetanus or diphtheria-pertussis-tetanus-poliomyelitis vaccine. American Journal of Diseases of Children 1988;142:309-311.

Simoes EA F., Padmini B, Steinhoff MC, Jadhav M, John TJ. Antibody response of infants to two doses of inactivated poliovirus vaccine of enhanced potency. American Journal of Diseases of Children 1985;139:977-980.

Simonsen O, Klaerke M, Klaerke A, Block AB, Hansen BR, Hald N et al. Revaccination of adults against diphtheria. II. Combined diphtheria and tetanus revaccination with different doses of diphtheria toxoid 20 years after primary vaccination. Acta Pathologica, Microbiologica, et Immunologica Scandinavica 1986;94:219-225.

Simpson LL. Molecular pharmacology of botulinum toxin and tetanus toxin. Annual Review of Pharmacology and Toxicology 1986;26:427-453.

Sinaniotis CA, Daskalopoulou E, Lapatsanis P, Doxiadis S. Diabetes mellitus after mumps vaccination (letter). Archives of Disease in Childhood 1975;50:749-750.

Singhi SC, Kaur A, Khajuria R, Datta N, Kumar V. Side effects of measles vaccine—as perceived by mothers. Indian Pediatrics 1987;24:215-219.

Sinha SK, Carlson SD. Immune responses of mentally retarded subjects to measles, mumps and rubella vaccines. Wisconsin Medical Journal 1975;74:S75-S77.

Sinyak KM, Chumakov MP, Voroshilova MK, Livanova LV, Zlatkovskaya NM, Ralko LP et al. [Controlled observation of the incidence of disease and postvaccinal reactions in children during three weeks after vaccination with live measles vaccine developed by the USSR Academy of Medical Sciences from ESC strain] Kontrolirovanie nabliudeniia za chastotoi zabolevanii i postvaktsinalnykh reaktsii u detei v trekhnedelnyi period posle nachala privivok zhivoi korevoi vaktsinoi AMN SSSR iz shtamma EShCh. Voprosy Virusologii 1967;12:406-415.

Sipila R, Hortling L, Hovi T. Good seroresponse to enhanced-potency inactivated poliovirus vaccine in patients on chronic dialysis. Nephrology, Dialysis, Transplantation 1990;5:352-355.

Sisk CW, Lewis CE. Reactions to tetanus-diphtheria toxoid (adult). Archives of Environmental Health 1965;11:34-36.

Sisk M, Griffith JF. Normal electroencephalograms in subacute sclerosing panencephalitis (letter). Archives of Neurology 1975;32:575-576.

Sitzmann FC. [Vaccination against measles and poliomyelitis with attenuated living virus in children with brain damage: problematic vaccinations] Masern- und Poliolebend-Impfung bei vorgeschadigten Kindern: Problem-Impfungen. Monatsschrift fur Kinderheilkunde 1981;129:69-71.

Skovrankova J, Domorazkova E. [Neurological complications after immunization] Neurologicke komplikace po ockovani. Ceskoslovenska Pediatrie 1991;46:169-172.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Skovrankova J, Komarek V, Domorazkova E. [Neurologic complications after vaccination against diphtheria, tetanus and whooping cough] Neurologicke komplikace po ockovani proti zaskrtu, tetanu a davivemu kasli. Ceskoslovenska Pediatrie 1992;47:122-124.

Smith DH, Madore DV, Eby RJ, Anderson PW, Insel RA, Johnson CL. Haemophilus b oligosaccharide-CRM197 and other Haemophilus b conjugate vaccines: a status report. Advances in Experimental Medicine and Biology 1989;251:65-82.

Smith JW. Diphtheria and tetanus toxoids. British Medical Bulletin 1969;25:177-182.

Smith JS. Suspended judgment: remembering the role of Thomas Francis, Jr. in the design of the 1954 Salk vaccine test. Controlled Clinical Trials 1992;13:181-184.

Smith JW, Wherry PJ. Poliomyelitis surveillance in England and Wales, 1969-1975. Journal of Hygiene 1978;80:155-167.

Smith MH. Mumps virus vaccine. Pediatrics 1969;43:907-909.

Smith PW. CRS Issue Brief: Vaccine Injury Compensation. Washington, DC: Congressional Research Service, The Library of Congress; 1987.

Smith P. Tetanus prophylaxis. Journal of the Arkansas Medical Society 1966;63:226-230.

Smith RE, Wolnisty C. Allergic reactions to tetanus, diphtheria, influenza and poliomyelitis immunization. Annals of Allergy 1962;20:809-813.

Snider GB, Gogate SA. A possible systemic reaction to hepatitis B vaccine (letter). Journal of the American Medical Association 1985;253:1260-1261.

Snyder RD. Facial palsy following measles vaccination, a possible connection. Pediatrics 1968;42:215-216.

Soderstron K, Halapi E, Nilsson E. Synovial cells responding to a 65-kDa mycobacterial heat shock protein have a high proportion of TcR-gamma-delta subtype uncommon in peripheral blood. Scandinavian Journal of Immunology 1990;32:503-515.

Soffer D, Feldman S, Alter M. Epidemiology of Guillain-Barre syndrome. Neurology 1978;28:686-690.

Sokhey J. Adverse events following immunization: 1990. Indian Pediatrics 1991;28:593-607.

Solberg LK. [DPT vaccination, visit to child health center and sudden infant death syndrome (SIDS)] DPT-Vaksinasjon, helsestasjonsbesok og plutselig spedbarnsdod (SIDS): evaluering av DPT-vaksinasjon. Oslo: Oslo Helserad; 1985.

Solomon GF, Rubbo SD, Batchelder E. Secondary immune response to tetanus toxoid in psychiatric patients. Journal of Psychiatric Research 1970;7:201-207.

Solomonova K, Damiyanova K, Damiyanova M, Betovska M. Active immunization against tetanus of children suffering with diabetes mellitus. Zeitschrift fur Immunitatsforschung—Immunobiology 1976;151:383-390.

Sood SK, Daum RS. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation. Pediatrics 1990;85(4 Pt 2):698-704.

Sood SK, Schreiber JR, Siber GR, Daum RS. Postvaccination susceptibility to invasive Haemophilus influenzae type b disease in infant rats. Journal of Pediatrics 1988;113:814-819.

Soothill JF, Dudgeon JA. Immunization reactions and immunodeficiency. Birth Defects: Original Article Series 1983;19:339-341.

Sosin DM, Cochi SL, Gunn RA, Jennings CE, Preblud SR. Changing epidemiology of mumps and its impact on university campuses. Pediatrics 1989;84:779-784.

South African Medical Journal. Poliomyelitis vaccines (editorial). South African Medical Journal 1977;52:868.

Spiess H, Staak M. [Anaphylactic reaction following active tetanus immunization] Anaphylaktische Reaktionen nach aktiver Tetanus-Immunisierung. Deutsche Medizinische Wochenschrift 1973;98:682.

Spinola SM, Sheaffer CI, Philbrick KB, Gilligan PH. Antigenuria after Haemophilus influenzae type b polysaccharide immunization: a prospective study. Journal of Pediatrics 1986;109:835-838.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Squires S. Hepatitis B vaccinations: pediatricians begin immunizing infants to curb the spread of the disease. Washington Post, Health. May 5, 1992:9.

Srivastava RN, Bagga A. Hemolytic uremic syndrome: recent developments. Indian Pediatrics 1992;29:11-24.

Staak M, Wirth E. [Anaphylactic reactions following active tetanus immunization] Zur problematik anaphylaktischer Reaktionen nach aktiver Tetanus-Immunisierung. Deutsche Medizinische Wochenschrift 1973;98:110-111.

Starke G, Hlinak P, Nobel B, Winkler C, Kaesler G. [Measles control—a possibility? Results and experiences with measles vaccination from 1967 to 1969 in the German Democratic Republic]. Maserneradikation—eine Moglichkeit? Ergebnisse und Erfahrungen mit der Masernschutzimpfung 1967 bis 1969 in der DDR. Deutsche Gesundheitswesen 1970;25:2384-2390.

Starr S, Berkovich S. Effects of measles, gamma-globulin-modified measles and vaccine measles on the tuberculin test. New England Journal of Medicine 1964;270:386-391.

Steele RW, Suttle DE, LeMaster PC. Screening for cell-mediated immunity in children. American Journal of Diseases of Children 1976;130:1218-1221.

Steffen R, Woodall JP, Nagel J, Desaules M. Evaluation of immunization policies for peacekeeping missions. International Journal of Technology Assessment in Health Care 1991;7:354-360.

Stehlikova J, Bergmannova V, Domorazkova E. [Immunization against diphtheria and tetanus in children with serious neurological disease] Ockovani proti zaskrtu a tetanu u deti se zavaznym neurologickym onemocnenim . Ceskoslovenska Pediatrie 1992;47:417-420.

Stehr-Green PA, Cochi SL. Diseases controlled primarily by vaccination: mumps. In: Last JM. Wallace RB, eds. Maxcy-Rosenau-Last Public Health and Preventive Medicine, 13th ed. Norwalk, CT: Appleton & Lange; 1992.

Steigman A. Allergic reactions to tetanus toxoid. Journal of Pediatrics 1968;73:648-649.

Steigman AJ. Abuse of tetanus toxoid. Journal of Pediatrics 1968;72:753-754.

Steinhoff MC, Auerbach BS, Nelson KE, Vlahov D, Becker RL, Graham NMH et al. Antibody responses to haemophilus influenzae type b vaccines in men with human immunodeficiency virus infection. New England Journal of Medicine 1991;325:1837-1842.

Steinman L. Neurologic complications of routine immunization. Western Journal of Medicine 1982;137:315-316.

Stephenne J. Development and production aspects of a recombinant yeast derived hepatitis vaccine. Vaccine 1990;8(Suppl.):S69-S73.

Stetler HC, Gens RD, Seastrom GR. Severe local reactions to live measles virus vaccine following an immunization program. American Journal of Public Health 1983;73:899-900.

Stevens CE. No increased incidence of AIDS in recipients of hepatitis B vaccine. New England Journal of Medicine 1983;308:1163-1164.

Stickl H. [Iatrogenic immunosuppression through vaccination] Iatrogene Immunosuppression durch Schutzimpfungen. Fortschritte der Medezin 1981;99:289-292.

Stiehm ER. Skin testing prior to measles vaccination for egg-sensitive patients (editorial). American Journal of Diseases of Children 1990;144:32.

Stoeckel P, Schlumberger M, Parent G, Maire B, van Wezel A, van Steenis G et al. Use of killed poliovirus vaccine in a routine immunization program in West Africa. Reviews of Infectious Diseases 1984;6(Suppl. 2):S463-S466.

Stoehr M. [Para infectious cerebral nerve mononeuritis and mononeuritis multiplex: a selectively located type of para infectious, postvaccination, serogenetic neuritis] Parainfektiose hirnnerven mononeuritis und -mononeuritis multiplexa: ein besonderer lokalisationstyp parainfektioser, postvaccinaler und serogenetischer neuritiden. Nervenarzt 1977;48:359-364.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Stokes JJ. Use of mumps vaccine. New England Journal of Medicine 1968;278:682.

Stokes JJ, Maris EP, Gelles SS. Chemical, clinical, and immunologic studies on the products of human plasma fractionation: XI. The use of concentrated normal human serum gamma globulin (human immune serum globulin) in the prevention and attenuation of measles. Journal of Clinical Investigations 1944;23:531-540.

Stokes JJ, Weibel RE, Villarejos VM, Arguedas JA, Buynak EB, Hilleman MR. Trivalent combined measles-mumps-rubella vaccine: findings in clinical-laboratory studies. Journal of the American Medical Association 1971;218:57-61.

Stolley PD. How to interpret studies of adverse drug reactions. Clinical Pharmacology and Therapeutics 1990;48:337-339.

Stolley PD, Joseph JM, Allen JC, Deane G, Janney JH. Poliomyelitis associated with type-2 poliovirus vaccine strain: possible transmission from an immunised child to a nonimmunised child. Lancet 1968;1:661-663.

Stopfkuchen H, Juengst BK, Wilutzky H. [Purpura fulminans associated with varicella and polyvalent protective inoculations] Purpura fulminans nach varizellen und polyvalenter impfung. Klinische Paediatrie 1976;188:190-193.

Storsaeter J, Olin P, Renemar B, Lagergard T, Norberg R, Romanus V et al. Mortality and morbidity from invasive bacterial infections during a clinical trial in acellular pertussis vaccines in Sweden . Pediatric Infectious Disease Journal 1988;7:637-645.

Strebel PM, Sutter RW, Cochi SL, Biellik RJ, Brink EW, Kew OM et al. Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Clinical Infectious Diseases 1992;14:568-579.

Struve J, Aronsson B, Frenning B, Granath F, von Sydow M, Weiland O. Intramuscular versus intradermal administration of a recombinant hepatitis B vaccine: a comparison of response rates and analysis of factors influencing the antibody response. Scandinavian Journal of Infectious Diseases 1992;24:423-429.

Sugg WC, Finger JA, Levine RH, Pagano JS. Field evaluation of live virus mumps vaccine. Journal of Pediatrics 1968;72:461-466.

Sugiura A, Yamada A. Aseptic meningitis as a complication of mumps vaccination. Pediatric Infectious Disease Journal 1991;10:209-213.

Sullivan KM, Halpin TJ, Marks JS, Kim-Farley R. Effectiveness of mumps vaccine in a school outbreak. American Journal of Diseases of Children 1985;139:909-912.

Sultz HA, Hart BA, Zielezny M, Schlesinger ER. Is mumps virus an etiologic factor in juvenile diabetes mellitus? Journal of Pediatrics 1975;86:654-656.

Sultz HA, Schlesinger ER, Mosher WE, Feldman JG. Long-term childhood illness. Pittsburgh: University of Pittsburgh Press; 1972.

Sun T-T, Chu Y-R, Ni Z-Q et al. A pilot study on universal immunization of newborn infants in an area of hepatitis B virus and primary hepatocellular carcinoma prevalence with a low dose of hepatitis B vaccine. Journal of Cellular Physiology 1986;129(Suppl. 4):83-90.

Sundar PS. Allergy to diphtheria and tetanus toxoid (a case report). Antiseptic 1978;75:458-459.

Sunderland S. Nerves and Nerve Injuries. Baltimore: The Williams and Wilkins Company; 1968.

Susser M. Causal Thinking in the Health Sciences. New York: Oxford; 1973.

Sussman GL, Dolovich J. Prevention of anaphylaxis. Seminars in Dermatology 1989;8:158-165.

Sutter RW, Patriarca PA, Suleiman AJ, Brogan S, Malankar PG, Cochi SL et al. Attributable risk of DTP (diphtheria and tetanus toxoids and pertussis vaccine) injection in provoking paralytic poliomyelitis during a large outbreak in Oman. Journal of Infectious Diseases 1992;165:444-449.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Sutton GC. Mumps, measles and rubella vaccination: a pragmatic study. Public Health 1991;105:133-138.

Swaak AJ. [Local reactions following booster injections with DWTP-vaccine (diphtheria-whooping cough-tetanus-poliovirus vaccine) in children born in 1960 and 1961] Lokale klachten bijkinderen van de jaarklassen 1960 en 1961 na een herbalingsinjectie met DKTP-entstof. Nederlands Tijdschrift voor Geneeskunde 1966;110:332-334.

Swaak AJ. [A study of children born in 1962 on the relation between local complaints and the type of vaccine used in the immunization for whooping cough, diphtheria, tetanus and poliomyelitis] Een onderzoek bij kinderen van de jaarklasse 1962 naar het verband tussen de lokale klachten en de aard van de entstof bij de immunisatie tegen kinkhoest, difterie, tetanus en poliomyelitis. Nederlands Tijdschrift voor Geneeskunde 1966;110:1696-1699.

Swanson PD, McAlister R, Peterson DR. Poliomyelitis associated with type 2 virus: paralytic disease in the father of a recently immunized child. Journal of the American Medical Association 1967;201:771-773.

Swartz TA, Klingberg W, Klingberg MA. Combined trivalent and bivalent measles, mumps and rubella virus vaccination: a controlled trial. Infection 1974;2:115-117.

Syrogiannopoulos GA, Hansen EJ, Erwin AL et al. Haemophilus influenzae type b lipooligosaccharide induced meningeal inflammation. Journal of Infectious Diseases 1988;157:237-244.

Szillat K, Meyke M, Kopsel G. [Sequelae following triple vaccination (epidemic parotitis, measles, rubella)?] Enzephalitis, Meningitis serosa und Parotitis nach MMR-Schutzimpfung? Kinderarztliche Praxis 1992;60:203.

Szmuness W, Stevens CE, Harley EJ, Zang EA, Oleszko WR, William DC et al. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. New England Journal of Medicine 1980;303:833-841.

Szmuness W, Stevens CE, Harley EJ, Zang EA, Alter HJ, Taylor PE et al. Hepatitis B vaccine in medical staff of hemodialysis units: efficacy and subtype cross-protection. New England Journal of Medicine 1982;307:1481-1486.

Tabor E. Guillain-Barre syndrome and other neurologic syndromes in hepatitis A, B, and Non-A, Non-B. Journal of Medical Virology 1987;21:207-216.

Takala AK, Eskola J, Leinonen M, Kayhty H, Nissinen A, Pekkanen E. Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. Journal of Infectious Diseases 1991 ;164:982-986.

Takasu T, Kondo K, Ahmed A, Yoshikawa Y, Yamanouchi K, Tsuchiya M et al. Elevated ratio of late measles among subacute sclerosing panencephalitis patients in Karachi, Pakistan. Neuroepidemiology 1992;11:282-287.

Takayama N, Kidokoro M, Suzuki K, Morita M. [Immunization of healthy children with measles-mumps-rubella trivalent vaccine simultaneously given with varicella vaccine]. Kansenshogaku Zasshi [Journal of the Japanese Association for Infectious Diseases] 1992;66:776-780.

Takeuchi K, Tanabayashi K, Hishiyama M, Yamada A, Sugiura A. Variations of nucleotide sequences and transcription of the SH gene arnong mumps virus strains. Virology 1991;181:364-366.

Tan KL, Oon CJ, Goh KT, Wong LY, Chan SH. Immunogenicity and safety of low doses of recombinant yeast-derived hepatitis B vaccine. Acta Paediatrica Scandinavica 1990;79:593-598.

Tanabayashi K, Takeuchi K, Hishiyama M, Yamada A, Tsurudome M, Ito Y et al. Nucleotide sequence of the leader and nucleocapsid protein gene of mumps virus and epitope mapping with the in vitro expressed nucleocapsid protein . Virology 1990;177:124-130.

Taranger J. Wiholm BE. [The low number of reported adverse effects after vaccination against measles, mumps, rubella] Litet antal biverkningar rapporterade efter vaccination mot massling-passjuka-roda hund. Lakartidningen 1987;84:948-950.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Tarlov IM. Paralysis caused by penicillin injection; mechanism complication—a warning. Journal of Neuropathology and Experimental Neurology 1951;10:158-176.

Taylor EM, Emery JL. Immunization and cot deaths (letter). Lancet 1982;2:721.

Telzak E, Wolff SM, Dinarello CA et al. Clinical evaluation of the immunoadjuvant murabutide, a derivative of MDP, administered with a tetanus toxoid vaccine. Journal of Infectious Diseases 1986;153:628-633.

Terpstra GK, Raaijmakers JA, Kreukniet J. Comparison of vaccination of mice and rats with Haemophilus influenzae and Bordetella pertussis as models of atopy. Clinical and Experimental Pharmacology and Physiology 1979;6:139-149.

Terpstra GK, Raaijmakers JA, Hamelink M, Kreukniet J. Effects of Haemophilus influenzae vaccination on the (para-)sympathic-cyclic nucleotide-histamine axis in rats. Annals of Allergy 1979;42:36-40.

Thacker SB. Meta-analysis: a quantitative approach to research integration. Journal of the American Medical Association 1988;259:1685-1689.

Themann J. Hepatitis B aktuell: erst lust—dann frust. Therapiewoche 1991;41:2154.

Thesen R. [Haemophilus influenzae type b vaccines] Hib-vakzine. Pharmazeutische Zeitung 1990;135:30, 32, 34, 36.

Thier SO. Importance of the single case. New England Journal of Medicine 1968;278:1347.

Thomas GA, O'Brien RT. Thrombocytosis in children with Haemophilus influenzae meningitis. Clinical Pediatrics 1986;25:610-611.

Thomas P. Immunization of children infected with HIV: a public health perspective. Pediatric Annals 1988;17:347-351.

Thomison JB. The price of safety (editorial). Southern Medical Journal 1990;83:494-496.

Thompson WL. Adverse drug reactions: finding sharp safety signals in a noisy haystack. Food Drug Cosmetic Law Journal 1991;46:487-502.

Thormar H, Mehta PD, Barshatzky MR, Brown HR. Measles virus encephalitis in ferrets as a model for subacute sclerosing panencephalitis . Laboratory Animal Science 1985;35:229-232.

Thraenhart O, Kuwert E. [Intratypic differentiation of poliovirus strains with special regard to complication after oral vaccination in West-Germany]. Intratypische charakterisierung von poliovirussammen unter besonderer Berucksichtigung der impfreaktion nach schluckimpfung. Sentralblatt fur Bakteriologic, Parasitunkunde, Infektionskrankheiten und Hygiene 1972;221:143-156.

Thurston A. Anaphylactic shock reaction to measles vaccine (letter). Journal of the Royal College of General Practice 1987;37:41.

Tidjani PO, Grunitzky B, Guerin N, Levy-Bruhl D, Lecam N, Xuereff C et al. [Comparative serological efficacy of anti-measles vaccine strains Edmonston-Zagreb, Schwarz and AIKC in Togolese infants of 4-5 months and 8-10 months]. Efficacité sérologique comparative des souches de vaccin antirougeoleux Edmonston-Zagreb, Schwarz et AIK-C chez des enfants togolois de 4-5 moise et 8-10 mois. Bulletin de la Societe de Pathologie Exotique 1991;84(5 Pt 5):873-884.

Tishon A, Oldstone MB. Persistent virus infection associated with chemical manifestations of diabetes. American Journal of pathology 1987;126:61-72.

Todd JK, Bruhn FW. Severe Haemophilus influenzae infections: spectrum of disease. American Journal of Diseases in Children 1975;129:607-611.

Toffler WL, Olenick JS, Wolf NE, Retzlaff ZH, Swanson JR, Kenny TA. The immunogenicity and safety of intradermal hepatitis B vaccine. Journal of Family Practice 1991;33:149-154.

Topaloglu H, Berker M, Kansu T, Saatci U, Renda Y. Optic neuritis and myelitis after booster tetanus toxoid vaccination (letter). Lancet 1992;339:178-179.

Topley WW. The role of active or passive immunization in the control of enteric infection. Lancet 1938;1:181-186.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Toraldo R, Tolone C, Catalanotti P, Ianniello R, D'Avanzo M, Canino G et al. Effect of measles-mumps-rubella vaccination on polymorphonuclear neutrophil functions in children. Acta Paediatrica 1992;81:887-890.

Toreki W. Risk management: National Childhood Vaccine Injury Act of 1986. Trends in Health Care, Law and Ethics 1992;7:41-44.

Torinuki W. Mucha-Habermann disease in a child: possible association with measles vaccination. Journal of Dermatology 1992;19:253-255.

Tosti A, Melino M, Bardazzi F. Systemic reactions due to thiomersal. Contact Dermatitis 1986;15:187-188.

Trinca JC. Active immunization against tetanus: the need for a single all-purpose toxoid. Medical Journal of Australia 1965;2:116-120.

Trinca JC. Combined diphtheria-tetanus immunization of adults. Medical Journal of Australia 1975;2:543-546.

Trinca JC. Over-immunization: an ever present problem. Australian Family Physician 1976;5:734-755.

Trollfors B, Lagergard T, Claesson BA, Thornberg E, Martinell J, Schneerson R. Characterization of the serum antibody response to the capsular polysaccharide Haemophilus influenzae type b in children with invasive infections. Journal of Infectious Diseases 1992;166:1335-1339.

Trump RC, White TR. Cerebellar ataxia presumed due to live, attenuated measles virus vaccine. Journal of the American Medical Association 1967;199:129-130.

Tsairis P, Dyck PJ, Mulder DW. Natural history of brachial plexus neuropathy: report on 99 patients. Archives of Neurology 1972;27:109-117.

Tsukada N, Koh C-S, Owa M, Yanagisawa N. Chronic neuropathy associated with immune complexes of hepatitis B virus. Journal of the Neurological Sciences 1983;61:193-211.

Tsukada N, Koh C-S, Inoue A, Yanagisawa N. Demyelinating neuropathy associated with hepatitis B infection: detection of immune complexes composed of hepatitis B virus surface antigen. Journal of the Neurological Sciences 1987;77:203-216.

Tubert P, Begaud B, Pere JC, Haramburu F, Lellouch J. Power and weakness of spontaneous reporting: a probabilistic approach. Journal of Clinical Epidemiology 1992;45:283-286.

Tudela P, Marti S, Bonal J. Systemic lupus erythematosus and vaccination against hepatitis B (letter). Nephron 1992;62:236.

Tudor-Williams G, Frankland J, Isaacs D, Mayon-White RT, MacFarlane JA, Rees DG et al. Haemophilus influenzae type b conjugate vaccine trial in Oxford: implications for the United Kingdom. Archives of Disease in Childhood 1989;64:520-524.

Tuft L et al. Allergic reactions following immunization procedures. Archives of Environmental Health 1966;13:91-95.

Tuohy PG. Guillain-Barre syndrome following immunization with synthetic hepatitis B vaccine (letter). New Zealand Medical Journal 1989;102:114-115.

Turner PC, Forsey T, Minor PD. Comparison of the nucleotide sequence of the SH gene and flanking regions of mumps vaccine virus (Urabe strain) grown on different substrates and isolated from vaccinees. Journal of General Virology 1991;72(Pt 2):435-437.

Tyufanov AV, Stefanov SB. [Seasonal differences in the pathomorphological reactions of monkeys to poliomyelitis vaccine] Sezonnye razlichiia patomorfologicheskikh reaktsii obez'ian na vaktsinu protiv poliomielita. Voprosy Virusologii 1983;2:238-240.

U.S. Department of Health, Education, and Welfare. Smoking and Health: Report of the Advisory Committee to the Surgeon General. PHS Publ. No. 1003. Washington, DC: U.S. Public Health Service, U.S. Department of Health, Education, and Welfare; 1964.

U.S. Department of Health and Human Services, U.S. Public Health Service. National Vaccine Injury Compensation Program; Revision of the Vaccine Injury Table; Proposed Rule. Federal Register, 42 CFR Part 100, August 14. 1992;57(158):36877-36885.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

U.S. Public Health Service. Interim document gives advice on use of Salk and Sabin vaccines. Journal of the American Medical Association 1962; 180:23-26.

Uchida T. Diphtheria toxin. In: Dorner F, Drews J, eds. Pharmacology of Bacterial Toxins IEPT Section 199. Oxford: Pergamon Press; 1986.

Uhari M, Rantala H, Niemela M. Cluster of childhood Guillain-Barre cases after an oral poliovaccine campaign (letter). Lancet 1989:2:440-441.

Ullberg-Olsson K. [Vaccination reactions after injection of tetanus toxoid with and without diphtheria toxoid] Vaccinationsreaktioner efter injektion av tetanus toxoid med och utan tillsats av difteritoxoid. Lakartidningen 1979;76:2976.

Vaandrager GJ, Molenaar JL, Bruining GJ, Plantinga AD, Ruitenberg EJ. Islet cell antibodies, mumps infection and mumps vaccination (letter). Diabetologia 1986;29:406-407.

Vadheim CM. Reduction of Hib disease in Southern California, 1983-1991. Program Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. Abstract 1726, p. 398. Washington, DC: American Society for Microbiology; 1992.

Vadheim CM, Greenberg DP, Marcy SM, Froeschle J, Ward JI. Safety evaluation of PRP-D Haemophilus influenzae type b conjugate vaccine in children immunized at 18 months of age and older: follow-up study of 30,000 children. Pediatric Infectious Disease Journal 1990;9:555-561.

Vallancourt RJ. Current poliovirus vaccines. Reviews of Infectious Diseases 1984;6(Suppl. 2):S328-S330.

Valman HB. Convulsions in the older infant. British Medical Journal 1989:299:1331-1333.

Valmari P, Lanning M, Tuokko H, Kouvalainen K. Measles virus in the cerebrospinal fluid in postvaccination immunosuppressive measles encephalopathy. Pediatric Infectious Disease Journal 1987;6:59-63.

van Alphen L, Bijlmer HA. Molecular epidemiology of Haemophilus influenzae type b. Pediatrics 1990;85(4 Pt 2):636-642.

Van Asperen PP, McEniery J, Kemp AS. Immediate reactions following live attenuated measles vaccine. Medical Journal of Australia 1981;2:330-331.

van Bogaert L. Une leucoencephalite sclerosante subaigue. Journal de Neurologie et de Psychiatrie 1945;8:101-120.

Van de Voorde A. Eye of the needle. Westword 1992;15:10-12, 15-16.

van der Meché FG, Schmitz PI, Dutch Guillain-Barre Study Group. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barre syndrome. New England Journal of Medicine 1992;326:1123-1129.

van Heyningen S. Tetanus toxin. In: Dorner F, Drews J, eds. Pharmacology of Bacterial Toxins IEPT Section 199. Oxford: Pergamon Press; 1986.

van Ramshorst JD, Cohen H, Levine L, Edsall G. The relation between animal potency tests and the human response to adsorbed tetanus toxoids. Journal of Biological Standardization 1973;1:215-220.

Varughese PV, Carter AO, Acres SE, Furesz J. Eradication of indigenous poliomyelitis in Canada: impact of immunization strategies. Canadian Journal of Public Health 1989;80:363-368.

Vassilev TL. Aluminium phosphate but not calcium phosphate stimulates the specific IgE response in guinea pigs to tetanus toxoid. Allergy 1978;33:155-159.

Vella PP, Staub JM, Armstrong J, Dolan KT, Rusk CM, Szymanski S et al. Immunogenicity of a new Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB). Pediatrics 1990;85(4 Pt 2):668-675.

Vellayappan K, Lee CY. Tetanus toxoid hypersensitivity. Journal of the Singapore Paediatric Society 1976;18:17-19.

Venulet J. Assessing Causes of Adverse Drug Reactions with Special Reference to Standardized Methods. London: Academic Press: 1982.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Verduzco Guerrero E, Calderon C, Velazquez Franco E. [Repercussions of vaccination against measles] Repercusiones de la vacunacion contra el sarampion. Salud Publica de Mexico 1974;16:707-720.

Vesikari T, Ala-Laurila EL, Heikkinen A, Kuusinen H, Terho A. [Efficacy and side effects of live attenuated single mumps and measles vaccines, and bivalent mumps-measles vaccine in young infants] Elava sikotautirokote yksin ja tuhkarokko-rokotteeseen yhdistettyna pienilla lapsilla. Duodecim 1982;98:839-847.

Vesikari T, Ala-Laurila EL, Heikkinen A, Terho A, D'Hondt E, Andre FE. Clinical trial of a new trivalent measles-mumps-rubella vaccine in young children. American Journal of Diseases of Children 1984;138:843-847.

Vesikari T, Andre FE, Simoen E, Florent G, Ala-Laurila EL, Heikkinen A et al. Evaluation in young children of the Urabe Am 9 strain of live attenuated mumps vaccine in comparison with the Jeryl Lynn strain. Acta Paediatrica Scandinavica 1983;72:37-40.

Vesikari T, Andre FE, Simoen E, Florent G, Ala-Laurila EL, Heikkinen A et al. Comparison of the Urabe Am 9-Schwarz and Jeryl Lynn-Moraten combinations of mumps-measles vaccines in young children. Acta Paediatrica Scandinavica 1983;72:41-46.

Vessal S, Kravis LP. Immunologic mechanisms responsible for adverse reactions to routine immunizations in children . Clinical Pediatrics 1976;15:688-696.

Vijay HM, Huang H, Young NM, Bernstein IL et al. Studies on alternaria allergens. I. Isolation of allergens from alternaria tenuis and alternaria solani. International Archives of Allergy and Applied Immunology 1979;60:229-239.

Vijay HM, Lavergne G, Huang H, Bernstein IL et al. Preferential synthesis of IgE reaginic antibodies in rats immunized with alum-adsorbed antigens. International Archives of Allergy and Applied Immunology 1979;59:227-232.

Villaca LM, de Macedo DD. [Subacute sclerosing panencephalitis with partial remission] Panencefalite esclerosante subaguda com remissao parcial. Arquivos de Neuropsiquiatria 1979;37:435-442.

Vivell O. [Oral vaccination against poliomyelitis] Poliomyelitis-Schluckimpfung. Deutsche Medizinische Wochenschrift 1973;98:1049.

Vogel C. [Complication by contact after vaccination against poliomyelitis]. Zum Thema Impfkomplikation (am beispiel einer impf-kontakt-poliomyelitis). Kinderarztliche Praxis 1980:48:296-299.

Volk VK. Safety and effectiveness of multiple antigen preparations in a group of free-living children. American Journal of Public Health 1949;39:1299-1313.

Volk VK, Gottshall RY, Anderson HD et al. Antibody response to booster dose of diphtheria and tetanus toxoids: reactions in institutionalized adults and noninstitutionalized children and young adults . Public Health Reports 1963;78:161-164.

Volk VK, Gottshall RY, Anderson HD, Top FH, Bunney WE, Serfling RE. Antigenic response to booster dose of diphtheria and tetanus toxoids: seven to thirteen years after primary inoculation of noninstitutionalized children. Public Health Reports 1962;77:185-194.

von Muhlendahl KE. [Side effects and complications of measles-mumps vaccination] Nebenwirkungen und Komplikationen der Masern-Mumps-Impfung. Monatsschrift fur Kinderheilkunde 1989;137:440-446.

von Muhlendahl KE. Side-effects of measles-mumps vaccination (letter). Lancet 1990;335:540-541.

von Muhlendahl KE, Eguiluz GC, Trallero EP, Thalayasingam B. Mumps meningitis following measles, mumps, and rubella immunization. Lancet 1989;2:394-395.

von Reyn CF, Clements CJ. Mann JM. Human immunodeficiency virus infection and routine childhood immunization. Lancet 1987;2:669-672.

Von Seefried A, Chun JH, Grant JA, Letvenuk L, Pearson EW. Inactivated poliovirus vaccine and test development at Connaught Laboratories LTD. Reviews of Infectious Diseases 1984;6(Suppl. 2):S345-S349.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

von Wirth G. Reversible kochlearisschadigung nach Tetanol-Injektion? Munchener Medizinische Wochenschrift 1965;107:379-381.

Voss L, Lennon D, Gillies M. Haemophilus influenzae type b disease in Auckland children 1981-87. New Zealand Medical Journal 1989;102:149-151.

Wahl M, Hermodsson S. Intradermal, subcutaneous or intramuscular administration of hepatitis B vaccine: side effects and antibody response. Scandinavian Journal of Infectious Diseases 1987;19:617-621.

Waight PA, Pollock TM, Miller E, Coleman EM. Pyrexia after diphtheria/tetanus/pertussis and diphtheria/tetanus vaccines. Archives of Disease in Childhood 1983;58:921-923.

Waisbren BA. A commentary regarding personal observations of demyelinizing disease caused by viral vaccines, borrelia infections, and proteolytic enzymes. Submitted to the Institute of Medicine Committee on Vaccine Safety, August 11, 1992.

Wakeel RA, White MI. Erythema multiforme associated with hepatitis B vaccine (letter). British Journal of Dermatology 1992;126:94-95.

Waksman BH, Adams RD. Allergic neuritis: an experimental disease of rabbits induced by the injection of peripheral nervous tissue and adjuvants. Journal of Experimental Medicine 1955;102:213-235.

Walker AM, Jick H, Perera DR, Thompson RJ, Knauss TA. Diphtheria-tetanus-pertussis immunization and sudden infant death syndrome. American Journal of Public Health 1987;77:945-951.

Walker AM, Martin-Moreno JM, Artalejo FR. Odd man out: a graphical approach to metaanalysis. American Journal of Public Health 1988;78:961-966.

Walter EB, Moggio MV, Drucker RP, Wilfert CM. Immunogenicity of Haemophilus b conjugate vaccine (meningococcal protein conjugate) in children with prior invasive Haemophilus influenzae type b disease. Pediatric Infectious Disease Journal 1990;9:632-635.

Walter Z, Walter T. [Six cases of poliomyelitis associated with oral immunization] Szesc przypadkow zachorowan na polio w powiazaniu ze szczepieniami doustnymi przeciw polio. Wiadomosci Lekarskie 1973;26:901-905.

Wands JR, Mann E, Alpert E. The pathogenesis of arthritis associated with acute hepatitis B surface antigen-positive hepatitis: complement activation and characterization of circulating immune complexes. Journal of Clinical Investigation 1975;55:930-939.

Ward BJ, Johnson RT, Vaisberg A, Jauregui E, Griffin DE. Cytokine production in vitro and the lymphoproliferative defect of natural measles infection. Clinical Immunology and Immunopathology 1991;61:236-248.

Ward JI. Commentary: results of efficacy trials in Alaska and Finland of Haemophilus influenzae type b conjugate vaccine. Pediatrics 1990;85(4 Pt 2):667.

Ward JI, Broome CV, Harrison LH, Shinefield H, Black S. Haemophilus influenzae type b vaccines: lessons for the future. Pediatrics 1988;81:886-893.

Ward JI, Cochi S. Haemophilus influenzae vaccines. In: Plotkin SA, Mortimer EA, eds. Vaccines. Philadelphia: W.B. Saunders; 1988.

Wassilak SG. Adverse events following IPV. Prepared for Meeting of Immunization Practices Advisory Committee. October 24-25, 1985.

Wassilak SG, Brink EW. Diseases controlled primarily by vaccination: tetanus. In: Last JM, Wallace RB, eds. Maxcy-Rosenau-Last Public Health and Preventive Medicine, 13th ed. Norwalk, CT: Appleton & Lange; 1992.

Wassilak SG, Orenstein WA, Tetanus. In: Plotkin SA, Mortimer EA. eds. Vaccines. Philadelphia: W.B. Saunders Co.; 1988.

Wassilak SG, Brink EW, Orenstein WA et al. Neurologic complications of oral poliomyelitis vaccine. Journal of Pediatrics 1987;110:996-998.

Watemberg N, Dagan R, Arbelli Y, Belmaker I, Morag A, Hessel L et al. Safety and immunogenicity of Haemophilus type b-tetanus protein conjugate vaccine, mixed in the same

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

syringe with diphtheria-tetanus-pertussis vaccine in young infants. Pediatric Infectious Disease Journal 1991;10:758-763.

Watson GI. The roseolar reaction (letter). British Medical Journal 1974;4:719-720.

Watson JG. A child of 3 years who developed an encephalitic reaction to MMR (mumps, measles, rubella) immunization at age 15 months (letter). International Journal of Pediatric Otorhinolaryngology 1990;19:189-190.

Weber G, Falk U. Vaccinations in the presence of skin diseases. International Journal of Dermatology 1975;14:136-140.

Weckx LY, Schmidt BJ, Herrmann AA, Miyasaki CH, Novo NF. Early immunization of neonates with trivalent oral poliovirus vaccine. Bulletin of the World Health Organization 1992;70:85-91.

Weekly Epidemiological Record. Expanded Programme on Immunization: reactions to tetanus toxoids. Weekly Epidemiological Record 1982;57:193-194.

Weekly Epidemiological Record. Poliomyelitis: evaluation of poliovirus-related cases. Weekly Epidemiological Record 1990;65:159-162.

Weekly Epidemiological Record. Expanded Programme on Immunization: serological and virological assessment of oral and inactivated poliovirus vaccines in a rural population. Weekly Epidemiological Record 1992;6:179-182.

Weekly Epidemiological Record. Expanded Programme on Immunization (EPI): safety of high titre measles vaccines. Weekly Epidemiological Record 1992;67:357-361.

Wehrle PF. Injury associated with the use of vaccines. Clinical Therapeutics 1985:7:282-284.

Weibel RE. Mumps vaccine. In: Plotkin SA, Mortimer EA, eds. Vaccines. Philadelphia: W.B. Saunders Co.; 1988.

Weibel RE, Stokes J, Buynak EB, Whitman JE, Hilleman MR. Live, attenuated mumps-virus vaccine. 3. Clinical and serologic aspects in a field evaluation. New England Journal of Medicine 1967;276:245-251.

Weibel RE, Villarejos VM, Hernandez G, Stokes JJ, Buynak EB, Hilleman MR. Combined live measles-mumps virus vaccine. Archives of Disease in Childhood 1973;48:532-536.

Weidmeier SE, Chung HT, Cho BH, Kim UH, Daynes RA. Murine responses to immunization with pertussis toxin and bovine albumin. I. Mortality observed after bovine albumin challenge is due to an anaphylactic reaction. Pediatric Research 1987;22:262-267.

Weinberg GA, Granoff DM. Polysaccharide-protein conjugate vaccines for the prevention of Haemophilus influenzae type b disease. Journal of Pediatrics 1988;113:621-631.

Weinberg GA, Granoff DM. Immunogenicity of Haemophilus influenzae type polysaccharideprotein conjugate vaccines in children with conditions associated with impaired antibody responses to type b polysaccharide vaccine. Pediatrics 1990;85(4 Pt 2):654-661.

Weinberg GA, Einhorn MS, Lenoir AA, Granoff PD, Granoff DM et al. Immunologic priming to capsular polysaccharide in infants immunized with Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine. Journal of Pediatrics 1987;111:22-27.

Weisman SJ, Cates KL, Allegretta GJ, Quinn JJ, Altman AJ. Antibody response to immunization with Haemophilus influenzae type b polysaccharide vaccine in children with cancer. Journal of Pediatrics 1987;111:727-729.

Weiss R. Change the U.S. polio vaccine or leave it alone? ASM News (American Society for Microbiology) 1988;54:560-562.

Weisse AB. Polio: the not-so-twentieth-century disease. Hospital Practice 1992;27:97-100, 104, 113-115, 119-120.

Wells EC. Neurological note on vaccination against influenza. British Medical Journal 1971:3:755-756.

Wenger JD, Fraser DW, Broome CV. Diseases controlled primarily by vaccination: Haemophilus

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

influenzae infections. In: Last JM, Wallace RB, eds. Maxcy-Rosenau-Last Public Health and Preventive Medicine, 13th ed. Norwalk, CT: Appleton & Lange; 1992.

Wentz KR, Marcuse EK. Diphtheria-tetanus-pertussis vaccine and serious neurologic illness: an updated review of the epidemiologic evidence. Pediatrics 1991;87:287-297.

Werne J, Garrow I. Fatal anaphylactic shock occurrence in identical twins following second injection of diphtheria toxoid and pertussis antigen. Journal of the American Medical Association 1946;131:730-735.

Werner CA. Mumps orchitis and testicular atrophy: I. Occurrence. Annals of Internal Medicine 1950;32:1066-1074.

Werner CA. Mumps orchitis and testicular atrophy. II. A factor in male sterility. Annals of Internal Medicine 1950;32:1075-1086.

West DH, Calandra GB, Ellis RW. Vaccination of infants and children against hepatitis B. Pediatric Clinics of North America 1990;37:585-601.

Westall FC, Root-Bernstein R. Cause and prevention of postinfectious and postvaccinal neuropathies in light of a new theory of autoimmunity. Lancet 1986;2:251-252.

Wharton M, Cochi SL, Hutcheson RH, Bistowish JM, Schaffner W. A large outbreak of mumps in a postvaccine era. Journal of Infectious Diseases 1988;158:1253-1260.

White CC, Koplan JP, Orenstein WA. Benefits, risks and costs of immunization for measles, mumps and rubella. American Journal of Public Health 1985;75:739-744.

White F. Measles vaccine associated encephalitis in Canada (letter). Lancet 1983;2:683-684.

White WG. Reactions after plain and adsorbed tetanus vaccines (letter). Lancet 1980;1:42.

White WG, Barnes GM, Barker E, Gall D, Knight P, Griffith AH et al. Reactions to tetanus toxoid. Journal of Hygiene 1973;71:283-297.

Whittingham HE. Anaphylaxis following administration of tetanus toxoid. British Medical Journal 1940;1:292-293.

Whittle E, Roberton NR. Transverse myelitis after diphtheria, tetanus, and polio immunization. British Medical Journal 1977;1:1450.

Whittle H, Hanlon P, O'Neill K, Hanlon L, Marsh V, Jupp E et al. Trial of high-dose Edmonston-Zagreb measles vaccine in the Gambia: antibody response and side-effects. Lancet 1988;2:811-814.

WHO Consultative Group. The relation between acute persisting spinal paralysis and poliomyelitis vaccine: results of a ten-year enquiry. Bulletin of the World Health Organization 1982;60:231-242.

Wiechers DO. New concepts of the reinnervated motor unit revealed by vaccine-associated poliomyelitis. Muscle and Nerve 1988;11:356-364.

Wiechers DO. Reinnervation after acute poliomyelitis. Birth Defects 1987;23:213-221.

Wiersbitzky S, Bruns R. [Bacterial meningitis following Hib-vaccination: a causal connection?] Meningitis purulenta nach Hib-Schutzimpfung: Kausaler zusammenhang? Kinderarztliche Praxis 1992;60:27.

Wiersbitzky S, Bruns R. [Hib vaccinations and complications?] Schwere Gastroenteritis nach Hib-Schutzimpfung? Kinderarztliche Praxis 1992;60:102.

Wiersbitzky S, Bruns R. Safety of vaccines in childhood. Lancet 1993;341:379.

Wiersbitzky S, Bruns R, Beyer B. [Incubation vaccination (''postexposure vaccination'') with MMR vaccine during a mumps epidemic? The Pediatric Vaccine Counseling Unit] Inkubationsimpfung ("Riegelungsimpfung") mit MMR-Vakzine wahrend einer Mumpsepidemie? Die padiatrische Impfberatungsstelle. Kinderarztliche Praxis 1992;60:207-208.

Wiersbitzky S, Bruns R, Griefahn B, Wiersbitzky H. [Near-miss sudden infant death (nearly sudden infant death syndrome/NSIDS) following second DPT vaccination?] Beinahe plotzlicher Kindstod (Nearly Sudden Infant Death Syndrome/NSIDS) nach der 2. DPT-Impfung? Kinderarztliche Praxis 1992;60:246-248.

Wiersbitzky S, Bruns R, Peters A, Mentel R. [Encephalitis, meningitis serosa and parotitis

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

after MMR preventive vaccination? The Pediatric Vaccination Counseling Unit] Enzephalitis, Meningitis serosa und Parotitis nach MMR-Schutzimpfung? Die padiatrische Impfberatungsstelle

. Kinderarztliche Praxis 1992;60:203-205.

Wiersbitzky S, Bruns R, Schroder C, Warmuth M. [Thrombocytopenic purpura following immunization with a live vaccine (mumps-measles-rubella vaccination)?] Thrombozytopenische Purpura nach Impfung mit Lebendvakzine (Mumps-Masern-Roteln-Schutzimpfung)? Kinderarztliche Praxis 1992;60:28-29.

Wiersbitzky S, Bruns R, Wiersbitzky H. [Hyperpyretic reaction following combined vaccination DPT, Hib and oral polio in an infant] Hyperpyretische Reaktion nach kombinierter Hib-, DPT- und oraler Polio-Schutzimpfung bei einem Saugling? Kinderarztliche Praxis 1992;60:304-305.

Wiesmann E, Keller HP, Steiner P. [Diphtheria vaccination of adults] Die Diphtherieimpfung Erwachsener. Schweizerische Medizinische Wochenschrift 1972;102:41-43.

Wiggins CA, Dykewicz MS, Patterson R. Idiopathic anaphylaxis: a review. Annals of Allergy 1989;62:1-4.

Wilfert CM. Epidemiology of Haemophilus influenzae type b infections. Pediatrics 1990;85(4 Pt 2):631-635.

Wilhelm DJ, Paegle RD. Thrombocytopenic purpura and pneumonia following measles vaccination. American Journal of Diseases of Children 1967;113:534-537.

Wilkinson JR. Measles immunization: contraindications perceived by general practitioners in one health district. Public Health 1986;100:144-148.

Williamson S. Anti-vaccination leagues. Archives of Disease in Childhood 1984 ;59:1195-1196.

Willinger M, James LS, Catz C et al. Defining the sudden infant death syndrome (SIDS): deliberations of an expert panel convened by the National Institute of Child Health and Human Development. Pediatric Pathology 1991;11:677-684.

Wilson GS. The Hazards of Immunization. London and New York: Oxford University Press (Athlone); 1967.

Wilson J, Robinson R. Poliomyelitis after contact with recently vaccinated infant (letter). British Medical Journal 1974;2:53.

Wilson LM. Some aspects of epidemiology in paediatric oncology. Proceedings of the Royal Society of Medicine 1975;68:657-659.

Wilson S, Aprile MA. Sensitizing versus immunizing properties of inactivated measles vaccine. Progress in Immunobiological Standardization 1970;4:657-660.

Winer JB, Hughes RA, Anderson MJ, Jones DM, Kangro J, Watkins RP. A prospective study of acute idiopathic neuropathy. II. Antecedent events. Journal of Neurology, Neurosurgery and Psychiatry 1988;51:613-618.

Winner SJ, Evans G. Age-specific incidence of Guillain-Barre syndrome in Oxfordshire. Quarterly Journal of Medicine 1990;77(New Series):1297-1304.

Wolters KL, Dehmel H. Abschliessende untersuchungen uber die Tetanus Prophylaxe durch active Immunisierung. Zeitschrift fur Hygeitschrift 1942;124:326-332.

Wong S, Dykewicz MS, Patterson R. Idiopathic anaphylaxis: a clinical summary of 175 patients. Archives of Internal Medicine 1974;150:1323-1328.

Wong VC, Ip HM, Reesink HW. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis B vaccine and hepatitis B immunoglobulin: double-blind randomised placebo-controlled study. Lancet 1984;1:921-926.

Wong WK, Tan C, Ng SK, Goh CL. Thimerosal allergy and its relevance in Singapore. Contact Dermatitis 1992;26:195-196.

Woods DR, Mason DD. Six areas lead national early immunization drive. Public Health Reports 1992;107:252-256.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Woolling KR, Ruston JG. Serum neuritis: report of two cases and brief review of the syndrome. Archives of Neurology and Psychiatry 1950;64:568-573.

World Health Organization. Measles Vaccines, Technical Report No. 263. World Health Organization: Geneva; 1963.

WRC-TV. DPT: Vaccine Roulette. Washington DC: WRC-TV, 1982.

Wright PF, Hatch MH, Kasselberg AG, Lowry SP, Wadlington WB, Karzon DT. Vaccine-associated poliomyelitis in a child with sex-linked agammaglobulinemia. Journal of Pediatrics 1977;91:408-412.

Wright PF, Kim-Farley RJ, de Quadros CA, Robertson SE, Scott RM, Ward NA et al. Strategies for the global eradication of poliomyelitis by the year 2000. New England Journal of Medicine 1991;325:1774-1779.

Wutzler P, Sprossig M, Schneider J et al. [A complication after oral protective immunization against poliomyelitis] Komplikation nach oraler Poliomyelitis-Schutzimpfung. Padiatrie und Grenzgebiete 1984;23:289-297.

Wyatt G. Planning an immunization schedule. Practitioner 1992;236:479-480, 482.

Wyatt HV. Poliomyelitis in hypogammaglobulinemics. Journal of Infectious Diseases 1973;128:802-806.

Wyatt HV. Provocation poliomyelitis: neglected clinical observations from 1914 to 1950. Bulletin of the History of Medicine 1981;55:543-557.

Wyatt HV. Did thalidomide promote poliomyelitis following oral poliovirus vaccination in West Berlin in 1960? Perspectives in Biology and Medicine 1983;27:93-106.

Wyatt HV. Injections cripple, injections kill (letter). Journal of the Indian Medical Association 1986;84:193-194.

Wyatt HV. Injections and poliomyelitis: what are the risks of vaccine associated paralysis? Developments in Biological Standardization 1986;65:123-128.

Wyatt HV. Poliovaccination in the Gambia (letter). Lancet 1987;2:43.

Wyatt HV. Incubation of poliomyelitis as calculated from the time of entry into the central nervous system via the peripheral nerve pathways. Reviews of Infectious Diseases 1990;12:547-556.

Wyatt HV. Provocation paralysis (letter). Lancet 1993;341:61-62.

Xu ZY, Margolis HS. Determinants of hepatitis B vaccine efficacy and implications for vaccination strategies. Viral Hepatitis in China: Problems and Control Strategies. Monographs in Virology 1992;19:87-98.


Yamada A, Takeuchi K, Tanabayashi K, Hishiyama M, Takahashi Y, Sugiura A. Differentiation of the mumps vaccine strains from the wild viruses by the nucleotide sequences of the P gene. Vaccine 1990;8:553-557.

Yamauchi T, Wilson C, St. Geme JW. Transmission of live, attenuated mumps virus to the human placenta. New England Journal of Medicine 1974;290:710-712.

Yanagi Y, Cubitt BA, Oldstone MB A. Measles virus inhibits mitogen-induced T cell proliferation but does not directly perturb the T cell activation process inside the cell. Virology 1992;187:280-289.

Yap I, Guan R, Chan SH. Recombinant DNA hepatitis B vaccine containing Pre-S components of the HBV coat protein—a preliminary study on immunogenicity. Vaccine 1992;10:439-442.

Yeoh EK, Chang WK, Ip P, Chan KH, Chan E, Fung C. Efficacy and safety of recombinant hepatitis B vaccine in infants born to HBsAg-positive mothers. Journal of Infection 1986;13(Suppl. A):15-18.

Yogev R, Arditi M, Chadwick EG, Amer MD, Sroka PA. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate): immunogenicity and safety at various doses. Pediatrics 1990;85(4 Pt 2):690-693.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×

Yohannan MD, Ramia S, al Frayh AR. Acute paralytic poliomyelitis presenting as Guillain-Barre syndrome. Journal of Infection 1991;22:129-133.

Yoon JW, Austin M, Onodera T, Notkins AL. Virus-induced diabetes mellitus. New England Journal of Medicine 1979;300:1173-1179.

Yoon JW, Eun HM, Essani K, Roncari DA, Bryan LE et al. Possible mechanisms in the pathogenesis of virus-induced diabetes mellitus. [Clinical and Investigative Medicine] Medecine Clinique et Experimentale 1987;10:450-456.

Yoon JW, Kim CJ, Pak CY, McArthur RG et al. Effects of environmental factors on the development of insulin-dependent diabetes mellitus. [Clinical and Investigative Medicine] Medecine Clinique et Experimentale 1987;10:457-469.

Yoon JW, Onodera T, Notkins AL. Virus-induced diabetes mellitus: XV. Beta cell damage and insulin-dependent hyperglycemia in mice infected with coxsackie virus B-4. Journal of Experimental Medicine 1978;148:1068-1080.

Yoon JW, Ray UR et al. Perspectives on the role of viruses in insulin-dependent diabetes. Diabetes Care 1985;8(Suppl. 1):39-44.

Yu DT, Winchester RJ, Fu SM, Gibofsky A, Ko HS, Kunkel HG. Peripheral blood Ia-positive T cells: increases in certain diseases and after immunization. Journal of Experimental Medicine 1980;151:91-100.

Yunginger JW. Anaphylaxis. Current Problems in Pediatrics 1992;22:130-147.

Zajac BA, West DJ, McAleer WJ, Scolnick EM. Overview of clinical studies with hepatitis B vaccine made by recombinant DNA. Journal of Infection 1986;13(Suppl. A):39-45.

Zaloga GP, Chernow B. Life-threatening anaphylactic reaction to tetanus toxoid. Annals of Allergy 1982;49:107-108.

Zevakov VF, Semak SY, Titarenko VI, Andreichenko NV, Gedzul OV. Poliomyelitis viruses in the etiology of aseptic meningitides in Odessa, 1979-1983. Voprosy Virusologii 1987;32:458-464.

Zieger B, Basener G, Berdrow J et al. [Vaccinations and complications after vaccination in travellers] Impfungen und Impfkomplikationen bei Auslandsreisenden. Deutsche Gesundheitswesen 1976;31:1956-1958.

Zilber N, Rannon L, Alter M, Kahana E. Measles, measles vaccination, and risk of subacute sclerosing panencephalitis (SSPE). Neurology 1983;33:1558-1564.

Zimmerman B, Gold R, Lavi S. Adverse effects of immunization: is prevention possible? Postgraduate Medicine 1987;82:225-229, 232.

Zimmerman RK, Giebink GS. Childhood immunizations: a practical approach for clinicians. American Family Physician 1992;45:1759-1772.

Zingher A, Park HW. Immunity results obtained in school children with diphtheria toxoid (modified toxin) with 1/10 L+ mixtures of toxin-antitoxin. Proceedings of the Society for Experimental Biology and Medicine 1923;21:383-385.

Zoltowska A. Immunomorphologic patterns in intensively immunized guinea pigs. Archivum Immunologiae et Therapiae Experimentalis 1971;19:417-429.

Zoltowska A. Sarcoidal reactions in animals intensively immunized with tetanus vaccine. Archivum Immunologiae et Therapiae Experimentalis 1974;22:341-347.

Zwemer R, Hodge S, Owen LG, Fliegelman MT. Persistent toxic erythema and chronic urticaria: possible association with the use of measles virus vaccine. Archives of Dermatology 1971;104:390-392.

Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 348
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 349
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 350
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 351
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 352
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 353
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 354
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 355
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 356
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 357
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 358
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 359
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 360
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 361
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 362
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 363
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 364
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 365
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 366
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 367
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 368
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 369
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 370
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 371
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 372
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 373
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 374
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 375
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 376
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 377
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 378
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 379
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 380
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 381
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 382
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 383
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 384
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 385
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 386
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 387
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 388
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 389
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 390
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 391
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 392
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 393
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 394
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 395
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 396
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 397
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 398
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 399
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 400
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 401
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 402
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 403
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 404
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 405
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 406
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 407
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 408
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 409
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 410
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 411
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 412
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 413
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 414
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 415
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 416
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 417
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 418
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 419
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 420
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 421
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 422
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 423
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 424
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 425
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 426
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 427
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 428
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 429
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 430
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 431
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 432
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 433
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 434
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 435
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 436
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 437
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 438
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 439
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 440
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 441
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 442
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 443
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 444
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 445
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 446
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 447
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 448
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 449
Suggested Citation:"Bibliography." Institute of Medicine. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: The National Academies Press. doi: 10.17226/2138.
×
Page 450
Next: Index »
Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality Get This Book
×
Buy Paperback | $120.00
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Childhood immunization is one of the major public health measures of the 20th century and is now receiving special attention from the Clinton administration. At the same time, some parents and health professionals are questioning the safety of vaccines because of the occurrence of rare adverse events after immunization.

This volume provides the most thorough literature review available about links between common childhood vaccines--tetanus, diphtheria, measles, mumps, polio, Haemophilus influenzae b, and hepatitis B--and specific types of disorders or death.

The authors discuss approaches to evidence and causality and examine the consequences--neurologic and immunologic disorders and death--linked with immunization. Discussion also includes background information on the development of the vaccines and details about the case reports, clinical trials, and other evidence associating each vaccine with specific disorders.

This comprehensive volume will be an important resource to anyone concerned about the immunization controversy: public health officials, pediatricians, attorneys, researchers, and parents.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!